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Summary 
Barrett's oesophagus (BO) arises from chronic gastro-oesophageal reflux disease 
(GORD). Patients have an increased risk of adenocarcinoma (ADC), which is the 
sixth most common cause of cancer mortality in the UK. All ADC develop from BO, 
and over the last twenty years there has been a marked increase in both conditions. 
The reasons for this are not known, however, as with some forms of gastric cancer, it 
is possible that there may be a bacterial aetiology. This study employed both culture-
based and molecular techniques to characterise microbial communities colonising 
the distal oesophageal mucosae in individuals with GORD, BO and ADC, together 
with healthy controls. Furthermore, in vitro models were designed to create an oral 
microbiota, from which an oesophageal community could develop.  
 
Microbial analysis identified a shift in oesophageal population composition with 
disease progression, with an incremental increase in total eubacterial scores related 
to the metaplasia-dysplasia sequence. Additionally, an increased proportion of Gram 
negative species and potentially pathogenic organisms, such as Peptostreptococcus 
were identified. Campylobacter spp. were isolated from 75%, 50% and 60% of 
GORD, BO and ADC patients, respectively, compared with 20% of controls. 
Helicobacter pylori, which has been proposed to be protective in oesophageal 
disease, was significantly reduced in disease, especially in ADC patients. In vitro 
models were successful, with a simple oral microbiota leading to the development of 
unique, varied oesophageal populations representative of those found in vivo. 
Additionally, after exposure of this community to bile acid, population dynamics 
were altered, with an increase in Gram negative species, associated with a rise in 
haemolytic and mucinolytic activities. Exposure of oesophageal cell lines to these 
 	  
 
xxi	  
stressed biofilms resulted in increased cell death, and in some cases, amplified 
expression of p53 and COX-2.  
 
In conclusion, this research proved an association between bacterial composition and 
oesophageal disease. With progression to adenocarcinoma, the community becomes 
increasingly diversified and Gram negative in character, and therefore, is proposed to 
be more pathogenic. Further research is required to investigate causal relationships, 
through which mechanisms for disease initiation and/or maintenance can be 
understood.  	  
 
  
 
 
 
Chapter 1 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
2 
1.1 Introduction 
Barrett's oesophagus (BO) is an acquired metaplastic change occurring after 
prolonged exposure of the lower oesophageal epithelium to refluxate due to gastro-
oesophageal reflux disease (GORD).  
 
In the United States, 20% of the population suffer from GORD, having the highest 
direct annual costs for healthcare compared to any other gastrointestinal disorder 
(Locke et al., 1997; Sandler et al., 2002). Between 5 and 12% of patients undergoing 
endoscopy for GORD will be diagnosed with BO (Falk, 2002), and 5-10% of BO 
patients will go on to develop adenocarcinoma, at a risk of 0.5% per year (Blot et al., 
1991; Shaheen et al., 2000; Solaymani-Dodaran et al., 2003). Therefore, much of the 
research in this area has been concerned with factors that lead to GORD, and how 
the condition may be prevented.  
 
The British Society of Gastroenterology has used a definition reviewed by a number 
of specialists in this area; an appropriate diagnosis views BO as “an oesophagus in 
which any portion of the normal squamous lining has been replaced by a metaplastic 
columnar epithelium which is visible macroscopically” (Watson et al., 2005).  
 
In 2010, Cancer Research UK stated that cancer of the oesophagus was the ninth 
most prevalent cancer in the UK, a dramatic increase after formally being the 
twentieth. However, in men it is the sixth most prevalent cancer, with 5,000 new 
diagnoses per year (CRUK, 2010). In June 2006, the Scottish Intercollegiate 
Guidelines Network (SIGN, 2006) published new data showing that collectively, 
gastric and oesophageal cancers account for 6.5% of newly diagnosed cancer cases, 
   
3 
with particular problems in Scotland, and specifically, Tayside (SIGN, 2006). Of 
greater concern, 5% of cancer deaths are due to oesophageal cancer, being the sixth 
most common cause of cancer death in the UK (CRUK, 2010).  
 
The majority of BO-associated adenocarcinomas are detected at an incurable, 
advanced stage of disease; therefore, the development of new treatments is urgently 
required. Studies show that patients in a proper surveillance regime have 
significantly increased survival rates upon detection, possibly due to their increased 
suitability for oesophageal resection (Fitzgerald et al., 2001). 
 
1.2 Barrett’s oesophagus and cancer 
1.2.1 Anatomy and physiology of the upper GI tract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1: Endoscopy image of the oesophagus, showing the oesophagogastric 
junction (this study). 
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The oesophagus is the canal leading from the mouth to the stomach (Fig. 1.1). This 
structure is on average 23 cm in length, and facilitates the passage of food and 
liquids into the upper gut. The oesophagus has three layers: muscular, cellular and 
mucosal. The muscles of the upper part of the tube are striated fibres, which allow 
for the voluntary action of swallowing, whereas lower oesophageal muscles are 
smooth and involuntary. Waves of contraction of these two muscle types cause 
peristaltic movement for the swallowing of food bolus. Small papillae coat the 
surface of the mucus layer, which covers a thick epithelium of stratified squamous 
cells (Fig. 1.2A). Glands are also present throughout the oesophagus in the 
submucosa. These produce mucus, providing lubrication for food bolus movement, 
and protection against abrasion. The oesophagogastric junction has an opening, or 
sphincter, which links the oesophagus to the stomach. The epithelial lining changes 
abruptly from a stratified squamous morphotype in the oesophagus to glandular 
tissue, as seen in Fig. 1.2B. The change in epithelial cell type occurs up to 2 cm back 
from the junction, and is called the squamo-columnar junction, or Z-line. The 
junction prevents reflux of acidic gastric contents back into the oesophagus due to 
pressure maintained between the stomach and oesophagus (Pettersson et al., 1980).  
 
A B 
 
Fig. 1.2: Histological images of the oesophagus. A: stratified squamous epithelium from the 
oesophagus, B: glandular epithelium of the oesophagogastric junction. 
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1.2.2 Definition and history of BO 
Barrett’s oesophagus was first noted at the beginning of the last century (Tileston, 
1906), where development of a columnar lined oesophagus was observed. Over the 
following 70 years, many papers were published describing the cellular morphology 
and hypothesising the causes of this condition. Dr Norman Barrett, a Consultant 
Surgeon at St. Thomas’s Hospital in London initiated discussions, which would lead 
to the correct definition of this condition. He incorrectly described two separate 
conditions, which were later redefined by Allison and Johnstone (1953). Barrett had 
made two hypotheses, one describing the columnar lined oesophagus to be stomach 
lining drawn up into a congenitally short oesophagus, while the second proposed that 
the oesophageal lining had been abnormally altered by metaplasia (Barrett, 1950). 
Allison quickly published a paper positing his latter description to be correct 
(Allison, 1951). Since then a series of publications have refined this definition. 
Bosher’s research described a patient with reflux oesophagitis whose mucosa 
contained goblet cells, more like those of the intestine, dismissing theories that this 
abnormal oesophageal lining could be from the stomach (Bosher and Taylor, 1951). 
Subsequently, Barrett published a small paper concurring with Allison, stating BO 
was not due to a congenitally short oesophagus (Barrett, 1957). A later study 
proposed the condition to be due to oesophagitis (Moersch et al., 1959), which was 
verified in a study confirming the relationship between gastro-oesophageal reflux 
and metaplastic columnar lined oesophagus (CLO) (Hayward, 1961). Hayward also 
defined the oesophagogastric junction (OGJ) to be the end point of the oesophagus 
where it meets the stomach, noting columnar shaped cells to line 1-2 cm above and 
below this junction. Hayward also disproved Barrett’s congenitally short oesophagus 
theory, stating that no babies had been found with this condition; therefore, it could 
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not be termed as congenital. However, confusion over this condition continued 
throughout the 1970s, until a large research study investigating biopsy tissue found 
three different types of Barrett’s mucosa, mainly of intestinal origin (Paull et al., 
1976). Paull and co-workers recruited 11 patients, taking 112 biopsies from the 
oesophageal mucosa, and 39 from the gastric mucosa. Their research revealed 
varying clinical and histological features, including hiatal hernias, and three types of 
mucosa: functional, gastric and a specialised columnar similar to intestinal mucosa. 
This groups histological studies found no parietal cells in the CLO, but villiform 
folds and goblet cells representative of intestinal lining. The study affirmed the now 
accepted view of BO, or columnar lined oesophagus, being due to metasplasia after 
long-term reflux.  
 
1.2.3 What is adenocarcinoma? 
Cancer is the common term for a malignant neoplasm and accounts for 13% of all 
deaths, with 7.9 million deaths being due to this condition in 2007 (WHO, 2010). 
Carcinogens such as those in tobacco smoke, radiation, chemicals and infectious 
agents can initiate cancer. However, familial trends exist in many cancers, with 
genetic defects and mutations being inherited. A changed growth pattern may 
preside, resulting in overgrowth due to uncontrolled cell division. These tumour cells 
may invade adjacent cells and spread (metastasis).  
 
Neoplasia, the abnormal proliferation of cells, facilitates subversion of the normal 
function of a cell, allowing clonal expansion to form a tumour. Cancer has a genetic 
basis, with functional errors relating to oncogenes (Huebner and Todaro, 1969) and 
tumour suppressor genes. Oncogenes destabilise controlled division, apoptotic 
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events and cell differentiation, conversely, tumour suppressor genes are anti-
oncogenes; their related proteins are involved in cell cycle and apoptosis regulation. 
Epigenetics and genetics both play individual roles in cancer development; the latter 
includes changes in DNA sequence due to mutations and chromosomal 
rearrangements. Conversely, epigenetics involves DNA methylation and histone 
acetylation (Sharma et al., 2010). Toxins or infectious agents generally cause 
epigenetic modifications, and it is thought they can be reversed after removal of 
these factors, and by treatment with enzyme inhibitors of methylation (Hussain and 
Harris, 2007). Of all epigenetic mechanisms, DNA methylation has been most 
extensively studied. This involves the addition of a methyl group to a cytosine ring 
of a CpG (cytosine-guanine with phosphodiester bond) dinucleotide. CpG 
dinucleotides are not evenly distributed along a genome, they are usually found 
gathered at the 5’ end of a gene, and are termed “CpG islands” (Bird, 1986). These 
islands range in size from 400 to 4000 bp, and generally have a GC content of >55%, 
five-fold higher than usual bulk DNA (Takai and Jones, 2002). The University of 
California Santa Cruz Genome Bioinformatics Site has identified approximately 
27,800 CpG islands in the human genome, with approximately 60% of genes 
containing these elements (Sato and Meltzer, 2006).  
 
Epigenetic changes in gastric cancer 
In gastric cancer, the frequency of aberrant CpG methylation is very high, with the 
number of methylated genes increasing significantly as disease progresses from 
gastritis to cancer along the metaplasia-dysplasia route (Kang et al., 2003). 
Helicobacter pylori infection is the main aetiologic agent in gastric cancer, and its 
association with gastric epithelia results in changes in cytokine expression, and the 
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production of reactive oxygen species (ROS) and nitric oxide (NO) (Nardone and 
Compare, 2008). These factors are major causes of DNA methylation; therefore, it is 
believed that removal of H. pylori could reverse these epigenetic modifications. 
 
The epithelial cell adhesin E-cadherin is a known factor in tumorigenesis, and in the 
invasiveness of cancer cells. A recent study by Chan and colleagues investigated the 
methylation status of E-cadherin in H. pylori positive and negative gastric cancer 
patients. Results showed that after eradication of this species, methylated E-cadherin 
was reduced, and the un-methylated form increased. Patients with persistent 
infection continued to have methylated protein, with two patients presenting with 
intestinal metaplasia. This research signifies the need for a fast response to this 
infection, because removal of these organisms could resolve epigenetic alterations 
and divert cancer progression (Chan et al., 2006). 
 
Table 1.1 identifies the main hypermethylated genes associated with gastric cancer, 
BO and adenocarcinoma of the oesophagus. Adapted from Sato and Meltzer, 2006. 
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Table 1.1: Hypermethylated genes in gastric and oesophageal carcinogenesis a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Constructed from Sato and Meltzer (2006), review of DNA hypermethylation in gastric carcinoma 
(GC), Barrett’s oesophagus (BO) and oesophageal adenocarcinoma (ADC). 
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Lessons learned for oesophageal adenocarcinoma 
Two types of oesophageal cancer exist, adenocarcinoma and squamous cell 
carcinoma. The incidence of adenocarcinoma has been increasing rapidly over the 
last three decades, especially in the Western world. In the UK, the prevalence of 
adenocarcinoma is now almost 50% of all oesophageal cancers (Watson, 2000). 
Squamous cell carcinomas are found in the upper third and middle oesophagus, 
originating in the epithelial lining, and are associated with alcohol intake and 
smoking damage (Ribeiro et al., 2005). Adenocarcinoma is prevalent in the lower 
third of the oesophagus, originating in gland cells of the mucous lining, developing 
from Barrett’s oesophagus as the result of acid reflux. 
 
Gastric cancer is a good model on which to base our current perception of 
oesophageal adenocarcinoma. It is a cancer of the upper GI tract, with a progressive 
lineage from inflammation (gastritis, GORD), to intestinal metaplasia, leading to 
neoplasia and adenocarcinoma. As discussed in the previous section, epigenetic 
modifications of the genome are involved in gastric cancer, with similar findings in 
oesophageal ADC. The presentation of acidic stomach contents to the oesophageal 
mucosa results in oxidative stress, inducing the development of metaplasia (BO) and 
dysplasia. The protective enzymes peroxidase and glutathione S-transferases are 
mechanisms of defence against oxidative stress from ROS and NO, however, a study 
of 159 patient samples (normal, BO and ADC) found that these enzymes genes were 
silenced due to hypermethylation at their transcriptional start sites in diseased 
patients (Peng et al., 2009). Figure 1.3 shows the changes involved in 
adenocarcinoma development.  
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Fig. 1.3: Progression of events resulting in oesophageal adenocarcinoma. Adapted from 
Manjunath and Jankowski (2000). 
 
1.2.4 Aetiology of GORD and BO 
In comparison to the healthy oesophagus, the disease state associated with BO 
results from changes in the normal tissue function, and BO is a complication of 
gastro-oesophageal reflux. Prolonged reflux disease results in oesophagitis, where 
the oesophageal lining becomes inflamed, with peptic strictures. The prime suspects 
in oesophagitis development are the contents of refluxate washed up from the 
stomach, particularly gastric acid and bile salts. A defective lower oesophageal 
sphincter allows entry of gastric juices into the oesophagus. This can occur due to 
hiatal hernias, increased abdominal pressure, or as the result of obesity. 
 
The lower oesophageal sphincter (LOS) 
When LOS resistance is lost due to gastric distension, either permanently or 
transiently, reflux can occur. This usually occurs after a meal, and can happen in 
normal patients without GORD. However, if reflux persists, the mucosa becomes 
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inflamed resulting in peptic strictures, being described as reflux oesophagitis. The 
first publication detailing the process of GORD used newly developed X-ray 
equipment to study regurgitation in a cat (Cannon, 1911). In 1956, Fyke’s group 
used oesophageal manometry to measure muscle pressure in the healthy oesophagus, 
demonstrating an intra-luminal high-pressure zone interposed between the 
oesophagus and stomach in humans, which is upheld by muscles of the distal 
oesophagus (Code et al., 1956). In a healthy oesophagus, the OGJ acts as a barrier 
between the acidic stomach contents and the oesophagus. The LOS was also studied 
with standard manometry, with data from normal subjects being compared to those 
of 272 GORD patients (Zaninotto et al., 1988). Results indicated that if the gastro-
oesophageal sphincter relaxes and opens inappropriately it allows the backflow of 
stomach contents into the oesophagus, resulting in mucosal damage. Another 
patient-based study examined 322 patients with 24 hour oesophageal pH monitoring 
for exposure to gastric juices, and verified a defective LOS as a factor in the 
occurrence of GORD (Stein et al., 1992). This group described a defective LOS with 
particular characteristics: less than 2 cm average length, and an average resting 
pressure of less than 6 mm Hg. The work showed two specific correlations: both 
defective LOS, and percentage time at pH less than 4, increased proportionally with 
mucosal injury.  
 
Obesity and increased LOS pressure 
As discussed previously, the incidence of adenocarcinoma has increased greatly in 
the last two decades, together with GORD and BO, which parallels the severe 
increase seen in obesity in western populations (Devesa et al., 1998). A National 
Health and Nutrition Examination Survey (NHANES) in the US, comprising adults 
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aged 20-74 years, showed an increased prevalence of obesity (BMI >30) from 15% - 
32.9% from 1976-2004 (Flegal et al., 1998, 2002; Ogden et al., 2006).  
 
Obesity increases abdominal pressure (Barak et al., 2002) along with other 
physiological changes which would cause reflux, such as reduced LOS pressure, 
increased frequency of sphincter relaxation and impaired gastric emptying (Hampel 
et al., 2005). The relationship between GORD and obesity appears to involve an 
increased gastro-oesophageal sphincter pressure gradient between this structure and 
the stomach (Mercer et al., 1987), intra-abdominal pressure (El-Serag et al., 2006) 
and hiatal hernia (Pandolfino et al., 2006). A study of 1224 patients undergoing an 
upper endoscopy, showed these obese patients were more likely to have a hiatal 
hernia and oesophagitis compared with lean individuals (Berstad, 1988). 
Additionally, impaired gall bladder and pancreatic function is more common in 
obese patients, resulting in an altered enzymatic composition. Wisen et al. (1988) 
found that output levels of pancreatic enzymes and bile were higher in the obese. If 
obesity is a risk factor for developing GORD, then diet must also be implicated. 
Many studies have shown that a decrease in fruit, vegetables, vitamins and fibre 
intake, accompanied by an increase in fat, will substantially increase the possibility 
of developing ADC due to GORD (Veuglers et al., 2006).  
 
Hiatal hernia 
Proposals for the involvement of hiatal hernias (Fig. 1.4) in GORD have also been 
explored (Allison, 1951) separate to obesity. There involvement is due to a distortion 
in oesophageal anatomy, which impairs normal peristalsis.  
   
14 
 
Fig. 1.4: Endoscopic image of a hiatal hernia (this study). 
 
A patient study showed those with large hiatal hernia (HH) to have weaker and 
shorter LOS, compared to those with a small or no hernia (Patti et al., 1996). A 
subsequent investigation scrutinised 375 patients with pH monitoring (Fein et al., 
1999). These investigators recruited patients with hiatal hernias, a defective LOS or 
both, into the study. Results showed that each factor seemed to be associated with 
GORD and its progression, and that collectively, the effects were intensified. Two 
recent patient studies reported that 63% of those with GORD-related BO had hiatal 
hernias (Westhoff et al., 2005), while those with longer segments of BO had a larger 
HH (Dickman et al., 2005).  
 
Stomach acids and bile salts 
In 1884, Reichman lowered a sponge into the oesophagus of a patient with heartburn 
and detected acid on its retrieval, postulating that gastric acid was involved in 
oesophagitis (Bennet, 1987). Most studies have emphasised that acid from the 
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stomach is mainly responsible for inflammation, and although bile is also implicated, 
these investigations were limited due to the lack of suitable experimental 
methodologies (Nehra et al., 1999). However, a new monitoring system for bilirubin 
was developed in the late 1990s, and Oh et al. (2006) employed this method to 
evaluate gastric acid and bilirubin exposure to the oesophagus over a 24 hour period. 
Their study showed that the combination of gastric acid and bile produced more 
severe mucosal injury than acid alone.  
 
Recurrent or continuous reflux of acidic gastric contents results in chronic mucosal 
damage of the lower oesophagus, which leads to a protective metaplastic alteration 
to the epithelial lining. These columnar cells are more resistant to acidic conditions, 
and are representative of BO. 
 
1.2.5 Pathophysiology of oesophageal disease  
Reflux disease: NERD and GORD 
A common misconception is that reflux (heartburn) and GORD are the same, 
however, they are two separate conditions. Reflux can nevertheless result in GORD, 
where erosion of the mucosa causes lesions in the oesophageal lining, while in some 
cases there is no obvious erosion, as in non-erosive reflux disease (NERD). GORD is 
considered a predisposing condition for ADC, due to its induction of BO, and is one 
of the most common conditions in the USA, leading to symptoms in 40% of the 
population every month (7% per week) (Gallup Organisation 1988; Moayyedi and 
Axon, 2005). 
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Regurgitation of gastric contents may also manifest as pulmonary disease (Peters et 
al., 1998; Jailwala and Shaker, 2000; D’Urzo and Jugovic, 2002), dental erosions 
(Jailwala and Shaker, 2000), reflux laryngitis (Catalano et al., 2004), or non-cardiac 
chest pain (Davies et al., 1985; Richter et al., 1989; Eslick et al., 2003). The latter is 
generally known as heartburn; however, its medical name is pyrosis, which is the 
most common symptom of reflux disease. Of patients presenting with reflux disease, 
it is approximated that 70% have NERD or endoscopically negative reflux disease 
(Martinez et al., 2003). These patients are less likely to respond to standard anti-
reflux therapy, possibly because the majority have normal ambulatory 24 hour pH 
tests. A study by Shi et al. (1995) reported on 771 patients who underwent 24 hour 
pH monitoring due to GORD symptoms, non-cardiac chest pain or both. Endoscopy 
allowed histological analysis of the oesophagus, and BO patients were excluded. 
This study showed that patients with a normal oesophagus and normal acid exposure 
could still have simultaneous reflux symptoms, although these were frequently 
related to a longer exposure with pH <4. These patients may have an ‘acid-
hypersensitive oesophagus’, since many patients with GORD and oesophagitis had 
symptom-free episodes. Therefore, NERD patients could benefit from treatments 
that reduce oesophageal sensitivity (Marrero et al., 1994), rather than reducing acid 
secretion. 
 
Barrett’s oesophagus and adenocarcinoma 
Prolonged exposure of normal oesophageal squamous cells above the OGJ to gastro-
duodenal refluxate can result in inflammation of the mucosa. These injured mucosal 
squamous cells undergo repair, and in a number of cases, are replaced by columnar 
epithelium, which are better able to withstand the low pH environment (Spechler, 
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2002). Biopsies taken from BO mucosae (Fig. 1.5) in the past were confused with 
gastric cells due to their columnar appearance. However, histologists can now 
distinguish tissue of oesophageal origin, due to the presence of glands and crypts 
situated in the mucosa representative of intestinal mucosa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.5: Endoscopic image of intestinal metaplasia 
from a patient with BO (this study). 
 
It is logical to conclude that as GORD symptoms and duration increase, Barrett’s 
severity would also increase proportionately. However, this does not seem to be the 
case, with the length of BO segment being typically established in only a few months 
(Cameron and Lomboy, 1992).  
 
If oesophageal cells continue to differentiate and proliferate, becoming more 
irregular and disorganised (dysplasia), tumours may develop resulting in 
adenocarcinoma of the oesophagus (Fig. 1.6) (Nandurkar and Talley, 2000) and 
ultimately death. This connection was first postulated in the early 1950s (Carrie, 
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1950; Bosher and Taylor, 1951; Morson and Belcher, 1952), due to the strong 
interest in BO and its connections to reflux. Morson and Belcher (1952) prepared a 
case report on a single patient with dysphagia (difficulty swallowing), taking 
biopsies from an ulcerated lesion found during gastro-oesophageal endoscopy. There 
were no other abnormalities in the lower oesophagus or gastric tissue, however, 
histology showed the lesion to be of intestinal origin, with many goblet cells, chronic 
inflammation and atrophy, that is, Barrett’s oesophagus.  
 
As with BO, many publications then appeared with studies looking at biopsies 
associating BO to adenocarcinoma (Adler, 1963; Hawe et al., 1973; Haggitt et al., 
1978). In 1987, Reid posited intestinal metaplasia to predispose for tumour 
development (Reid and Weinstein, 1987), and it was subsequently confirmed that 
this intestinal metaplasia was the most common and clinically important with respect 
to BO leading to ADC (Spechler, 1994).  
 
 
Fig. 1.6: Endoscopic image of a cancerous lesion from a patient with oesophageal 
adenocarcinoma (this study). 
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1.2.6 Clinical investigations  
Upper gastrointestinal endoscopies allow visualisation of the oesophagus with pinch 
samples (biopsies) taken for histology and research purposes. The documented 
increase in BO and ADC prevalence is alarming, however, whether this is a true 
increase, or is due to increased endoscopy investigations is unclear. In Tayside, 
where the incidence of GORD and BO is the highest in Scotland, upper GI 
endoscopies increased by 168% between 1980 and 1995, with newly diagnosed 
oesophagitis rising by 117% (a decrease of 18% per 1000 procedures), and Barrett’s 
by 4533% (Todd et al., 2002). Studies by Conio et al. (2001) and Irani et al. (2005) 
showed a correlation between increased incidence and endoscopy use, whereas 
conflicting data from Prach et al. (1997) and van Soest et al. (2005) illustrate an 
independent increase in incidence. A 1996-2002 study by Musana et al. (2008) 
considered only histologically confirmed BO, and found a prevalence of 0.26% in a 
rural, non-referral population from Wisconsin. They also found that the prevalence 
rate increased with age, with a higher incidence in men. Over this seven-year period, 
incidence rates for initial diagnosis remained constant, despite the increase in 
endoscopy procedures. With a definite increase in incidence of adenocarcinoma of 
the oesophagus, it seems likely that GORD and BO incidence is also rising, 
irrespective of improved screening, treatments and awareness.  
 
Surveillance systems for identifying BO patients progressing to dysplasia are time 
consuming and expensive with a low yield, because neoplastic progression occurs as 
little as once per 200 patient years (Shaheen et al., 2000). Therefore, an improved 
method for detecting “at risk” patients would be extremely beneficial, and much 
research into molecular biomarkers is currently underway. As discussed previously, 
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DNA methylation occurs early in the progression of BO to ADC, and therefore 
biomarkers for hypermethylation of specific genes could be effective in predicting 
neoplastic risk. Collaborative work by the Meltzer group at John Hopkins University 
has previously identified p16, RUNX3 and HPP1 hypermethylation in BO-associated 
ADC (Schulmann et al., 2005). Further studies by this group for specific gene 
methylation in 259 patients identified hypermethylation in five other genes, which 
led to a double-blinded validation study to measure the accuracy of these biomarkers 
in predicting neoplastic progression (Jin et al., 2009). Results showed that 
methylation values of HPP1, p16 and RUNX3 were higher in patients progressing to 
neoplasia compared with non-progressors, 50% of which would not have been 
diagnosed early without these biomarkers. This study model has the potential to 
reduce the number of endoscopic procedures needed, and increase the identification 
of “at risk” patients.  
 
1.2.7 Treatments 
Patients presenting with reflux symptoms are generally prescribed proton pump 
inhibitors (PPI), which reduce gastric acid secretion, thereby increasing pH. Studies 
have shown that these drugs reduce pain and can heal areas of oesophagitis (Katz 
and Zavala, 2010). No side effects have been confirmed to be directly associated 
with these drugs to date. However, bacterial overgrowth in the stomach due to 
increased pH may have delayed effects in diseases of the gastrointestinal tract and 
this needs to be further studied.  
 
Post-diagnosis of BO, treatments are directed at preventing progression of disease to 
ADC, and the neutralisation of GORD symptoms. Drastic measures such as 
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fundoplicative surgery to reduce reflux have been compared with medicative 
treatments, showing no reduction in rates of adenocarcinoma progression (Corey et 
al., 2003). PPI to prevent reflux do not shorten the length of existent BO (Sharma et 
al., 1997), although if used before BO development, can reduce reflux symptoms 
giving an increased prevalence of short segment BO (3.2 cm vs. 4.8 cm without PPI 
therapy) (El-Serag et al., 2004). The NSAID, rofecoxib, was administered to 12 
patients with BO and biopsies were taken before and after 10 days of therapy. After 
10 days, COX-2 expression, prostaglandin-E2 (PGE2) content and proliferating cell 
nuclear antigen (PCNA, a marker of cell proliferation) expression were reduced in 
BO tissue, indicating this drug could be used as therapy for ADC prevention along 
with acid-suppression (Kaur et al., 2002).  
 
In an animal study by Oyama et al. (2005), 120 rats underwent a surgical 
duodenoesophageal reflux procedure; half were given standard chow, while the 
others were given celecoxib (NSAID). The animals were sacrificied at 10, 20, 30 and 
40 weeks for real-time PCR analysis and immunohistochemistry of COX-2 
expression, and protein levels, respectively. In the control group, GORD, BO and 
ADC developed over time, compared with the treatment group, where incidence of 
oesophagitis was reduced or mild with no ADC found. No significant differences 
were observed for COX-2 expression between groups however, PGE2 and Ki-67 
(cell proliferation) were markedly reduced in the treatment group (P<0.05). These 
studies indicate a preferred role for NSAIDs/COX-2 inhibitors rather than PPI in 
preventing progression to BO and ADC if detected early, or used in conjunction, to 
reduce effects of reflux and minimize inflammation.  
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If disease is not caught early, ablation, argon plasma coagulation and photodynamic 
therapy are possibly the best treatments for high grade dysplasia, as these may be 
better tolerated than surgery and offer the chance of complete removal of dysplastic 
epithelia (Johnston, 2005). Although oesophagectomy offers the best possible 
success rates for obliteration of disease, the risks involved can be anywhere between 
3% and 15% dependent on care facilities and volume of oesophagectomies 
performed (Swisher et al., 2000). Additionally, ablation carries a risk of only 
removing surface epithelia while leaving metaplastic islands to develop below the 
healthy appearance of the mucosal cells, which can develop to ADC (Barham et al., 
1997). However, in patients with early stage cancer who are not good candidates for 
surgery, endoscopic resection, laser therapy and photodynamic therapy offer 
remission rates of 45-75% (Overholt et al., 1999; Ell et al., 2000; Van Laethem et 
al., 2001; Wolfsen et al., 2002).  
 
1.2.8 The immune response 
The intestinal mucosa and epithelium form a barrier to unwanted molecules and 
microorganisms, which is regulated by the innate and acquired immune system, and 
physical and chemical defences. Immune cells have an elaborately developed 
network of lymphoid tissue, with lymphocytes free in the mucosa and lymph nodes, 
and aggregated in follicles such as Peyer’s patches. Mucosal antibodies (secretory 
IgA) and T cells play a highly significant role in these mucosal defence mechanisms. 
Innate responses do not require a previous exposure to infection, involving the 
activation of toll-like receptors (TLR), a type of pathogen-associated molecular 
pattern (PAMP) (Akira et al., 2001). This initial line of defence results in induction 
of inflammatory mediators (cytokines, reactive oxygen species and NO). These have 
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significant anti-microbial effects, however, they must be tightly controlled to avoid 
development of chronic inflammation and damage. Stimulation of TLR can also lead 
to further recruitment of macrophages, dendritic cells, natural killer cells (NK cells) 
and the resultant development of an adaptive immunity to the antigen (Akira and 
Takeda, 2004).  
 
In the case of H. pylori and gastric cancer, this bacterium and its LPS activate TLR, 
which induce cytokine production as part of the innate response. TLR upregulate 
genes for various cytokines such as IL-2, IL-3 and IL-12. Figure 1.7 represents the 
full immune response to H. pylori (Wilson and Crabtree, 2007). Helicobacter pylori 
also activates the adaptive immune response through macrophages and dendritic cell 
recruitment, which produce IL-12 and stimulate Th1 cells. Macrophages are 
involved in the production of IL-1, IL-6 and TNF-α, possibly resulting in further 
NF-kappa B pathway signalling (Pathak et al., 2006). 
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Fig. 1.7: The immune response to H. pylori infection. Dotted lines are speculative 
components, items in green are of bacterial origin and black are host. (Wilson and 
Crabtree, 2007). 
 
 
Macrophages can also act as effector cells upon infection with this bacterium, 
producing NO via the enzymes inducible nitric oxide synthase (iNOS and iNOS2). 
However, H. pylori has adapted a number of evasive mechanisms. The organisms 
can release arginase, an enzyme that produces urea from host L-arginine, leading to 
ammonia production by urease. This neutralises HCl in the gastric lumen. However, 
arginase can also compete with macrophages for iNOS substrate (L-Arg), reducing 
production of NO and protecting the bacterium (Gobert et al., 2001). Urease and 
outer membrane proteins also have the capacity to cause apoptosis of immune and 
epithelial cells, leading to reduction and dysregulation of the immune response. 
Therefore, H. pylori infection is multi-factorial, with inflammatory responses leading 
to disruption in pH homeostasis, which then allows continued colonisation by the 
organism and further immune cell invasion. Helicobacter pylori strains with the cag 
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pathogenicity island (PAI) further promote cytokine and chemokine responses, 
resulting in peptic ulcer development though a prolonged Th1 response (Hida et al., 
1999). 
 
In the case of GORD and BO mucosal damage via bile and acid reflux recruits 
inflammatory cells such as TNF-α and IL-1β. Studies with TNF-α knockout mice 
reveal their resistance to skin carcinogenesis, implicating this cytokines involvement 
in tumourigenesis, possibly through direct mechanisms or the further recruitment of 
other cytokines and metalloproteinases (Tselpsis et al., 2002). These workers 
investigated TNF-α expression in 40 BO patients, compared with 20 normal, 20 
GORD, 20 dysplasia and 85 ADC biopsies. Results showed that TNF-α expression 
was increased throughout disease, with large areas of expression around glands in 
dysplastic areas of tissue. Moons et al. (2005) recruited 40 GORD and BO patients, 
revealing an increased Th2 response in BO patients compared with GORD. BO 
patients had higher levels of mast cells and IgG presenting plasma cells, confirming 
the progression to a humoral-based response as BO and ADC develop. This could be 
due to increased expression of COX-2, which inhibits the Th1 response and 
upregulates Th2 cytokines such as IL-4 and IL-10 (Fitzgerald et al., 2002a). Two 
studies by Dvorakova and co-workers have investigated the role of IL-6 and its 
related pathways in BO. Initially, biopsies were taken from 15 patients with 
intestinal metaplasia, revealing increased production of IL-6 in IM tissue compared 
with duodenum or adjacent squamous epithelia (Dvorakova et al., 2004). Later, the 
same group exposed the Seg-1 adenocarcinoma cell line to a bile acid cocktail at pH 
4, resulting in increased STAT-3 activation and expression of IL-6 (Dvorak et al., 
2007). 
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A study by O’Riordan investigated the inflammatory response in GORD, BO and 
ADC patient biopsies using ELISA techniques (O’Riordan et al., 2005). A 
correlation between disease progression and increased expression of NF-Kappa B, 
IL-1β and IL-8 was noted, however, NF-kappa B negative ADC patients had 
reduced levels of these two cytokines. The Fitzgerald laboratory in Cambridge 
recruited 50 patients with BO to investigate cytokine expression relating to the 
inflammatory gradient using ELISA. Biopsies were taken from IM segments and 
squamous epithelia in these patients. Proximal BO biopsies had increased expression 
of IL-8 and IL-1β compared with the distal BO segment, conversely, IL-10 
expression was higher in distal tissues. Expression of IL-4 protein was increased in 
IM biopsies, compared with normal squamous mucosa (Fitzgerald et al., 2002a).  
 
The main pro-inflammatory cytokines implicated in cancer development are IL-1, 
IL-6, TNF-α, IL-15 and MIF (macrophage migration inhibitory factor). IL-6 has 
been shown to enhance and maintain hypermethylation of the p53 gene and decrease 
promoter methylation of the epidermal growth factor receptor (Hussain and Harris, 
2007). COX-2 is also involved in infection-induced inflammatory responses, and 
prostaglandin production. Its over abundance or degradation can result in synthesis 
of mutagenic compounds (Hussain and Harris, 2007). The pro-inflammatory 
cytokine profile of BO and ADC is evidenced by these studies, with TNF-α, IL-1β, 
IL-4, IL-6 and IL-8 representing the major players. This mirrors the pattern seen in 
gastric cancer initiated by H. pylori, with the pro-cancer immune cells TNF-α and 
IL-6. In gastric cancer, the immune response to infection also depends on the hosts’ 
genetics, and this may also be a factor in oesophageal adenocarcinoma, where 
mucosal biofilms may be involved in the inflammatory process. 
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1.3 Microbial colonisation of the healthy upper GI tract  
The human gastrointestinal tract (GIT) is highly complex and on anatomical 
grounds, can be divided into five separate parts: mouth, oesophagus, stomach, small 
bowel and large intestine. The GIT plays host to a large range of bacteria, which help 
the body digest food, while boosting immunity to a range of antigens including 
microbes, from birth. The immune system requires the presence of commensal 
bacteria to facilitate its development and maintain its natural immunity to pathogenic 
microorganisms. These organisms are progressively acquired after birth and colonise 
from the mouth to the anus, both in luminal contents and over mucosal surfaces. 
Significant microbial growth occurs throughout this multi-compartment system, 
however, the density and complexity of individual microbiotas is defined by the 
structure and function of each organ. Microorganisms enter the mouth on inhalation 
and during eating. Many move through the GI tract to the stomach and lower gut, 
however, great numbers remain in the oral cavity. The mouth contains saliva 
consisting of enzymes such as amylase and lysozyme. The function of lysozyme is to 
destroy bacteria, however, these organisms often grow in biofilms on the tongue, 
cheek and teeth, which facilitates their protection from environmental hazards 
(Bowden and Hamilton, 1998). An estimated 750 different bacterial species may be 
present in the mouth, with numbers up to 106 cells per gram (Avila et al., 2009). The 
mouth leads into the trachea of the upper respiratory tract, and the oesophagus of the 
digestive system. The oesophagus leads down to the stomach, with rapid movement 
of food via peristalsis and gravity. Little work has been done on colonisation of the 
oesophagus, although the few studies to date have indicated the presence of 
significant bacterial communities, with thirteen predominant genera at ca. 104 per 
mm2 (Pei et al., 2004; Macfarlane et al., 2007). The stomach contains gastric acid 
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(pH <2), which is not suitable for bacterial growth (103 cells per gram), and acid 
tolerant bacteria such as streptococci and lactobacilli are most commonly found 
attached to the gastric mucosa (O’May et al., 2005a). The small intestine has a rapid 
transit time for food (four to six hours), and this together with the secretion of 
pancreatic juices and acids reduces microbial colonisation. The distal ileum has little 
peristaltic movement compared to the duodenum, and contains less acid, allowing 
for increased bacterial colonisation, with bacterial numbers reaching 108 cells per ml 
(Macfarlane and Cummings, 1991). In contrast, the large intestine, which has a long 
transit time, facilitates bacterial colonisation and biofilm formation, with microbial 
cell densities reaching 1012 cells per gram of contents (Macfarlane et al., 2000). 
Numerous microbiological studies have been done on the lower intestine, with great 
interest in inflammatory bowel diseases (IBD), such as Crohn’s and ulcerative colitis 
(Macfarlane et al., 2009).  
 
The oesophagus is now becoming an area of greater interest due to the dramatic rise 
in incidence of BO and oesophageal adenocarcinoma over the past two decades. The 
microbiota and its dysregulation leads to chronic inflammation, as seen in gastric 
cancer and possibly colon cancer (Rowland, 2009). In the GIT, these organisms play 
a major role in immune regulation, and therefore, changes in bacterial composition 
in GORD due to cellular modifications may initiate and maintain neoplastic 
progression to oesophageal ADC.  
 
 
1.3.1 Colonisation of the healthy oesophagus 
The oral cavity plays host to a wide variety of bacteria, which are present in very 
high numbers. It is known that a change in the normal oral microbiota permits 
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colonisation by pathogenic bacteria, which can result in disease states such as 
gingivitis (Avila et al., 2009). Unlike the oral cavity, there have been few studies on 
the microbiota of the healthy oesophagus, and therefore little consideration of the 
role bacteria may have in cancer of these tissues. The oesophagus can be infected 
with a number of organisms, including Candida (Dean and Burchard, 1998), 
Cryptococcus, mycobacteria (Jain et al., 2002) and herpes virus (Nagri et al., 2007), 
therefore, it is reasonable to assume that the healthy oesophagus may also play host 
to its own unique and commensal microbiota.  
 
An initial study by Osias et al. (2004) carried out Gram stains and aerobic culture 
with biopsies from patients with a normal oesophagus. This was a highly elusive 
publication, omitting actual CFU counts, giving only Gram scores and percentages 
of patients with bacteria. However, results indicated colonisation occurred in the 
normal oesophagus (increasing with disease), with a majority of Gram positive 
cocci. A molecular based study by Pei et al. (2004) also examined microbial 
colonisation of the oesophagus, taking biopsies for PCR and cloning. This group 
only analysed biopsies from four patients that were known to be healthy, and 
although only one biopsy showed bacterial colonisation after culturing, all four had 
identifiable bacteria with PCR. Six phyla were identified among the four individuals: 
Firmicutes, Actinobacteria, Proteobacteria, TM7, Bacteroidetes and Fusobacteria. 
Genera included Streptococcus, Veillonella, Clostridium, Rothia, Actinomyces, 
Bacteroides and Prevotella, the majority of which appeared to be of oral origin. A 
culture-based study by Macfarlane et al. (2007) compared seven healthy and seven 
BO patient biopsies. Mucosal colonisation was found in three of the seven healthy 
individuals after aerobic, microaerophilic and anaerobic culture. Eighteen species 
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were identified in these patients from 16S rRNA gene sequencing including 
streptococci, lactobacilli, bifidobacteria, actinomyces, veillonella and prevotella.  
These studies show that the oesophagus has its own distinct and diverse microbiota. 
Although the majority of species were of an oral origin, the oral phyla spirochaetes 
were not present, along with other commonly isolated oral organisms, providing 
evidence that not all oral bacteria can colonise these oesophageal tissues. However, 
larger studies are needed to confirm that the microbiota is stable over time, and 
common in all individuals. 
 
1.4 Colonisation of the oesophagus in disease 
1.4.1 Associations between bacteria and cancer 
It has been estimated that 15.6 – 18% of cancers can be attributed to some form of 
infection (Pisani et al., 1997; Parkin, 2006). Infectious agents can cause a multitude 
of cancers: H. pylori (gastric cancer), human papilloma virus, hepatitis B and C, and 
Epstein-Barr virus (cervical, liver and Burkitts Lymphoma, respectively), the 
schistosome S. haemotobium (bladder cancer) and Opisthorchis viverrini, a liver 
fluke (gall bladder) (Parkin, 2006). Carriers of Salmonella typhi following enteric 
fever are at higher risk of developing gall bladder cancer (Kumar et al., 2006). It is 
not yet understood how this species is involved in disease aetiology, however, the 
degradation of bile salts by these bacteria may produce substances which act as co-
carcinogens (Aries et al., 1969). In lung cancer patients, high levels of Chlamydia 
pneumoniae antibodies, specifically IgG and IgA, were seen (Koyi et al., 2001). 
These high titres of IgA are indicative of chronic infection, and possibly chlamydia’s 
role in the development of neoplasia. In 2005, Barry J. Marshall and Robin Warren 
were awarded the Nobel Prize for the discovery of H. pylori involvement in peptic 
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ulceration, gastric adenocarcinoma and gastric lymphoma (Marshall and Warren, 
1983). Due to this discovery, it has been considered that bacteria may be a 
mechanism in driving the progression of BO and its associated adenocarcinoma. 
 
1.4.2 Bacterial colonisation in GORD and BO 
Two studies by Pei and co-workers at the New York School of Medicine have 
investigated bacterial colonisation in patients with reflux oesophagitis and BO (Pei et 
al., 2005; Yang et al., 2009). The first recruited 24 patients, 12 of which had GORD 
on histopathology examination. Broad range 16S rDNA gene PCR was employed for 
clone and sequence analysis, only two clones were analysed from each patient as 
part of this preliminary study. Seventeen species were identified in these patients, 
however, only nine were defined, with the other eight being unknown non-cultivated 
species. In contrast, only five species were detected in the BO patients. However, 
they then went on to analyse 99 clones from one of the BO patients, resulting in 21 
bacterial species being identified. Greater than 60% of these species were classed as 
unidentified rumen and oral isolates, while 32% of species belonged to the genera 
Prevotella, Gemella, Porphyromonas and Veillonella. The second, much larger study 
from this group (Yang et al., 2009) involved 34 patients (12 healthy, 12 GORD, 10 
BO). Identical 16S rRNA gene analysis techniques were employed in the 
investigation, producing 200 sequences per sample. This study used hierarchical 
clustering analysis to investigate the genetic distance between sample microbiotas, 
and identified two distinct clusters; type I and type II microbiomes. The type I 
microbiome consisted mainly of aerobic streptococci (78%), with the other 22% 
being small percentages of other species (15% Gram negative). Conversely, the type 
II microbiota, which was predominantly found in oesophageal disease, had a 
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proportion of only 29% streptococci, with the majority being mainly Gemella spp. 
(8%) and Gram negative species (54%). The most common Gram negative species 
found in this group were anaerobic or microaerophilic, including prevotella/ 
bacteroides, neisseria, veillonella, haemophilus and fusobacteria. The type I 
microbiota was found in 11/12 normal patients, while the type II microbiota was 
found in 7/12 GORD and 6/10 BO patients.  
 
The Macfarlane group studied 14 oesophageal samples from BO and normal patients 
equally (Macfarlane et al., 2007). They obtained both aspirates and mucosal tissue 
for pH monitoring (aspirate only), and traditional culture of colonised bacteria for 
species identification with 16S rRNA gene sequence analysis. Bacterial populations 
and biofilm formation were increased in Barrett’s patients compared with healthy 
subjects (Section 1.3.1). Although total CFU in healthy and BO patients were similar 
(ca. log10 5.0 cells cm-2), there was great species diversity (18 vs. 38 species) with 
only 10 common to both patient groups. Similar bacteria were found to those in other 
studies i.e. streptococci, staphylococci, gemella, veillonella, neisseria, prevotella and 
fusobacteria. Additionally, the potentially pathogenic bacterium Campylobacter 
concisus was found in 4/7 BO patients.  
 
1.4.3 Colonisation in adenocarcinoma of the oesophagus 
Studies have been published investigating the microbiota of the oesophagus in 
patients with carcinoma (Lau et al., 1981, Finlay et al., 1982, Mannell et al., 1983) 
and megaoesophagus (Pajecki et al., 2002). However, all of these studies used 
aspirate samples to culture aerobic and anaerobic bacteria, except Finlay’s study, 
which analysed mucosal tissue. These investigations isolated mainly streptococci, 
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staphylococci and bacteroides.  
There has been no work done on the presence of bacteria on oesophageal cells in 
adenocarcinoma patients, but with the presence of many different types of bacteria in 
healthy and Barrett’s oesophageal tissue, it seems likely that a new and varied 
microbiota will be discovered. As oesophageal disease progresses, there is an 
increase in opportunistic pathogens, with a shift towards a Gram negative biofilm. It 
is likely that the microbiota in ADC patients will continue to become more diverse, 
and increasingly Gram negative due to the greater surface area of disorganised, 
morphologically varied, epithelial cells. The investigations in this study will aim to 
characterise the microbiota in patients with ADC. 
 
Tables 1.2 and 1.3 summarise data from five key papers dealing with oesophageal 
microbiology, highlighting the main genera found, and the number of species in each 
genus identified. In the case of those using cloning methods, the number of clones 
sequenced are also noted.  
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Table 1.2: A summary of the main publications relating to the oesophageal  
microbiota in health and disease. 
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Table 1.3: Summary of the main oesophageal species found in key  
research articles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a No. of patients positive for genus in 4 control patients (no. of species, clones). b No. of clones per 
genus: 9 control, 12 GORD, 3 BO (no. of species). c No. of patients positive for genus: 7 control and 
7 BO patients (no. of species). d No. of species for each genus: 12 control, 12 GORD, 10 BO 
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patients. e ND, not detected. 
 
1.5 The microbiota 
1.5.1 Oral biofilms 
As with much of the human microbiota, microbiological analysis of diseased tissue 
has been more extensively studied than healthy. The oral microbiota is no exception, 
with many research articles on the oral biofilm of patients with periodontal diseases. 
Cultivation of bacteria from the oral cavity is problematic, with more than 50% 
being difficult to culture. However, over 700 bacterial species have been identified 
(Aas et al., 2005). Molecular cloning techniques have produced over 2,500 16S 
rRNA clones, yielding 141 different taxa. These included Firmicutes, 
Actinobacteria, Proteobacteria, Bacteroidetes, Fusobacteria and TM7 (never 
cultivated). The main genera found were streptococci, gemella, veillonella, 
actinomyces, neisseria and rothia. However, fusobacteria, porphyromonas, 
campylobacter and leptotrichia were also found.  
 
1.5.2 Biofilm interactions 
A biofilm is a population of individual or multiple species, which can develop from a 
single species or community of cells. The biofilm represents an interdependent 
community, and can grow on a variety of biotic or abiotic surfaces. Some bacteria 
present in biofilms will produce extracellular products (EPS, nucleic acids, proteins) 
which provide essential nutrients, growth components and protection for the 
community. A biofilm population can contain various groupings of bacterial types 
called guilds, which have an array of metabolic requirements (Davey and O’Toole, 
2000). Varying guilds include fermenters, methanogens, sulphate- and sulphur-
reducers. Chemical connections in these biofilms allow communication between 
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bacteria, promoting survival strategies; this is named quorum sensing (Shapiro, 
1998). Figure 1.8 shows the development of a biofilm from its early establishment to 
maturity.  
 
 
Fig. 1.8: Diagram detailing the development of a biofilm. Early colonisers such as 
streptococci, actinomyces and fusobacteria (a bridge organism) associate with epithelium. 
This is followed by attachment, accumulation, exopolysaccharide production and further 
bacterial attachment. 
 
Streptococcal species are main organisms found in the healthy oesophagus and oral 
cavity. In the mouth, they are the primary (early) colonisers, along with Gram 
positive rods such as Actinomyces naeslundii. This genus is mostly commensal, 
although S. mutans is associated with dental caries. In the studies mentioned 
previously, the principal bacteria found in the oesophagus were streptococci, 
actinomyces, veillonella, fusobacteria and prevotella/ bacteroides. Veillonella (V. 
atypica and V. parvula) is a secondary (late) coloniser, being able to coaggregate 
with streptococcus. Veillonella can also coaggregate with fusobacteria (F. 
nucleatum), which is classed as a bridge organism due to its ability to adhere to both 
primary and secondary colonisers. Fusobacteria can also attach to actinomyces, 
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porphyromonas, H. pylori, and directly with streptococci (Rickard et al., 2003; Kreth 
et al., 2009). Streptococci are major colonisers of the oesophagus where they adhere 
to epithelial cells directly. Therefore, they have close interactions with the immune 
system, and can mediate the effects of other species when coaggregated. For 
example, F. nucleatum triggers expression of IL-8, however, when adhered with 
streptococci, the effect is attenuated (Kreth et al., 2009). Biofilms have been 
described as a “consortia of cells that often possess a metabolic activity greater than 
that of the component species” (Rickard et al., 2003). They must be able to 
withstand stresses due to shearing, washing and anti-microbial treatments. Therefore, 
in the oesophagus, it is likely that bacteria grow in biofilms (Macfarlane et al., 2007) 
to withstand the harsh environment.  
 
1.5.3 Helicobacter pylori 
As discussed previously in this chapter, Helicobacter pylori are the main aetiologic 
agent in gastric cancer development, being able to induce gastritis after its 
introduction to previously negative patients. There has also been much debate over 
the role of H. pylori in oesophageal ADC development. The majority of studies 
concur that this bacterium has a protective effect against this form of cancer, and that 
there is an inverse relationship with BO and ADC (de Martel et al., 2005). Large 
community-based studies by Anderson et al. (2008) and Corley et al. (2008) 
investigated a total of 1870 patients (542 GORD, 542 BO, 227 ADC and 559 
controls). Serological antibody testing with western blots gave data on H. pylori and 
CagA status, while enzyme assays were used to measure gastric atrophy, as defined 
by pepsinogen I/II ratios. These two studies confirmed the inverse association 
between H. pylori and oesophageal cancer: CagA seropositivity was lower in 
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oesophageal compared with junctional adenocarcinomas, and there was a reduced 
risk of GORD, BO and ADC in patients with the seropositive bacterium. 
Approximately nine percent of patients with the H. pylori-seropositive phenotype 
had gastric atrophy compared with 1.4% of seronegative patients. This latter result 
suggests that reduced oesophageal adenocarcinoma is not simply due to gastric 
atrophy and that other mechanisms are involved. Other mechanisms of action have 
been proposed for this negative association, including the presence of H. pylori at the 
gastric cardia leading to atrophy of acid secreting mucosa, or the production of 
alkaline ammonia substances protecting the oesophageal mucosa from acid (McColl 
et al., 2008). 
 
1.5.4 Campylobacter species 
Campylobacters are so named for their twisted shape; they are spiral, curved slim 
rods, with a Gram negative morphology (Fig. 1.9). These bacteria have a single or 
bi-polar flagellum allowing rapid movement. Campylobacters prefer a 
microaerophilic environment, however, a number of species can survive 
anaerobically. The cell wall of these organisms is typically Gram negative, and with 
the ability to shift their antigenic composition, campylobacters can change the LPS 
molecules involved in adherence. The natural habitat for campylobacters is the 
intestines of warm-blooded animals, particularly birds and poultry. They are also 
found in the oral cavity and urogenital tract of humans and during infections of the 
gut. Human infection is thought to occur through the faecal-oral route, due to food 
contamination, contaminated water and handling of livestock (Bourke et al., 1998; 
Miller and Mandrell, 2004).  
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Fig. 1.9: Scanning electron micrograph of Campylobacter jejuni. Photo by De Wood; 
digital colorization by Chris Pooley, USDA. 
 
 
Although campylobacters were identified over 50 years ago, our understanding of 
their mode of pathogenesis is still relatively limited. These bacteria are not easily 
cultured, having variable biochemical activities and a time consuming, fastidious 
growth pattern. Due to their highly similar molecular sequences, campylobacters are 
also not easily identified with standard molecular techniques. Campylobacter jejuni 
was the first food-borne pathogen to be completely sequenced (Parkhill et al., 2000). 
This group found many regions of hypervariability, specifically in regions encoding 
biosynthesis and the modification of surface structures. Major structural changes can 
occur in these bacteria due to insertion of new DNA sequences, and this could 
account for their varied behaviours and modes of interaction with the human host. 
 
Taxonomy, classification and origins of campylobacters 
Members of the genus Campylobacter were first identified and classified as vibrios 
due to their spiral appearance, however, in 1963 they were reclassified forming a 
new genus (Sebald and Veron, 1963). After many years of taxonomic and structural 
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analyses, these bacteria are now part of the Campylobacteraceae family (Vandamme 
et al., 1990); which also comprises the genera Arcobacter and Helicobacter. As with 
the sequencing of many Proteobacteria, polyphasic rRNA homology and DNA-DNA 
hybridisation experiments were carried out to complete their phylogenic tree. This 
amended genus now contains seventeen species, six subspecies and two biovars (bv): 
C. coli, C. concisus, C. curvus, C. fetus subsp. (fetus and venerealis), C. gracilis, C. 
helveticus, C. hominis, C. hyointestinalis subsp. (hyalointestinalis and lawnsonii), C. 
insulaenigrae, C. jejuni subsp. (jejuni and doylei), C. lanienae, C. lari, C. mucosalis, 
C. rectus, C. showae, C. sputorum (bv. faecalis and paraureolyticus), and C. 
upsaliensis (Korczak et al., 2006). Of these species, only 15 have been shown to 
cause human illness. Campylobacter helveticus has only been found in cats and 
dogs, while C. hyalointestinalis subsp. lawsonii is found in the stomachs of pigs with 
ulcerative disease. Although previously identified in human disease, infections with 
C. mucosalis are now thought to be misdiagnosed cases of the closely related C. 
concisus (On, 1994).  
 
Campylobacteriosis in humans 
Infections with campylobacters are now three times as common as those with 
salmonella. The Center for Disease Control reports that approximately 2.4 million 
persons are infected every year with Campylobacter, and these occur more 
frequently in the summer months, with an estimated 124 persons dying of this 
infection annually. Human intestinal disorders are most commonly caused by C. 
jejuni and C. coli (Skirrow, 1994). Campylobacter fetus and C. jejuni can inititate 
pericarditis and myocarditis (Uzoigwe, 2005), while C. rectus is found in the oral 
cavity of patients with periodontal infections (Ihara, 2003). Campylobacter jejuni is 
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also associated with the autoimmune disease Guillain-Barre Syndrome (GBS) 
(Kuwabara, 2004), an acute peripheral neuropathy with shredding of the nerves 
along the spine leading to muscle weakening and paralysis of the limbs and face. 
This disease can also be triggered by the Epstein-Barr virus, cytomegalovirus and 
Mycoplasma pneumoniae. Campylobacter jejuni infection leads to the acute motor 
axonal neuropathy (ANAN) subtype of GBS, considered to be a result of molecular 
mimicry. Reports of the AIDP (acute inflammatory demyelinating polyneuropathy) 
form of GBS being due to C. jejuni infection were recently invalidated by a patient 
study (Kuwabara et al., 2004). A subsequent post-campylobacter autoimmune 
disease is reactive arthritis (ReA). Patient studies in Oregon and Helsinki have 
shown that 88% and 10% of patients with this syndrome previously had either C. 
jejuni or C. coli infection, respectively (Hannu et al., 2002; Townes et al., 2008). 
With campylobacters being involved in a number of human infections, potentially 
resulting in more serious conditions, it is important that their mode of pathogenicity 
is clearly understood, allowing successful identification and treatment of these 
patients. 
 
1.5.5 Mechanisms of virulence in campylobacter  
Campylobacters possess a number of virulence factors that contribute to their 
survival inside the host, and subsequent progression to disease. The ability of these 
organisms to move rapidly using their flagella allows chemotaxis and invasion of 
host epithelial cells. It has recently been shown that these flagella not only facilitate 
the above functions, but that they are also involved in the secretion of virulence 
proteins, and allow microcolony formation and avoidance of host innate immune 
responses (Guerry, 2007). 
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Flagella  
Flagella are constructed of a basal body, filament and hook. A motor in the bacterial 
cell envelope drives rotation of the filament, with the hook acting as a coupling 
structure between filament and motor (Bardy et al., 2003). Flagella are an important 
virulence determinant for bacteria, and are essential to the majority of 
gastrointestinal disease causing organisms, including salmonella and other 
enterobacterial species.  
 
Studies with C. concisus isolated from subgingival plaque showed that this species 
demonstrated chemotactic movement towards formate (Paster and Gibbons, 1986), 
whereas with C. jejuni, mucin was the strongest chemoattractant (Hughdahl et al., 
1988). Hughdahl investigated the ability of individual mucin constituents to 
chemoattract these organisms, and found that intermediates of the TCA cycle were 
the main source of chemotaxis. Similar findings were observed with S. typhimurium, 
E. coli, V. cholerae and P. aeruginosa (Allweiss et al., 1977). Campylobacters use 
intermediates of the TCA cycle as energy sources, with L-fucose being the 
predominant stimulus, operating through upregulation of FlaA promoter regions 
(Allen and Griffiths, 2001).  
 
 
Campylobacter invasion antigens (Cia proteins) 
Interaction and invasion of human intestinal cells has been modelled with a number 
of gut epithelial cell lines (Fauchere et al., 1986). More recently, Grant et al. (1993) 
have investigated the role of campylobacter virulence factors in their internalisation 
and translocation across the epithelial cell barrier. These bacteria adhere to the 
epithelial surface using their flagella, LPS coating and various secreted proteins. 
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This research group constructed flagella mutants that were unable to cross the 
epithelial barrier, indicating that either complete motility or an active flaA gene is 
needed for this action. Malik-Kale et al. (2008) grew C. jejuni on agar plates with 
the bile acid sodium deoxycholate. Under bile acid stress, the bacteria had amplified 
expression of virulence genes, including ciaB, and increased secretion of Cia 
proteins, although there was no change in motility.  
 
 
Campylobacter survival strategies  
Campylobacters can survive in a number of mammalian cell types. During 
gastrointestinal infection, they reside within epithelial cells, macrophages and 
paracellular structures of the lamina propria. However, these organisms can produce 
a number of toxic species, such as hydrogen peroxide, during aerobic metabolism, 
which can then form more toxic intermediates when in contact with nitric oxide 
sythase and reduced iron products. These toxic substances such as hydroxyl radicals 
and nitrogen dioxide aid survival. Catalase formation by these organisms provides 
resistance to hydrogen peroxide through its inactivation, therefore increasing intra-
macrophage survival (Day et al., 2000). A further study by Pogacar et al. (2009) 
used murine macrophage cell lines to study C. jejuni infection and survival under 
normal or stressed conditions. After environmental stress was induced (oxygen, heat 
or nutrient starvation), survival was impaired, however, regardless of stress it was 
reported that these bacteria could not survive for more than 30 hours inside this 
hostile cell. Nutrient limitation reduced the ability to adhere to and invade 
mammalian cells, however, oxidative stress for five hours increased their adhesive 
and invasive properties. This could be due to upregulation of mechanisms that inhibit 
toxic oxygen products, therefore enhancing their persistence in the host.  
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Cytolethal distending toxin (CDT) 
CDT was identified over 20 years ago (Johnson and Lior, 1987) when Chinese 
Hamster Ovary (CHO) cell lines infected with E. coli became distended and died. 
This group went on to look at its presence in other gastrointestinal pathogens, 
leading to its discovery in campylobacters (Johnson and Lior, 1988). CDT has now 
been purified and sequenced from a number of pathogenic bacteria, including 
Shigella and Campylobacter. To date, the protein has been identified in C. jejuni, C. 
coli, C. lari and C. fetus, and a recent study found a CDT-like effect on Vero cells by 
C. concisus (Engberg et al., 2005). This toxin is the product of three genes cdtA, 
cdtB and cdtC, where cdtAC are binding units for cdtB that allow its entry into a 
host cell. Once inside the cell, cdtB enters the nucleus producing a DNase I-like 
activity leading to double strand breaks in host DNA. This damage results in a block 
at the G2 phase of the cell cycle prior to mitosis, the cells can no longer divide, 
become distended and die (Smith and Bayles, 2006). If there are mutations in any 
genes of the cdtABC complex, cytotoxicity is lost. 
 
Surface lipopolysaccharide 
LPS is a surface structure found anchored in the outer membrane of Gram negative 
bacteria. This molecule contains three parts; the lipid A moiety found in the outer 
membrane, the core and O-antigen. Lipid A is endotoxic, being released during 
bacterial killing, resulting in an inflammatory response. Bacterial LPS is involved in 
adherence to host cells, and the component molecules on the surface can vary in their 
antigenic profile, enabling immune avoidance. The core of this structure is built up 
of various sugars, and the presence of sialic acid has been associated with GBS when 
attached to β-D-galactosidase (Schwerer et al., 1995). A recent patient study by 
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Mortensen et al. (2009) further investigated the role of sialylation in C. jejuni in 
association with disease severity and joint pain/reactive arthritis. Campylobacters 
with a sialic acid positive lipo-oligosaccharide (LOS) isolated from patients were 
correlated with bloody diarrhoea, increased duration of illness and arthritic 
symptoms. LPS and its components are very important factors in campylobacter 
infection, where sialylation increases serum resistance, therefore prolonging their 
presence in the host. Additionally, these molecules may increase bacterial invasion 
abilities and the host inflammatory response.  
 
Nitrate reduction and nitric oxide (NO) 
Many campylobacters are nitrate reducers, being able to produce nitrite via the 
enzyme nitrate reductase (Pitmann and Kelly, 2005). Nitrite can then be reduced to 
NO in the presence of acid. As mentioned earlier, NO is an antimicrobial agent, that 
modifies bacterial DNA and respiratory complexes. Interestingly, humans do not 
possess nitrate reductase, relying on oral bacteria to reduce salivary nitrate to nitrite, 
thereby implying a symbiotic relationship. One patient study found that individuals 
with fewer dental caries had increased concentrations of salivary nitrate and a 
microbiota with enhanced nitrate reducing ability (Doel et al., 2004). This group 
conducted a further study investigating the nitrate-reducing bacteria present in the 
oral microbiota (2005). The main species found were Veillonella, Actinomyces and 
Rothia, with the tongue containing the largest nitrate reducing potential of mainly 
Gram negative cocci (58.1%).  
 
Once oral bacteria have reduced salivary nitrate to nitrite, it is swallowed and 
encounters gastric acid, whence it is converted to NO. In a patient-based study with 
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15 healthy H. pylori-negative volunteers, pH, NO concentration, serum nitrite and 
salivary nitrate were measured at the OGJ. After ingestion of a nitrate meal, pH and 
NO levels were significantly higher at the OGJ and gastric cardia compared with 
areas above and below this region (Iijima et al., 2002). Suzuki et al. (2005) 
progressed this work, investigating the effects of a nitrate meal in 10 BO patients. 
Simultaneous recordings of pH and nitric oxide concentration were made throughout 
the oesophagus before and after nitrate consumption. Before feeding, reflux episodes 
did not increase NO, however, after nitrate ingestion reflux episodes reducing pH to 
1-2 generated 20 µM nitric oxide. This can have a number of physiological effects in 
the body, and could possibly lead to mutagenesis and carcinogenesis in this part of 
the gut (Burnett et al., 2000). If NO is further oxidised to N2O3, deamination can 
occur through reaction with primary amines on DNA bases (Burney et al., 1999). 
Production of N-nitrosocompounds via NO reactions with secondary amines can also 
result in nitrosative damage of DNA (Wink et al., 1999).  
 
Previous studies of the oesophageal microbiota have identified the presence of 
nitrate reducing Veillonella, Rothia and Actinomyces on the oesophageal mucosa. 
Therefore, in patients with reflux disease, where acid is introduced regularly, NO 
production could lead to inflammation and damage. Additionally, Macfarlane et al. 
(2007) found the pathogenic nitrate-reducing species Campylobacter concisus in 
patients with reflux disease. Campylobacters could therefore be involved in the 
initiation and/or maintenance of carcinogenesis through NO formation and the 
subsequent inflammatory response. 
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1.5.6 Immune response to campylobacters 
Campylobacter infection initiates an innate immune response in the host, through the 
activation of TLR. Wang et al. (2000) investigated the inflammatory effect of C. 
rectus on Hep-2 cells (larynx) over a period of up to three days, to examine the role 
of these organisms in periodontitis. Production of IL-6, IL-8 and TNF-α was 
significantly increased in the human cell line, with a transient increase in IL-1α and 
IL-1β at 1-2 hours post infection. Campylobacter jejuni is the most common test 
species in this genus, because it is the most commonly found agent in gastroenteritis. 
Therefore, the majority of studies use this organism in modelling experiments. Hu et 
al. (2006) infected dendritic cell (DC) cultures with C. jejuni to monitor the 
inflammatory response. DC are antigen-presenting cells (APC), they are part of the 
innate and adaptive immune response, and play a key role in the initial reaction to 
microbial infection. This study found that these bacteria entered the cells within two 
hours, and up-regulated CD40, CD80 and CD86 surface components, a sign of cell 
maturation. These infected DC also triggered an innate and Th1 response, 
represented by IL-1β, IL-6, IL-8, IL-10, TNF-α, IL-12 and IFNγ. Zheng et al. (2008) 
then investigated the role of C. jejuni’s CDT on intestinal epithelial cells. Bacteria 
were added to T84 monolayers at a MOI of 10. Eleven different strains showed 
varying degrees of effectiveness with respect to adhesion, invasion and transcytosis 
(movement within cell). Despite these variations, all strains induced IL-8 expression, 
with similar levels for cell-free supernatants compared with live culture. The group 
also produced CDT and flagellar mutants, which invoked a lower IL-8 response, 
indicating the importance of these for the innate immune response through TLR/NF-
kappa B signalling.  
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A recent study by Friis et al. (2009) measured the IL-6 response of Caco-2 cells to 
C. jejuni (MOI of 1000) compared with cells mutated for TLR-2 and MyD88 (part of 
NF-kappa B signalling pathway). MyD88-mutant cells had similar IL-6 expression 
to normal Caco-2 cells, whereas TLR-2 mutants had reduced levels of secretion on 
ELISA testing after three hours. Stimulation with purified surface polysaccharides 
(capsular polysaccharide) showed a correlation between concentration of 
polysaccharide and IL-6 secretion.  
 
These studies indicate that campylobacters induce an innate response through 
dendritic cells of the immune system and direct contact with epithelial cells. 
Production of IL-1β, IL-6, IL-8, TNF-α and IL-12 through TLR related NF-kappa B 
signalling mirrors the immune response seen in H. pylori infection of the gastric 
epithelium resulting in chronic inflammation and metaplasia.  
 
 
1.6 Summary and research hypothesis 
Summary  
• BO is a progressive condition resulting from acid/bile refluxate; 
• This condition is multi-factorial, involving acid/bile, HH, obesity, gender, 
ethnicity, diet, genetics and the resulting inflammatory response; 
• Genetic and epigenetic modifications are key markers of oesophageal ADC; 
• Epithelial damage as a consequence of refluxate leads to sensitive cells, 
which are more prone to continuing damage; 
• BO hosts an increasingly Gram negative microbiota compared with the 
squamous cell oesophagus; 
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• Gram negative bacteria have increased LPS, bacterial flagella and ability for 
N-nitrosocompound formation; 
• LPS induce TLR/ NF-kappa B pathways; 
• NF-kappa B pathways increase production of pro-inflammatory cytokines 
such as TNF-α, IL-1 and IL-6; 
• The presence of bacteria in the distal oesophagus can lead to increased 
production of ROS and nitrosative compounds when presented with acid; 
• ROS and NO trigger genetic modifications and inflammatory responses 
(cytokines, COX-2). 
 
The continual presence of acid and bile salts in the oesophagus due to reflux disease 
results in sensitive epithelial cells. Dietary and salivary nitrates are converted to 
nitrite by oral bacteria, and possibly, the oesophageal microbiota when swallowed. 
Nitrite is normally converted to NO in the stomach, when in contact with gastric 
acid, however, in patients with acid reflux, NO can be produced in the distal 
oesophagus during a reflux episode. This process further damages the epithelium 
leading to an inflammatory response. 
 
Hypothesis 
The research hypothesis is that microbial composition in the distal oesophagus 
changes throughout disease, becoming increasingly Gram negative in 
adenocarcinoma patients. Through a variety of mechanisms, these bacteria may 
initiate or maintain this chronic inflammatory condition, with a possible key 
involvement for nitrate-reducing Campylobacter species. Comparisons between H. 
pylori involvement in gastric adenocarcinoma and the progression of BO to 
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oesophageal ADC have been made in this Introduction. Many comparable events 
take place between these two neoplastic pathways, with almost identical immune 
responses and genetic changes. Therefore, campylobacter, a helicobacter-like 
organism may be a key aetiologic agent in this disease. 
 
Aims of this study 
This project aims to recruit statistically significant cohorts of control, GORD, BO 
and ADC patients for real-time PCR analysis of major oesophageal genera. These 
main bacterial groups will be identified by cultural analysis of a small subset of each 
patient cohort. Once key organisms and population changes have been identified, in 
vitro models will be designed to further investigate biofilm composition, and the 
effects of refluxate on virulence expression. These models will be in the form of 
continuous culture (chemostats), and oesophageal cell lines. The aim will be to 
identify key changes in inflammatory responses and DNA modifications, proving the 
importance of bacteria in the development of oesophageal adenocarcinoma.  
 
 
  
 
Chapter 2 
 
Bacterial colonisation of the 
oesophagus in different 
stages of disease 
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2.1 Introduction 
The study of microbiology goes back three centuries, and although modern 
technologies allow for the identification of medically related microorganisms 
genetically, they should not be viewed as being able to completely replace the 
culture of viable bacteria. Microorganisms are constantly introduced to the human 
body, and opportunistic bacteria adhere to epithelia and biofilms if the environment 
is suitable and nutrients are available. Therefore, when looking for an aetiologic 
agent in gastrointestinal diseases, the viability of bacteria colonising epithelial 
surfaces should be fully investigated.  
 
For these reasons, the work described in this thesis has employed traditional 
culturing methods to identify the principal viable microorganisms colonising 
inflamed tissues in groups of patients with oesophageal disease; the resulting data 
facilitating the development of standards for real-time PCR detection and 
quantification of the target organisms in larger patient cohorts. The use of traditional 
culturing methods has allowed development of in vitro models, using clinical 
isolates with cell lines and in continuous culture. These experiments were designed 
to investigate the impact of refluxate on the virulence of the oesophageal microbiota, 
and the consequent oncogenic effects in epithelial cells.  
 
2.1.1 Molecular tools in microbiology 
It is true that without molecular technologies, which are mainly based on 16S rRNA 
approaches, knowledge of the human gastrointestinal microbiota would still be very 
limited. These methodologies, such as PCR/sequencing, dot-blot hybridisation, 
microarrays, metagenomics (clone libraries), fluorescent in situ hybridisation (FISH) 
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and real-time PCR can be time-effective, more sensitive and most importantly allow 
for identification of non-culturable bacteria (Zoetendal et al., 2006). However, 
without the ability to culture these bacteria originally for identification, DNA and 
gene sequences, phenotypic and metabolic data, would not be available. Many of 
these techniques require primers or a probe, which relies on effective sequencing of 
these organisms. There is a large variety of primer sequences in the literature for 
many intestinal bacteria, however, with genetic diversity between each species and 
sub-species, finding primers that are universal for each genus and species can be 
challenging. The majority of research with Campylobacter species use molecular 
techniques, however this study has found that many of the primer sets do not work 
on isolates from different niches. Therefore, it is extremely important that the art of 
traditional culture is not lost completely to molecular approaches, and that the two 
can be used in harmony. 
 
2.1.2 Microbial Identification System (MIDI) 
A number of methods are available for identifying intestinal bacteria, with both 
culture and chemotaxonomy and the more modern molecular methods such as PCR 
and clone libraries. However, sequencing involved in some types of molecular 
analysis is expensive when all of the cultured bacteria from 34 patient biopsies are to 
be identified, as in this study. It was therefore necessary to find a less expensive, yet 
fast and reliable method for analysing all of the clinical isolates obtained in this 
research.  
 
All bacteria possess fatty acids, not only in cell membranes, but also in LPS and 
lipoteichoic acids, and over 300 different types have been found to date. Each 
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bacterial genus and species has its own specific composition of between 5 and 10 
cellular fatty acids (CFA), analogous to a human fingerprint. Each fatty acid has 
between 9 and 20 carbon atoms on average, and the length, branching groups and 
bonding positions vary between each genus and species dependent on their 
biosynthetic pathways. These changes in length (odd or even carbon atoms), 
saturation and branching vary among Gram negative and Gram positive organisms, 
with some CFA being common to all, such as hexadecanoic acid (palmitoleic acid), 
which is found in most prokaryotes (Welch, 1991). When these fatty acids undergo 
catalysis with methanol, they produce fatty acid methyl esters (FAME). The MIDI 
system uses gas chromatography (GC) to analyse these extracted cellular fatty acids 
from individual isolates. The system contains a number of libraries (aerobic, 
anaerobic, clinical), which allow comparisons of unknown fatty acid profiles with 
those of known bacteria, using dendograms, for fast identification through pattern 
recognition. Cellular fatty acids from bacterial lipid membranes can be affected by 
environmental changes, therefore, culturing for FAME extraction must be carried out 
under precise conditions to prevent changes to their relative proportions. The media 
used and nutritional content, incubation conditions, and injection port temperatures 
must be uniform throughout all analysis.  
 
The MIDI system has a library of over 100,000 FAME profiles for bacterial genera, 
species and strains collected worldwide (Stager and Davis, 1992). The ability of this 
technology to correctly identify Gram negative species is 80-93% (Olson, 1996), and 
compared with other chemotaxonomic systems, which use substrate utilization for 
recognition, its ability to identify to the species and strain level is more reliable.  
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2.1.3 The oral and gastric microbiotas 
As described previously in Section 1.5.1, a small study of the healthy oral cavity 
found 141 taxa, belonging to six phyla, isolated from nine areas of the mouth (Aas et 
al., 2005). The study used PCR amplification of 16S rRNA genes to clone and 
sequence the samples. Streptococci were the main genus found, with S. mitis being 
found in all locations, comprising >15% of the total number of clones in the majority 
of patients and sites. The opportunistic pathogen Granulicatella adiacens was also 
found in all sites in the five patients examined. Prevotellas colonised all oral surfaces 
investigated, while Rothia denticariosa was only found on teeth and subgingival 
surfaces. Campylobacters were found in four of the five patients, with C. concisus 
being the main species found, however, C. gracilis, C. showae and C. curvus were 
isolated from tonsil samples and subgingival plaque (Aas et al., 2005).  
 
Studies into oral diseases identify Porphyromonas gingivalis, Treponema denticola 
and T. forsythia as the main aetiologic agents in gingivitis and periodontitis. These 
species were not found in any healthy patients, however, streptococci (S. mitis, S. 
oralis, S. angiosus), rothia, actinomyces, lactobacilli, bifidobacteria and candidas 
have been shown to be part of these cariogenic plaques (Filoche et al., 2010; Kumar 
et al., 2003); many of which were also not found as part of the healthy oral 
microbiota. This data indicates that these oral diseases are polymicrobial rather than 
being due to a single species or genus. Bacteria colonising oral sites should be 
looked at as a microbial ecosystem, where all of the microorganisms in the niche 
function together, in the context of both biotic and abiotc factors (Filoche et al., 
2010). Bacteria in oral biofilms survive in the community due to interdependent 
relationships, both metabolically and ecologically, and this may explain why so 
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many of these organisms cannot be cultured in the laboratory, and have only been 
detected using molecular techniques.  
 
In the case of the gastric microbiota, only a small number of species can survive due 
to the harsh environment. The main organisms found are streptococci and 
lactobacilli, and in a number of individuals, H. pylori, with total eubacterial numbers 
reaching 103 CFU ml-1 (O’May et al., 2005a). The low pH found in the stomach 
suppresses colonisation of most microorganisms, with a pH <4 being the main 
barrier to microbial growth. However, biofilms can create protective niches, 
allowing organisms that would not normally survive to co-exist with acid tolerant 
species such as lactobacilli, thus providing metabolic synergy (Stoodley et al., 2002).  
Many patients with H. pylori do not develop gastric disease, however, it can lead to 
gastric cancer in those who develop corpus gastritis. This condition leads to 
hypochlorhydria, where production of gastric acid is reduced, resulting in increased 
pH, and therefore, enhanced microbial colonisation (Dicksved et al., 2009). This 
study used terminal restriction fragment length polymorphism (T-RFLP) techniques 
to clone and sequence gastric biopsies from 10 cancer and 5 control patients. Five 
phyla were identified (Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, 
Fusobacteria) in the gastric cancer group. The abundance of H. pylori was very low, 
being found in only one of the cancer patients. This research corresponds with 
previous reports of hypochlorhydria, indicating that although H. pylori creates an 
altered environment for pathogenesis, it is the developing community as a whole 
which progresses the disease to cancer, possibly via the production of N-
nitrosocompounds. 
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The normal oesophageal microbiota is believed to originate from the oral cavity, 
with a proportion of the organisms found in the oesophagus being part of the normal 
microbiota in the mouth. In patients with GORD, BO and ADC refluxate from the 
stomach may also contain bacteria able to colonise the oesophageal mucosa, 
resulting in a newly developed and unique microbiota.  
 
This study aims to identify the predominant organisms colonising the oesophagus, 
and to investigate whether there are specific species present in diseased patients 
which promote pathogenesis, or whether a complete shift in the microbial 
community promotes this reaction. 
 
2.2 Materials and Methods 
2.2.1 Patient recruitment  
Tissue for analysis of biofilm composition, structure and related host responses was 
obtained from patients during attendance for an upper gastrointestinal endoscopy at 
Ninewells Hospital Endoscopy Unit. Patients with gastro-oesophageal reflux disease 
(37), Barrett’s oesophagus (45), oesophageal adenocarcinoma or squamous cell 
carcinoma (34), and normal controls (39) were recruited. Patients were all aged >18 
years, with controls attending for upper GI endoscopy that was not related to 
oesophageal illness. Patients were excluded if they were receiving any medications 
that could disrupt their normal microbiota, principally antibiotics. 
   
Four biopsies were taken from each patient approximately 5 cm above the 
oesophagogastric junction (OGJ), at place of inflammation, BO or ADC site. Eight 
biopsies from each cohort (10 from ADC) were analysed for bacterial colonisation 
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and total cell counts, while all others were frozen (-80oC) for subsequent real-time 
PCR analysis (bacteria and cytokines, Chapter 3). 
 
The patients gave informed consent for participation in the investigation, and the 
Tayside Committee on Medical Research Ethics approved the study. 
 
2.2.2 Traditional culturing of oesophageal biopsies  
Eight specimens from the control, GORD and Barrett’s cohorts, and 10 from the 
cancer patients were cultured on a variety of growth media. Upon collection, the 
biopsies were placed in Wilkins-Chalgren broth for carriage to the laboratory for 
immediate processing. Individual biopsies were homogenised with half strength 
peptone water, and serially diluted to 10-3 before spreading on a wide range of 
selective plates in duplicate. Selective culture media used were as follows: Nutrient 
agar; MacConkey agar No. 2 (both aerobic); Blood azide agar (aerobic and 
anaerobic); Columbia blood agar (with Campylobacter and Helicobacter pylori 
growth supplements); Chocolate agar (all microaerophilic growth); Columbia blood 
agar supplemented with succinate, nitrate, formate and fumarate (1g L-1 each, 
Sigma-Aldrich, UK) for increased Campylobacter selection (microaerophilic and 
anaerobic growth); Wilkins-Chalgren blood agar (plain, non-spore forming and 
Gram negative supplements); Beerens agar (Beerens, 1990); Rogosa agar; MRS agar 
(de Man et al., 1960) and Reinforced clostridial agar (all anaerobic). All blood plates 
contained 5% (v/v) defibrinated horse blood, with all agars, supplements and blood 
purchased from Oxoid, Basingstoke, UK.  
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Anaerobic incubation was performed in a MACS MC-1000 Anaerobic Workstation 
(Don Whitley Scientific Ltd., Shipley, West Yorkshire, UK) with 10% hydrogen and 
carbon dioxide, and 80% nitrogen atmosphere. A 2.5% CO2 incubator (Flow 
Laboratories, Irvine, UK) was used for aerobic growth, and atmosphere generation 
jars with CampyGen and CO2Gen sachets (Oxoid) were employed for 
microaerophilic and facultative anaerobic growth. Both incubators were set at 37oC 
for 3-5 days, before colonies were picked, counted and sub-cultured for purity, prior 
to freezing at -80oC for future microbial identification using the MIDI system (see 
below), or 16S rRNA gene sequencing analysis. 
 
2.2.3 Microbial Identification System (MIDI) 
All bacteria were grown on WC agar, unless they required blood (WC blood), under 
the same temperature and gas conditions, before injecting into their appropriate 
broths. The majority of patient bacterial isolates were anaerobes, while organisms 
that preferred aerobic or microaerophilic growth were grown on BBL Trypticase soy 
agar (Becton Dickinson Ltd., Oxford, UK) overnight to produce 40 mg of bacterial 
cells. For anaerobic growth: Gram positive organisms were inoculated into peptone-
yeast basal medium with glucose (PYG) and Tween-80, while Gram negative 
isolates were grown in PYG without Tween-80. Fastidious organisms, such as, C. 
concisus, and other campylobacter species preferred PYG supplemented with a 
formate-fumarate solution. PY (no glucose) with lactate was the medium of choice 
for veillonellas.  
 
FAME were extracted by saponification, methylation and a final wash step (Miller 
and Berger, 1989), before removal into a crimped GC vial with rubber septa (Stager 
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and Davis, 1992). The majority of isolates were tested using the Anaerobe Library, 
while aerobes were identified via the Clinical Aerobe Library. Calibrations were 
used before each set of samples and after each run of ten. Only calibrations that 
reached >99% allowed sample analysis. Blank controls were made with each batch 
of extractions, positive controls were also run periodically; Escherichia coli for 
aerobes and Streptococcus stenotrophomonas for anaerobes, while a C. concisus 
type strain was also tested regularly.  
 
The gas chromatograph comprised a Hewlett-Packard 6890 GC Series system fitted 
with a 5% phenyl-methyl silicone capillary column (0.2 mm x 25 m), a flame 
ionisation detector, a Hewlett-Packard model 7637A automatic sampler and a Vectra 
XM computer (Hewlett-Packard Ltd., Palo Alto, CA, USA). Experimental 
parameters were as follows: column head pressure – 60 kPa; injection volume – 2 µl; 
column split ratio – 100:1; septum purge – 5 ml min-1; column temperature – 170-
270oC; injection port and detector temperatures – 300oC; gases – nitrogen, ultra high 
purity hydrogen and zero grade laser air – “make up” gas, carrier gas and flame 
support, respectively.  
 
2.2.4 DNA extraction and sequencing analysis of Campylobacter isolates 
Campylobacter isolates grew well on Columbia blood agar supplemented with 
formate, fumarate, succinate and nitrate, which proved to be a better isolation 
medium for these bacteria than standard antibiotic supplemented agar (Oxoid). These 
organisms were also distinguishable microscopically, however, FAME profiles did 
not match on occasions. Consequently, all isolates suspected to be campylobacter 
 62   
 
species due to their morphology and growth patterns, or by FAME analysis, were 
sent for sequencing for confirmation.  
 
Pure campylobacter cells were swabbed into PBS and centrifuged to form a pellet, 
before resuspension with 450 µl molecular grade water (VWR Ltd., Leicestershire, 
UK) and 50 µl lysozyme (50 mg ml-1) prior to incubation at 37oC for 30 min. To this 
suspension, 25 µl Proteinase K (Qiagen), 50 µl 20% SDS and 500 µl molecular 
grade water was added, together with 350 mg of 0.1 mm sterile glass beads. Two 
bead-beating steps (Mini-beadbeater 8, Biospec, Bartlesville, OK, USA) of 2 min, 
with incubations at 60oC for 10 min between these steps, facilitated release of DNA 
into the supernatant from the lysed cells. Cell debris was removed by centrifugation 
(3 min, 5000 g) before purification, washing and elution of the DNA in a Qiagen 
mini-column (DNeasy Blood and Tissue Kit, Qiagen Ltd., West Sussex, UK), 
according to the manufacturer’s instructions. 
 
The DNA was amplified using a campylobacter primer pair (Camp405F – GGA 
TGA CAC TTT TCG GAG and Camp633R – AAT TCC ATC TGC CTC TCC 
(Rinttilä et al., 2004) with 25 µM MgCl2 Mg-free thermophilic 10 x buffer, 100 µM 
dNTP’s, and Taq DNA polymerase (1 unit). Cycling parameters were as follows: 
95oC for 5 min, 35 cycles of 95oC for 1 min, 62oC for 1 min and 45 sec at 72oC, 
followed by a final elongation step of 10 min at 72oC. Product was run on 3% 
agarose gel before purification (QiaQuick PCR purification kit, Qiagen) and 
sequencing at the University of Dundee DNA Analysis Facility using the above 
forward primer (BigDye terminators in an ABI 3100 Genetic Analyser, Applied 
Biosystems).  
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2.2.5 Statistical analysis 
Statistical analysis was conducted using Prism Statistical Package (Prism 4 for 
Macintosh, Version 4.0, Graphpad software Inc., CA, USA). All numerical data 
were analysed using unpaired Student’s t-tests, with a normal distribution assumed 
(K-S test). A P-value of <0.05 was classed as highly significant, while values of 
<0.08 were considered to be close to significance.  
 
2.3 Results 
2.3.1 Demographics 
All patients involved in the study were between the ages of 40 and 87. The mean 
ages of controls, GORD and BO patients were 64, 65 and 66, respectively. However, 
the mean age of cancer patients was 58. In this investigation, the ratio of males to 
females was 3:5, 3:5 and 2:6 for controls, GORD and BO, respectively. True to 
previously published data, the ratio of males to females in adenocarcinoma was 
higher (nine males, one female). The majority of these patients did not smoke or 
drink alcohol. Eighty-seven percent of Barrett’s patients were prescribed a PPI (57% 
omeprazole, 43% lansoprazole), while only 50% of ADC patients were taking these 
drugs. Although endoscopically classed as normal, two control patients were taking 
PPIs, indicating reflux symptoms or gastritis. Four of the Barrett’s patients had 
intestinal metaplasia confirmed by histology, and one had intestinal metaplasia with 
low-grade dysplasia. This data is summarised in Table 2.1. 
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       Table 2.1: Clinical details of patients taking part in study for cultural analysis of 
oesophageal microbiotas.	  
	  
 
	   	  
 
 
 
 
 
     
 
 
 
 
 
     a Biopsies taken 5 cm above the OGJ. b Intestinal metaplasia. 	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2.3.2 The microbial ecosystem in oesophageal disease 
Bacteria were cultured on a variety of solid growth media to investigate bacterial 
colonisation of the oesophageal mucosa, and any alterations in microbiota 
composition at different stages of disease progression. With only eight samples from 
the control, reflux and Barrett’s patients, and 10 from the adenocarcinoma patients, 
statistically significant variances were difficult to identify. However, as disease 
progressed microbial communities increased in size, although reflux patients often 
had reduced numbers of certain bacteria.  
 
 
 
 
 
 
 
 
 
 
Fig. 2.1: Total colony forming units cm-2 taken from WC blood agar plates grown under 
anaerobic conditions, data points represent the number of patients in each cohort with 
presence of the stated bacteria. Control (8), GORD (8), BO (8), ADC (10), bars  
represent the mean. Comparison of GORD with ADC gave a  
P value approaching significance (P = 0.06).  
 
Figure 2.1 shows total anaerobic CFU for all eubacteria isolated from WC blood 
agar plates for each biopsy sample. Although total counts were also done for aerobic 
and facultative anaerobes, the majority of isolates from aerobic plates also grew 
anaerobically.  
Control GORD Barrett's ADC
3
4
5
6
7
8
9
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Investigation of oesophageal microbiotas in the control group, and those with 
varying stages of disease, indicated that the oesophagus housed a normal microbiota 
established from a number of species from the oral cavity. Less common oral species 
such as lactobacilli and bifidobacteria, and others rarely seen in this habitat, were 
also isolated from the oesophagus, indicating that this organ contains its own unique 
community. A number of streptococci (Fig. 2.2) were present in all of the patients 
except for one GORD. Bacterial cell numbers ranged from log10 3.4 to 7.5 CFU cm-
2, with a mean across all patients of log10 5.5. Streptococcus intermedius was the 
main species found in this genus, being present in all controls and ADC patients, 6/8 
GORD and 5/8 BO biopsies. Staphylococci (Fig. 2.3) were present in 7 control 
patients (log10 4.1 ± 1.1 CFU cm-2), however, these diminished in reflux patients 
(log10 3.9 ± 0.2 CFU cm-2 (n = 4)), indicating susceptibility to acid and bile, before 
re-establishing in Barrett’s and cancer patients (log10 4.6 ± 0.9 (n = 5) and log10 5.1 ± 
1.5 CFU cm-2 (n = 6), respectively).  
 
Actinomyces again indicated a response to refluxate in some species (Fig. 2.4, Table 
2.3) with normal populations of log10 4.5 ± 0.8 CFU cm-2 in 7 patients, with similar 
numbers in 4 GORD. Neisseria (Fig. 2.5) colonised the oesophagus of 5 control 
patients (log10 3.8 ± 0.9 CFU cm-2), with N. sicca being isolated from all subjects. 
Counts were reduced in GORD and BO patients, with N. sicca rarely being isolated. 
In ADC patients, these organisms were found in varying numbers, with a slight 
increase in mean CFU (log10 4.1 ± 1.2 CFU cm-2 (n = 4)). Prevotella (Fig. 2.6) were 
present consistently throughout disease in these subjects, whereas the prevalence and 
absolute numbers of Rothia denticariosa (Fig. 2.7) decreased through each stage of 
disease progression - from 7 patients (log10 4.5 ± 0.7 CFU cm-2), to 3 (log10 3.7 ± 0.3 
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CFU cm-2). Conversely, lactobacilli (Fig. 2.8) were only identified in 3 control 
patients (log10 3.3 ± 0.2 CFU cm-2), and increased in GORD (4.4 ± 0.8 CFU cm-2 (n 
= 4)), through to Barrett’s and cancer (4.6 ± 0.7 (n = 3) and 4.9 ± 1.6 CFU cm-2 (n = 
6)) respectively. Statistical analysis of these results showed significant variation in 
colonisation between control and reflux patients (P = 0.07), and control and Barrett’s 
patients (P = 0.02). Results did not significantly differ between patients with respect 
to bifidobacteria (Fig. 2.9), which were present in the majority of subjects. 
Bacteroides (Fig. 2.10) were isolated from 4 controls, 3 GORD and 4 ADC patients, 
with varying cell population densities, however, these bacteria were only found in 
one BO patient. Veillonella (Fig. 2.11) were detected in less than half of each patient 
group, and no significant differences were seen with respect to disease.  
 
Fusobacteria (Fig. 2.12) occurred in low levels in each disease group, and their 
numbers were reduced in GORD compared to controls (log10 4.5 ± 0.5 (n = 3), and 
log10 5.4 ± 0.9 CFU cm-2 (n = 3), respectively). Campylobacters (Fig. 2.13) were 
found in only two controls, while 6 of 8 reflux patients were colonised with these 
bacteria (log10 4.1 ± 0.8 CFU cm-2). Four Barrett’s and 6 ADC patients harboured 
campylobacters (log10 5.6 ± 0.4, and log10 5.3 ± 1.2 CFU cm-2, respectively). 
Significant variation was found between GORD and BO patients (P = 0.01). 
Comparison of controls with BO and ADC gave P values approaching significance 
(P = 0.07, and P = 0.08, respectively). Both controls carried Campylobacter 
concisus, while those with GORD and ADC had C. concisus, C. jejuni, C. coli, C. 
rectus or a combination of two species. All Barrett’s patients had Campylobacter 
concisus alone, or in combination with Campylobacter jejuni or Campylobacter coli.
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Fig. 2.2: Log CFU cm-2 of biopsy showing individual counts of streptococcus for each 
patient. For further information refer to Fig. 2.1 legend. 
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Fig. 2.3: Log CFU cm-2 of biopsy showing individual counts of staphylococcus for each 
patient. For further information refer to Fig. 2.1 legend. 
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Actinomyces
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Fig. 2.4: Log CFU cm-2 of biopsy showing individual counts of actinomyces for each patient. 
For further information refer to Fig. 2.1 legend. 
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Fig. 2.5: Log CFU cm-2 of biopsy showing individual counts of neisseria for each 
patient. For further information refer to Fig. 2.1 legend. 
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Prevotella
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Fig. 2.6: Log CFU cm-2 of biopsy showing individual counts of prevotella for each  
patient. For further information refer to Fig. 2.1 legend. 
 
 
 
Rothia
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Fig. 2.7: Log CFU cm-2 of biopsy showing individual counts of rothia for each  
patient. For further information refer to Fig. 2.1 legend. 
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Lactobacillus
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Fig. 2.8: Log CFU cm-2 of biopsy showing individual counts of lactobacillus foreach  
patient. For further information refer to Fig. 2.1 legend. Comparison of controls 
with reflux and Barrett’s patients gave P values of 0.07 and 0.02 respectively.  
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Fig. 2.9: Log CFU cm-2 of biopsy showing individual counts of bifidobacteria for each 
patient. For further information refer to Fig. 2.1 legend. 
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Bacteroides
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Fig. 2.10: Log CFU cm-2 of biopsy showing individual counts of bacteroides for each 
patient. For further information refer to Fig. 2.1 legend. 
 
 
 
Veillonella
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Fig. 2.11: Log CFU cm-2 of biopsy showing individual counts of veillonella for each 
 patient. For further information refer to Fig. 2.1 legend. 
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Fusobacterium
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Fig. 2.12: Log CFU cm-2 of biopsy showing individual counts of fusobacteria for each 
patient. For further information refer to Fig. 2.1 legend. 
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Fig. 2.13: Log CFU cm-2 of biopsy showing individual counts of campylobacter for each 
patient. For further information refer to Fig. 2.1 legend. Changes in Barrett’s patients 
compared with control patients reaching significance (P value = 0.07), comparison of 
GORD to Barrett’s and ADC patients P values of 0.01 and 0.08 respectively. 
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Tables 2.2 – 2.4 show all of the viable count data, with mean results for each species. 
In the 34 patients, 111 species representing 26 genera were isolated. In controls, 56 
species belonging to 19 genera were detected, compared with 55 species and 22 
genera in GORD. Sixty-one species from 23 genera were detected in BO, with 73 
species and 23 genera in ADC. Although the overall microbiota composition was 
generally consistent in all patient cohorts, significant variations were seen at the 
species level in some bacterial groups, such as with lactobacilli.  
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Table 2.2: Viable counts of Gram positive cocci colonising the 
oesophageal mucosa a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     a Numbers represent the mean log10 CFU cm-2 for all patients ± SD, number in parenthesis show      
    number of patients in each cohort harbouring this species. 
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Table 2.3:Viable counts of Gram positive rods colonising  
the oesophageal mucosa a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                a See footnote to Table 2.2. 
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Table 2.3 cont.: Viable counts of Gram positive rods colonising 
the oesophageal mucosa a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
 
   
 
 
 
       a See footnote to Table 2.2. 
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Table 2.4: Viable counts of Gram negative bacteria colonising the  
oesophageal mucosa a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     a See footnote to Table 2.2. 
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2.3.3 Bacterial colonisation of the oesophagus 
Figures 2.14 – 2.16 show the percentage that each bacterial group constitutes in each 
patient cohort (control, GORD, BO, ADC). The data provide a global view of the 
microbial composition of each disease group. Figure 2.14 identifies all groups in 
each microbiota, however, those genera constituting 6% or less each of the control 
patients were classified as Group B, while those composing less than 2% of the 
control microbiota were placed in Group C. This information is presented in Figs. 
2.15 and 2.16, respectively.  
 
Figure 2.14 identifies the major organisms isolated, constituting between 6% and 
13% of the microbiota in the control subjects. Streptococci were similar in controls 
and diseased patients, while bifidobacterial numbers went down from 10% of the 
control population to 7% in each disease group. Rothia constituted 9.5% of the 
control microbiota, reducing to 6% in GORD, 4.5% in BO, and 2.5% in ADC. 
Neisseria made up 6% of the control population, falling to 2-3% in the disease 
cohorts. Group B organisms constituted 25-29% of the microbiota, while Group C 
accounted for ca. 10% of the total normal microbiota, increasing to 27% in GORD, 
25% in BO and 30% in ADC.  
 
In group B (Fig. 2.15), bacteroides comprised 6% of the microbiota in controls, 1% 
in BO and 4.5% in ADC. Gardnerellas were found in 50% of BO patients, 
constituting 6% of the total microbiota. This proportion was reduced to 1% in ADC, 
where the organisms were found in only 1 patient. As shown in Fig. 2.8, lactobacilli 
increased with disease progression, comprising 3% of the control microbiota, and 
7% in ADC.  
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Group C bacteria (Fig. 2.16) varied through the disease cohorts, with 6 genera 
isolated in controls, and 8 in GORD, due to the appearance of Arcobacter and 
Eubacterium species. Barrett’s patients had 9 genera in Group C, with 
Faecalibacterium prausnitzii being present in 3 of the 8 patients, but not in any other 
patient group. ADC also had 9 different genera, with peptostreptococci colonising 3 
of the 10 subjects in this cohort. Campylobacter colonisation increased from 2% of 
the control microbiota to 8% in GORD, 6% in BO, and 7% in ADC. This genus 
showed the largest percentage increase of all bacterial species in these patients. 
Gemella increased from 2% in controls to 5.5% in ADC, while corynebacteria 
increased slightly in GORD patients compared to the other two disease cohorts (2% 
to 5%). Escherichia coli was found only in 1 control and 1 GORD patient (1% each), 
while eubacteria were found in GORD, BO and ADC patients, but not in any of the 
controls. Arcobacter cryaerophilus, a member of the Campylobactericeae family 
was only found in two reflux patients, constituting 3.3% of the total GORD 
microbiota. Lactococcus lactis was found in 1 Barrett’s patient, however, this 
species comprised 5% of the ADC microbiota, being isolated from three of these 
patients, with a high mean CFU (log10 6.7 cm-2). Enterococci were similarly only 
found in BO and ADC patients.  
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Fig. 2.14: Global percentages of the total bacteria found throughout the  
patient groups (8 control, 8 GORD, 8 BO and 10 ADC). Bacteria in  
Groups B and C are represented in Figs. 2.15 and 2.16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.15: Percentage separation of organisms in Group B. These genera 
 each constituted 6% or less of the total control population. 
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Fig.  
 
 
2.16: Percentage separation of organisms in Group C. These genera  
constituted less than 2% each of the total control population. 
 
 
2.4 Discussion 
The research in this chapter aimed to expand on the published data investigating the 
microbiota colonising the oesophageal mucosa. Previous research looked at healthy 
patients compared with those diagnosed with GORD and BO. This research used 
culturing techniques to look more closely at these patients, and additionally recruited 
subjects diagnosed with adenocarcinoma of the oesophagus.  
 
This study represents the first investigation of the oesophageal microbiota in ADC 
patients. Ten subjects with oesophageal ADC were analysed in this first part of the 
study, with 34 ADC and squamous cell carcinoma subjects being investigated 
throughout the project, both through culturing and molecular techniques. 
 
Bacterial populations play an important role in the maintenance of local gut 
physiology, and often disease pathology, as indicated by the development of 
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inflammatory bowel diseases (Macfarlane et al., 2009). It is hypothesised that the 
oesophageal microbiota is chiefly acquired from that of the oral cavity, and in 
disease, may also contain microorganisms originating from the stomach due to 
regurgitation of its contents during reflux. Oesophageal physiology, and alterations 
in cell morphology acquired during reflux disease, may have an effect on the host 
microbiota, leading to ADC development.  
 
Results from this part of the study indicated a shift in the oesophageal microbiota 
during disease progression. Five bacterial phyla were identified in all 34 patients: 
Firmicutes, Actinobacteria, Proteobacteria, Bacteroidetes and Fusobacteria. In these 
phyla, 11 genera of Firmicutes were found: Streptococcus, Staphylococcus, 
Peptostreptococcus, Gemella, Lactobacillus, Veillonella, Enterococcus, Clostridium 
Lactococcus, Faecalibacterium and Eubacterium. Seven genera of Actinobacteria 
were identified: Bifidobacterium, Actinomyces, Rothia, Gardnerella, Micrococcus, 
Propionibacterium and Corynebacterium. The Bacteroidetes, prevotella and 
bacteroides were found, while the Proteobacteria Campylobacter, Arcobacter and 
Neisseria were identified, along with Fusobacterium and Leptotrichia from the 
phylum Fusobacteria. These results concur with previous studies investigating the 
oesophageal microbiota in health and disease (Pei et al., 2004, 2005; Macfarlane et 
al., 2007; Yang et al., 2009). In total, 111 species representing 26 genera were 
isolated, however, in controls only 19 genera and 56 species were detected, 
compared with 23 genera and 73 species in all ADC patients.  
 
The data for controls is similar to that of the 4 patients in the Pei et al. (2004) study 
of the healthy oesophagus. Research into the oesophageal microbiota performed by 
Pei et al. (2004, 2005) and Yang et al. (2009) used PCR clone libraries and statistical 
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clustering analysis methods. There are arguments against using traditional culture, 
with over 50% of the 700 species in the oral cavity being uncultivable, or more 
correctly, difficult to culture (Aas et al., 2005). However, sequenced DNA could 
have multiple origins: viable bacteria adhering to the mucosal surface; transient 
organisms moving through the oesophagus, whether live or dead; and DNA 
fragments from dead bacterial cells. Nevertheless, results from these molecular 
based studies were similar to those obtained by Macfarlane et al. (2007) and the 
present study, with comparable pattern shifts in the microbiota being observed 
during disease progression. Consequently, the advantages of molecular techniques 
compared to culturing may not be as significant as previously thought.  
 
The phylum and genus TM7 was isolated from patients in the molecular-based 
studies (Pei et al., 2004, 2005; Yang et al. 2009). This genus has previously been 
recovered from a variety of habitats, ranging from hydrothermal sediments to the 
human mouth (Luo et al., 2009). A study by Marcy et al. (2007) used single cell 
genetic analysis techniques and FISH to identify and sequence TM7, before 
comparative analysis to identify possible similarities with other genera. This has 
given some insight to the biochemistry, and possible virulence of this genus. They 
identified this bacterium from an oral biofilm, discovering a possible Gram positive 
phenotype with thick rod morphology. This study found a small number of genes 
with similarities (>60%) to fusobacteria, clostridia and bacilli, however, these may 
have originated from DNA contamination. Additionally, genes encoding type IV 
pilus proteins were identified, suggesting gliding motility (Marcy et al., 2007). TM7 
species may be an important component of the oesophageal biofilm, with a 
significant role in disease pathogenesis; however, much is still to be discovered 
about this bacterium. With no TM7 cultured to date, it is not known whether the 
 85   
 
 
TM7 sequences found during studies of the oesophageal microbiota (Pei et al., 2004, 
2005; Yang et al., 2009) are from viable colonising organisms. 
 
Results obtained in studies described in this chapter did not reveal any specific 
organisms that were present in the majority of disease phenotypes that did not occur 
in any of the healthy controls. Thus, a single aetiologic agent could not be linked to 
oesophageal disease. Nevertheless, differences in the prevalence of particular 
bacterial groups and relative bacterial numbers were observed, with the microbiota 
becoming increasingly Gram negative. This was particularly evident with 
staphylococci, actinomyces and neisseria, which were reduced in GORD. However, 
as oesophageal cell morphologies continued to change with disease progression, 
becoming columnar, and then metaplastic/dysplastic, the prevalence of these species 
reverted to that found in normal patients. This data indicates that changes in the 
extracellular environment, cell surface structure and gastric secretions could affect 
these organisms, rendering them less able to colonise inflamed mucosa. These 
organisms may also be particularly acid and bile acid-sensitive. However, with the 
addition of other acid-resistant species forming microcolonies and biofilms on the 
modified host cells, they may be able to repopulate the mucosa.  
 
As disease progressed, lactobacillus diversity increased, with 13 different species 
being detected in ADC alone. Three control patients harboured lactobacilli at levels 
of log10 3.0 CFU cm-2, while 4 GORD, 3 BO and 6/10 ADC patients had numbers as 
great as 7.5 log10 CFU cm-2. Lactobacilli are present in a large number of fermented 
foods; therefore, many of these organisms could simply have been in transit through 
the upper GI tract. Rothia denticariosa displayed a reduced ability to colonise the 
oesophageal mucosa during disease, with a proportional reduction both in the 
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number of patients colonised and CFU cm-2 of tissue. This is converse to the results 
of Yang et al. (2009), where significantly higher numbers of this organism were 
found in disease patients. 
 
The recent study by Yang et al. (2009) used statistical clustering analysis to further 
investigate their results. Two distinct microbial populations were detected, 
distinguishing healthy individuals from those with oesophageal disease. This group 
designated these ‘Type I’ and ‘Type II’ microbiomes, with the former being found in 
healthy patients (92%), and the latter in those with GORD (58%) and BO (60%). 
The type I microbiota was characterised by having a majority of streptococcal 
species; 78% compared with 29% in the type II microbiota. The percentage of 
gemellas was reduced in the abnormal oesophagus of type II microbiome patients, 
while Gram negative species were increased. The genera Prevotella/Bacteroides, 
Campylobacter, Neisseria and Fusobacterium increased significantly in the 
abnormal microbiota, with total Gram negative species increasing from 14.9% to 
53.5% between type I and type II. Finally, 16.3% of the type I microbiota was 
comprised of anaerobic/microaerophilic organisms, compared with 61% of the type 
II microbiome (Yang et al., 2009). This study is in line with our hypothesis, 
indicating that the normal (type I) microbiota is predominantly established from the 
oral cavity, while in diseased patients, the biofilm becomes increasingly colonised 
with gastric bacteria and Gram negative species, signifying that it is not a single 
genus or species that stimulates disease progression, but a whole shift in the 
microbiome.  
 
The global population analyses done in this study found a shift in microbiota 
composition between control and abnormal patients. Figures 2.14 – 2.16 show the 
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key changes in percentage populations of each genus with Fig. 2.14 identifying the 7 
most abundant genera which comprised 6-13% of the control population. In contrast 
to the study by Yang et al. (2009), streptococci constituted similar proportions of the 
microbiome in all patients, with an opposing shift in proportions of bifidobacteria, 
rothia, bacteroides and gemella. Similar to the study by Yang et al. (2009), 
lactobacilli, campylobacter, leptotrichia and peptostreptococcus populations 
increased with disease progression, suggestive of this type II microbiome. 
 
Although these two studies do not show a complete correlation of results, the 
proposal of a whole shift in biofilm composition, rather than one specific pathogen 
being responsible for disease progression, is plausible. The results of all of these 
studies into the oesophageal microbiota do not identify one organism present only in 
disease; however, campylobacters manifested the greatest increase during disease 
progression in both studies using culture techniques (Macfarlane et al., 2007; this 
investigation). The increased presence of pathogenic nitrate-reducing Campylobacter 
species in disease patients is of some concern. These bacteria are fastidious, slow 
growing microaerophilic organisms that often require special filtration methods for 
their isolation. Additionally, they are sensitive to many of the antibiotics used in 
selective culture media for the isolation of C. jejuni and C. coli. Therefore, a new 
medium was designed to selectively grow these organisms, in which no antibiotics 
were added and the preferred energy sources formate, fumarate, nitrate and succinate 
were provided to enhance the growth of C. concisus, the main species found in BO 
patients by Macfarlane et al. (2007). The use of this medium proved successful, in 
that it was able to isolate these organisms with greater ease under microaerophilic 
and anaerobic conditions. Campylobacter concisus was the main campylobacter 
found in this study, however, some patients that harboured this species were also 
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colonised with one or more of C. jejuni, C. coli or C. rectus. Campylobacter 
concisus has previously been associated with periodontal diseases in humans 
(Tanner et al., 1979), and has been linked to enteritis in children (Lindblom et al., 
1995). The organism was found in multiple areas of the healthy mouth (Aas et al., 
2005), indicating that it may be a potential pathogen found in the normal commensal 
microbiota of some humans.  
  
As discussed in Section 1.5.5, nitrate reduction by oral bacteria such as veillonella, 
rothia and actinomyces, may provide a mechanism for further oesophageal damage, 
through the production of nitric oxide during gastric reflux. The increased 
prevalence of nitrate reducing C. concisus, not only in BO patients as found 
previously (Macfarlane et al., 2007), but also in those with GORD and ADC, may 
increase the mutagenic effects of refluxate alone at the OGJ. Campylobacter 
concisus has a varied virulence potential, and some strains have been shown to 
invade Hep-2 (human epidermal) cells faster than C. jejuni (Russell and Ward, 
1998), producing cytotoxic effects similar to those of H. pylori. In the pathology of 
gastric adenocarcinoma, H. pylori has been identified as the main aetiologic agent, 
however, this is dependent on the strain’s virulence status, in particular, possession 
of the CagA pathogenicity island (Lochhead and El-Omar, 2008). In the present 
study, although campylobacters were increasingly isolated in disease, they were also 
isolated from two healthy controls; therefore, virulence genes may be a key factor in 
disease aetiology. Further research is essential to fully sequence these isolated 
campylobacters, and investigate the presence of pathogenicity islands and 
consequently, virulence potential. 
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The oral pathogens Treponema denticola, Tannerella forsythia and Porphyromonas 
gingivalis can co-adhere in vivo, forming what is known as the “Red Complex” 
(Socransky et al., 1998). The growth of these organisms in close juxtaposition on 
mucosal surfaces amplifies their pathogenicity to levels greater than possible 
individually. The polymicrobial disease theory suggests that this complex is 
accompanied by a variety of organisms (Section 2.1.3) often not found in healthy 
individuals. Therefore, the presence of these virulent organisms may modify 
community behaviour to enhance bacterial survival and virulence.  
 
Oral microorganisms bind to saliva adsorbed onto surfaces in the oral cavity; the 
varying surfaces in the mouth present an array of receptors (immunoglobulin, α-
amylase, fibronectin, lactoferrin). These proteins preferentially bind certain species 
compared with others, accounting for the variations in biofilm communities in 
different areas of the mouth (Socransky et al., 1998). As tissue becomes diseased 
these surface receptors can become altered. This provides an increased proteinaceous 
environment supporting the growth of proteolytic organisms, and thus escalating the 
disease pathway due to further alterations from a commensal, healthy community. 
Hence, in the case of oesophageal disease the presence of campylobacters alone may 
not initiate the disease process but alterations in oesophageal cell morphology, and 
consequently the adhering microbiota, might lead to the development of a 
pathogenic community. 
 
Interestingly, a recent mouse model study (Strachan et al., 2008) infected 5 male and 
4 female mice with C. jejuni under maintained environmental conditions, 
investigating a possible sexual dimorphism in this genus. Results found statistically 
increased colonisation of male mice compared with females by this species, 
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indicating that physiological differences associated with gender affect campylobacter 
colonisation. Men are at increased risk of developing oesophageal ADC; therefore, 
this data gives credence to the hypothesis of campylobacter being an aetiologic agent 
in oesophageal disease progression, possibly in synergy with other species. 
 
This initial study of the oesophageal microbiota in healthy, GORD, BO and ADC 
patients has not identified a specific aetiologic agent. However, it has given credence 
to the hypothesis of bacterial involvement in oesophageal ADC development. Due to 
the relatively small number of individuals in each patient cohort, a common pattern 
could not be identified and environmental factors such as PPI use could not be 
assessed. The patients recruited for this study had a diverse age range compared with 
the molecular-based studies by Pei et al. (2004, 2005) and Yang et al. (2009) which 
recruited from an all male veteran centre with the majority of volunteers over the age 
of 70 years. The patient demographics in these three studies may have affected their 
results, due to the general shift in the commensal microbiota with age (Hopkins et 
al., 2001).  
 
The proposal that Barrett’s oesophagus and adenocarcinoma may have a 
polymicrobial disease aetiology is plausible, with many human diseases being due to 
multiple species. Campylobacter concisus chiefly colonised patients in juxtaposition 
with other campylobacter species, leptotrichia, arcobacter and fusobacteria. These 
organisms are all known pathogens, and therefore, when complexed together in a 
biofilm could have amplified virulence effects, similar to that of the oral “Red 
Complex”.  
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The human microbiota is a highly complex system, although there is a baseline of 
common bacteria, microbial composition is most likely completely unique to each 
individual. Presence of a type I or type II microbiota (Yang et al., 2009) could be 
due to the effect of refluxate, or individuals may habitually contain one or the other 
microbiome phenotype. Data from all of these studies on the oesophageal 
community do however, indicate a shift in composition with disease progression, in 
that it becomes increasingly diverse and Gram negative based. There are many 
environmental factors that could initiate this modification, including other disease 
status, antibiotic use, and life-style choices such as diet. Further research into the 
microbiota is required, with a larger cohort of patients in each disease group. 
Moreover, experimentation with individual bacteria, such as campylobacter, is 
essential to understand both their virulence potential, and consequently, their 
interactions with the host.  
  
 
Chapter 3 
 
Molecular analysis of oesophageal 
biofilm communities 
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3.1 Introduction 
The previous chapter reported on the bacteriological analysis of four patient cohorts 
(controls, GORD, BO, ADC), and identified the predominant viable organisms 
colonising the oesophageal mucosa in health and disease. These results, used together 
with earlier data obtained by Macfarlane et al. (2007) were used to design assays for 
real-time PCR. Molecular techniques such as this allow large numbers of patient 
samples to be quantitatively analysed at a greater rate than is possible with culture-based 
microbiology. The use of molecular technologies is expanding greatly, and will continue 
to do so in the future. It is inconceivable, at this time, to know what will be learned 
about human and environmental microbial ecosystems. The study of human genetics has 
expanded greatly in recent years, with the establishment of the Human Genome Project, 
and this has yielded important insights into human diseases, and consequently, potential 
treatments. With the Human Microbiome Project (National Institutes of Health) 
underway, the relationship of the host with the GI ecosystem will be better understood, 
allowing new areas of research to be developed.  
 
Experiments with mono- and dizygotic twins, compared with unrelated individuals, 
show that host genotype has a considerable impact on the gut community (Zoetendal et 
al., 2001; Stewart et al., 2005). The interplay between host and microbial genetics seems 
to involve cross-talk (Bry et al., 1996; Hooper and Gordon, 2001; Hooper et al., 2002), 
allowing management of nutrient production, metabolism and immune regulation. The 
latter has been understood for many years, however, researchers are currently finding 
the genetic basis for the former.  
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Insight into these intricate interactions is of great relevance to the aetiology of gut 
disorders, especially gastrointestinal cancers. The involvement of H. pylori in gastric 
ulcers leading to ADC is one of the most significant findings in this area, with much 
research dedicated to these interactions between host and bacteria. As discussed in 
Section 1.2.8, variation in the immune response to infection is dependent on host 
genetics. This study aims to further identify the mucosal biofilms present in control, 
GORD, BO and ADC patients using real-time PCR. This technology will also be 
employed to assess cytokine responses to the oesophageal microbiota, aiming to identify 
links between mucosal populations, the inflammatory process and the potential 
progression to, or maintenance of, adenocarcinoma.  
 
3.1.1 Real-time PCR 
The traditional polymerase chain reaction (PCR) technique was devised nearly 40 years 
ago (Kleppe et al., 1971), however, the discovery of heat stable taq polymerase, isolated 
from the bacterium Thermus aquaticus, led to the full development of this technique 
during the following decades (Mullis, 1990). In 1993, Dr Kary Mullis was awarded the 
Nobel Prize in Chemistry for the invention of PCR. This technique allows logarithmic 
amplification of short DNA sequences, using primers (short sequences of ca. 20 base 
pairs) which bind to their complementary bases, extending upon heated reaction to 
produce multiple copies of double-stranded DNA. Continuing from this revolutionary 
technology, Higuchi and co-workers at Roche Molecular Systems constructed a system 
that allows the real-time analysis of this amplification reaction (Higuchi et al., 1993). In 
contrast to traditional PCR, where product is analysed at end-point using agarose gel 
electrophoresis, during the real-time PCR reaction, a video camera measures the level of 
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bound fluorescent dye during each cycle, facilitating quantification of double-stranded 
DNA relating to the exact starting quantity. Originally, ethidium bromide allowed 
visualisation of fresh double-stranded DNA, however, new and safer probes such as 
TaqMan and Sybr green are now available. There are two techniques available for 
quantification in real-time PCR: absolute and relative. The former relies on a serially 
diluted standard curve with specific input values for gene copy number, while the latter 
determines only the fold-difference in material.  
 
In this study, standard curves were prepared for each target gene employing cloning 
techniques to produce a plasmid with a known value, as illustrated in Fig. 3.1. This 
shows an example of a real-time PCR amplification report, showing graphs of relative 
fluorescence units (RFU) per cycle, and the associated standard curve plotted from these 
results. These graphs were taken from a H. pylori assay in this study, with a serially 
diluted plasmid of 106-101 molecules of target µl-1. 
 
Real-time PCR offers a number of advantages over traditional PCR, such as collection 
of data during the exponential growth phase, which minimises the use of post-PCR 
processing (gel electrophoresis). The increase in relative fluorescence units is directly 
proportional to the number of amplicons generated, giving quantitative rather than 
qualitative data for presence of the gene, and therefore, bacterial load in the starting 
material. Real-time PCR is a sensitive technique, although it is not necessarily more 
specific or sensitive than traditional culture. However, in a study such as this, where 
such large sample numbers are required, real-time PCR provides a time saving and 
reliable technique for analysis of mucosal populations.  
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Fig. 3.1: Real-time PCR amplification graph (top) and associated standard curve (bottom). The 
amplification graph shows the exponential phases for the serially diluted plasmid, with the 
standard curve plotted from the baseline, identifying the gene copy number for each biopsy 
sample (red squares). This image is taken from the H. pylori assay in this study. 
 
3.1.2 Issues with campylobacter and cytokine assays  
The quantification of campylobacters provided the biggest challenge in this project, due 
to both specificity and sensitivity issues. Real-time PCR is a very sensitive technique, 
therefore, even minor primer dimer production led to alteration of the results. 
Publication searches resulted in a number of possible primers for universal 
campylobacter, C. rectus and C. concisus quantification. These primers (Table 3.1) were 
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tested using standard PCR (Section 3.2.7) with culture collection Campylobacter species 
(Table 3.2) and additional genera and species isolated from the human gastrointestinal 
tract (Strep. salivarius, Staph. aureus, L. acidophilus, Bif. longum, F. nucleatum CCUG 
53249, H. pylori, V. parvula, B. vulgatus, Prev. tannerae, Pept. anaerobius, E. coli, Ent. 
faecalis) for specificity.  
 
Table 3.1: Details of primer pairs tested for campylobacter PCR assays, results of their 
use, with reasons for insufficiency. 
 
 
 
 
 
 
 
 
 
Table 3.1 identifies the main primers tested and the results of the assays, indicating 
reasons for discard, such as primer-dimer production. The primer set designed by 
Rinttilä et al. (2004) offered the best detection, allowing for universal amplification of 
all tested campylobacters. This primer set was employed for PCR and sequencing of 
suspected campylobacters isolated by traditional culture (Chapter 2), however, under 
real-time PCR conditions, unsuitable levels of primer dimer were produced. The 
company Primer Design Ltd (Southampton, UK) provided sponsorship to develop a 
new, highly specific and sensitive primer, for detection of the Campylobacter genus. 
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Throughout months of consultancy, a primer pair very similar to that of Rinttilä et al. 
(2004) was designed, however, upon real-time PCR, this primer set still resulted in a 
low level of primer dimer product. A search for short sequences to amplify DNA from 
genes other than 16S rRNA was also performed, including the heat shock protein groEL, 
Type II topoisomerase gyraseB, the enzyme phospholipase A and finally the β-subunit 
of RNA polymerase, rpoB. This final gene provided the best match upon PCR analysis, 
and was highly specific to the tested campylobacters (Table 3.2), with no amplification 
of other bacteria (listed above). Quantitative results were obtained for all biopsy samples 
utilizing these rpoB primers (CampRpoBF/R, this study, Table 3.1) with real-time PCR. 
Although some primer dimer was still observed during real-time PCR, the levels were 
low (101 - 102 SQ mean), which is common for this technique. To eliminate doubt, all 
products were tested for amplicon size using agarose gel electrophoresis, with results 
only taken from those with a band of the correct size (112 bp). 
 
The second component of this research was to investigate host responses in oesophageal 
tissue relating to carriage of these organisms. Problems were encountered with primer 
sets for cytokine analysis of these biopsy tissues. Development of assays for a selection 
of cytokines was proposed (TNF-α, IL-1α, IL-1β, IL-8, IL-18, IL-4, IL-6, IL-10, 
Interferon-γ, IL-10). However, due to time constraints, only those for TNF-α, IL-1β, IL-
8 and IL-18 were performed with cDNA from the tissue samples. Problems were 
encountered with either primer design or the final assay, yet it is unclear whether this 
was due to unspecific primer sets, or issues with positive samples taken from blood 
donors, including the methods for extraction.  
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3.1.3 Cytokine analysis in oesophageal disease 
The induction of host responses due to infection was discussed in the Introduction 
(Sections 1.2.8 and 1.5.6). Interleukin-8 is a well studied cytokine in the immune 
response to BO and its development to ADC. Research has revealed an increased IL-8 
expression in GORD patients compared with BO and non-inflamed squamous tissue 
(Fitzgerald et al., 2002b), while Isomoto et al. (2003, 2007) discovered an increase in 
this cytokine with disease severity, and a correlation between increased expression and 
recurrence of oesophagitis. It is possible that this cytokine could be employed as a 
marker for disease severity and potential disease relapse. A further study by Fitzgerald 
et al. (2002a) investigated the response of Il-1β to oesophageal inflammation. They 
exposed patient samples to a bile acid cocktail (pH 4), finding increased expression after 
a pulsed, rather than continuous exposure, providing insight into the pathological 
differences between patients with varying patterns of reflux episodes. IL-1β is involved 
in the cellular activities of proliferation and apoptosis, and can additionally induce 
COX-2 production, contributing to inflammatory pain hypersensitivity (Samad et al., 
2001; Binshtok et al., 2008). Conversely, Isomoto and co-workers found no significant 
difference in IL-1β levels between GORD and control subjects. However, expression of 
this cytokine correlated with IL-8 production, both of which, together with TNF-α, are 
regulated by NF-kappa B pathways, also found to be activated in these GORD patients 
(Isomoto et al., 2003). A study investigating levels of IL-8 and IL-1β found higher 
levels in NF-kappa B positive compared with negative patients, being most significant 
in those with ADC. Additionally, expression of IL-8 and IL-1β increased with grade of 
GORD, presence of dysplasia and stage of ADC (O’Riordan et al., 2005).  
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The similarity between gastric and oesophageal ADC has been discussed throughout this 
study, with comparable profiles for host responses. A study by Thong-Ngam and co-
workers recruited 68 patients with either gastric cancer or gastric ulcers, employing 
ELISA to measure a range of immune responses (Thong-Ngam et al., 2006). The 
expression of IL-18 was increased significantly in ADC vs. gastric ulcer samples. IL-18, 
formally known as IFN-γ inducing factor, stimulates both innate and adaptive responses 
(Th1 and Th2), inducing NK cell activity and apoptosis, and inhibiting angiogenesis in 
tumour cells. However, inappropriate production of this cytokine is thought to influence 
the clinical outcome of ADC, being involved in its pathogenesis (Lebel-Binay et al., 
2000). A significant difference in the protein levels of IL-18 was found in ADC patients 
compared with those with gastric ulcers; IL-18 might therefore be used as a diagnostic 
marker (Thong-Ngam et al., 2006). There is no published research investigating the role 
of IL-18 in oesophageal adenocarcinoma, although Diakowska et al. (2006) used blood 
samples from 41 patients with oesophageal squamous cell carcinoma to measure serum 
levels of this cytokine. A correlation was observed between the expression of this 
protein and stage of disease, with significantly higher levels in stage IV compared with 
stage II and III patient cohorts. Consequently, if similar associations are found with 
oesophageal ADC, expression of this cytokine may be used for prognosis as well as 
diagnosis.  
 
Chapter 2 of this study investigated the presence of viable organisms colonising the 
mucosa throughout various stages of oesophageal disease. The presence of 
campylobacters in GORD, BO and ADC is of great interest, and warrants further 
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research. A number of studies have investigated the inflammatory response to 
campylobacter, with induction of a number of cytokines (IL-1α, IL-1β, IL-6, TNF-α, 
IL-8), triggered by cytolethal distending toxin (CDT), LPS, flagellins and their related 
secreted proteins (van Putten et al., 2009). These cytokines recruit neutrophils and 
monocytes to the site of infection, and result in tissue damage. The induction of IL-8 by 
campylobacters when introduced to intestinal epithelial cell lines shows that C. jejuni 
and C. coli increase expression of this cytokine within 4 hours, with protein detection at 
24 hours (MacCallum et al., 2006; Borrmann et al., 2007). The study by MacCallum 
and co-workers, used cell culture and human tissue recovered during surgery, to 
investigate the differences in response of these intestinal cell types. Although similar 
patterns of induction occurred after infection with C. jejuni, increased levels of IL-8 
were found with human tissue, which was likely due to the full range of inflammatory 
cell types present and their ability to cross-talk. Interestingly, they also identified a 
difference in the response dependent on the anatomical site from which tissue was 
removed, proving the importance of primary tissue in understanding the bacteria-host 
interactions during health and disease.   
 
Hence, research reported here aimed to identify the key organisms present in the 
oesophagus of patients in health and disease, and the possible effect of these mucosal 
populations on the host immune response, employing molecular real-time PCR 
technologies. 
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3.2 Materials and Methods 
3.2.1 DNA extraction from bacterial isolates for assay development 
Bacterial cultures were grown on Wilkins-Chalgren agar (Oxoid) for DNA extraction. 
Cells were swabbed into PBS and spun down to form a pellet, which was resuspended 
with 450 µl of molecular grade water (VWR Ltd., Leicestershire, UK) and 50 µl 
lysozyme (50 mg ml-1) before incubating at 37oC for 30 min. To this suspension, 25 µl 
Proteinase K (Qiagen kit), 50 µl 20% SDS and 500 µl molecular-grade water was added, 
together with 350 mg 0.1 mm sterile glass beads. Two bead-beating steps (Beadbeater-8, 
Biospec, Bartlesville, OK, USA) of 2 min with incubation at 60oC for 10 min between, 
allowed release of the DNA into the supernatant from the lysed cells. The cell debris 
was removed by centrifugation (3 min, 5000 g) before purification, washing and elution 
of the DNA in a Qiagen mini-column (DNeasy Blood and Tissue Kit, Qiagen Ltd., West 
Sussex, UK) according to the manufacturer’s instructions. 
 
3.2.2 RNA extraction from peripheral blood 
Blood was removed from the donor and mixed with a wash buffer (RPMI 1640, 
penicillin/streptomycin, HEPES buffer (all Invitrogen, UK) and Ficoll Paque (GE 
Health Systems, VWR, UK)). This suspension was centrifuged at 2600 rpm for 17 min 
(18oC), before removing the white blood cells into fresh wash buffer, and spinning at 
1750 rpm for 10 min. Wash buffer was then removed and the white blood cells shaken 
to break the pellet. The cells were kept on ice for 5 min before disruption with 350 µl 
lysis buffer (RTL buffer and mercaptoethanol). Lysates were poured into Qiashredder 
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columns (RNeasy Tissue Kit, Qiagen Ltd., West Sussex, UK) and the RNA extracted, 
washed and eluted as per the manufacturers instructions. 
 
3.2.3 Reverse transcription PCR (RT-PCR) 
Reverse transcription was performed with RNA, to produce more stable cDNA for use 
in PCR and real-time PCR. mRNA (Section 3.2.2) underwent a thermal cycle of 42oC 
for 90 min followed by 95oC for 5 min. Reagents and protocol used were provided by 
Primer Design Ltd. (Southampton, UK). 
 
3.2.4 Primer development 
Primer sets were designed, or further optimised, to target the small 16S rRNA (or rpoB 
for campylobacters) gene subunit of a select range of bacteria and cytokines for use in 
real-time PCR. Bacterial primers were selected based on knowledge obtained from 
previous culture and molecular-based studies of oesophageal microbiota composition in 
both health and disease (Pei et al., 2004, 2005; Osias et al., 2005; Macfarlane et al., 
2007; this investigation). Primer pairs for these assays are shown in Table 3.3. Primer 
sets for specific species were designed having aligned 16S rRNA gene sequences to 
highlight variations. 
 
Lyophilised primers were purchased from Invitrogen. To prepare for PCR, they were 
dissolved in 300 µl PCR water (molecular biology grade water, BDH, VWR, 
Lutterworth, UK) and left on ice for 20 min, before being mixed and diluted 1:100 to 
determine concentration spectrophotometrically. The spectrophotometer was set to 
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measure absorbance at 260 nm for DNA. DNA concentrations were then measured 
using the following equation:     
 
                                              A260 x 20 
      x dilution factor (100)  
       Number of nucleotides in the primer x 0.33 
      
 
Equation 3.1: Measurement of primer concentration 
 
 
This equation is designed based on the knowledge that one unit of absorbance at 260 nm 
is equal to 20 µg µl-1 DNA nucleotides, and that one nucleotide has a molecular weight 
of 0.33 gmol-1, giving the final concentration in µM. Once the concentrations of the 
primers were known, they were prepared into 10 µM aliquots for use in the PCR 
reactions. All primers were stored at -80oC. 
 
3.2.5 Campylobacter assays 
Five Campylobacter species were purchased from CCUG (Culture Collections, 
University of Goteborg, Sweden), with another two isolated from patient studies.  The 
accession numbers for these species are provided in Table 3.2. The CCUG cultures were 
provided in their lyophilised form in ampoules.  Upon delivery they were reconstituted 
with Wilkins-Chalgren broth warmed to 37oC and spread on multiple plates of both WC 
blood agar and Columbia Blood supplemented with formate, fumarate, succinate and 
nitrate (1 g L-1 each) before storing for 3 days at 37oC anaerobically and 
microaerophilically.  
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Table 3.2: Accession numbers for different campylobacters (CCUG) required for 
universal campylobacter primer development. 
 
 
 
 
 
 
 
 
 
 
All bacteria were sub-cultured several times and observed microscopically before 
storage in freezing medium (WC broth, 2% mucin and 10% glycerol). Additionally, 
eubacterial primers (Table 3.3) were used for sequencing of the 16S rRNA, confirming 
their taxonomy. Section 3.1.2 gives full information on the experiments and design work 
for a highly specific and sensitive assay for whole campylobacter genus, with a primer 
pair for amplification of the rpoB gene being the final assay of choice.  
 
3.2.6 Attaining optimum temperatures for PCR 
Bacterial DNA was subjected to PCR (section 3.2.7) in an Eppendorf Mastercycler 
gradient machine. This allowed duplicate samples to be tested at a range of different 
temperatures. These samples had a standard protocol of 95oC denaturation and 72oC 
elongation steps, however, the annealing stage had temperatures ranging from 54oC to 
65oC, with increments of 0.5oC - 1oC. When the PCR products were run using gel 
electrophoresis, the optimum temperature (Table 3.3) was identified as the assay where 
most product was present, and after which none was visible, due to primer denaturation.  
Campylobacter species Accession number/origin 
Campylobacter concisus CCUG 34767 
Campylobacter fetus CCUG 41521 
Campylobacter coli CCUG 36766 
Campylobacter lari CCUG 22395 
Campylobacter hyalointestinalis CCUG 26151 
Campylobacter jejuni Barrett’s oesophagus patient 
Campylobacter rectus Barrett’s oesophagus patient 
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3.2.7 Polymerase chain reaction  
Standard amounts of DNA corresponding to target sequences were required for real-
time PCR. Briefly, DNA and cDNA extracted from previously isolated bacteria or blood 
(cytokines), containing the target sequence, was amplified using each PCR primer pair 
(Table 3.3). Forty-nine µl of master mix was added to 1 µl of purified DNA. PCR 
amplification was undertaken on a Techne Thermal Cycler with the temperature profile 
as follows: an original 2 min cycle set at 42oC, followed by 35 cycles; 1 min at 95oC for 
incubation, annealing step for 1 min at the optimum temperature (dependent on the 
individual primer sets (Table 3.3)), elongation stage of 45 seconds at 72oC. A final 
elongation stage of 10 min at 72oC left the DNA ready for analysis by agarose gel 
electrophoresis. The amplicons were separated on 3% (wt/vol) agarose gel to identify 
products. The gel was made with 1.5 g of agarose heated with 50 ml 1 x TTE buffer, 
with 0.4 µl ethidium bromide added for visualisation of the bands with UV trans-
illumination at 305 nm. The products were run at constant 90 V for 20 min before 
visualisation. Band sizes were determined using a DNA ladder (2-log DNA ladder, 0.1 - 
10 kb, New England Biolabs, Beverly, MA).  
 
3.2.8 Ligation, transformation and purification 
The product of correct size and sequence was purified using the QIAquick PCR 
purification kit (Qiagen) and ligated into a vector using the pGEM-T® Easy Vector 
System I (Promega, Madison, USA) employing pGEM-T Easy Vector plasmids (Fig. 
3.2). The vector, DNA and ligase were incubated for 30 min at room temperature, before 
transformation into JM109 competent E. coli cells (>108 CFU µg-1, Promega). The 
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bacteria were defrosted quickly on ice, before being added to sterile Falcon tubes with 
the above reaction mixture, and incubated for a further 30 min on ice. Transformants 
were heat shocked in a 42oC water bath for 45 sec before being placed back on ice for 2 
min. Four hundred and fifty µl of SOC (Sambrook and Russell, 2001) also heated to 
42oC, was then added to the transformed cells and incubated for 1 hour at 37oC in an 
orbital shaker (New Brunswick G24 Tabletop Incubator/Shaker) at 150 rpm.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2: pGEM-T Easy Vector Plasmid 
 
The suspension was centrifuged (5 min, 1000 g) to collect the cultured cells, 350 µl of 
supernatant was removed, and the bacteria resuspended with remaining SOC prior to 
spreading on LB agar plates containing ampicillin for selection of transformed colonies. 
After overnight incubation, colonies contained the insert, because the pGEM®-T Easy 
Vector contains an ampicillin resistance gene for its selection. Colonies were picked and 
incubated in LB Broth with ampicillin overnight in the orbital shaker at 37oC. To check 
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the presence of insert in the plasmid, PCR was carried out with the overnight culture. 
Five hundred µl of the broth was centrifuged (5 min, 5000 g) to collect cultured cells. 
All supernatant was removed before resuspending the cells in 50 µl lysis buffer (1 ml 
1% Triton-X-100, 2 ml 20 mM Tris-HCl and 74 mg 2 mM EDTA in 100 ml PCR water) 
and incubating on ice for 30 min to lyse the cells and release the plasmid. The 
suspension was then centrifuged at 20,000 g for 1 min, and 5 µl of this supernatant was 
removed for PCR using the appropriate primer pair (Table 3.3) for each clone, to check 
for the presence of the gene. 
 
Plasmids were purified using the QIAprep Spin Miniprep Kit. Concentration of the 
plasmid preparation was determined by agarose gel electrophoresis, with known 
standards (New England Biolabs). The samples were diluted to 1010 molecules µl-1, 
aliquoted and stored (-80oC). 
 
3.2.9 Patient recruitment 
Biopsies were collected from patients as described in Chapter 2 (Section 2.2.1). 
 
3.2.10 DNA extraction from patient biopsies 
Extraction of bacterial DNA was carried out with a Qiagen DNeasy Blood and Tissue 
kit. Biopsy tissues were transferred aseptically from L-glutamine solution (GIBCO®, 
Invitrogen) into a sterile Eppendorf tube for storage at -80oC. Frozen biopsies were 
suspended in 200 µl lysis buffer and 50 µl lysozyme (50 mg ml-1) before incubating at 
55oC for 30 min. To mechanically disrupt the cells, 350 mg 0.1 mm glass beads 
(Biospec, Barlesville, OK, USA) were added to the biopsy suspension with 25 µl 
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Proteinase K, 200 µl Buffer ATL (both Qiagen kit) and 200 µl ethanol (96-100%) prior 
to bead beating for 2 min before and after incubation at 70oC for 30 min. Centrifugation 
(3 min, 5000 g) removed all cell debris, allowing purification of DNA in the 
supernatant. DNA was adsorbed onto Qiagen mini-columns (DNeasy Blood and Tissue 
Kit) by centrifugation, and purified according to manufacturers instructions. 
 
3.2.11 RNA extraction from biopsies 
The liquid nitrogen technique for extraction of mRNA from biopsies was employed. A 
pestle and mortar were cooled with liquid nitrogen before adding biopsy tissue and 
grinding. The resultant powder was then poured into a Falcon tube, and after 
evaporation, 350 µl of lysis buffer (RTL buffer and mercaptoethanol) was added. The 
lysate was then poured onto a Qiashredder column and the RNA was extracted, washed 
and eluted as per the manufacturers instructions. cDNA was obtained using methods 
described in Section 3.2.3. 
 
3.2.12 Quantitative real-time PCR 
The appropriate plasmid preparation (Table 3.3) was diluted to give a standard curve of 
106-101 molecules µl-1 for all assays, except GapDH, which had a standard curve of 108-
101 molecules µl-1. Real-time PCR was performed using an iCycler and iQ SYBR Green 
Supermix (Bio-Rad, Hercules, CA, USA) using the optimum annealing temperature for 
each primer set (Table 3.3). Test samples (bacterial DNA and host cDNA) were added 
in duplicate at 2 µl per well in a 20 µl total reaction volume. Results are expressed as 
means of two separate experiments.  
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3.2.13 Statistical analysis 
Statistical analysis was conducted using Prism Statistical Package (Section 2.2.5). Data 
were tested for Gaussian distribution using the Kolmogorov-Smirnov (K-S) test, with 
skewed results undergoing transformation before analysis. ANOVA (one-way analysis 
of variance) with Bartlett’s test for equal variances, and Newman-Keuls post-hoc testing 
was carried out on data showing significance. Student’s t-tests (two-tailed) were also 
carried out to measure variation between individual groups where no significance was 
seen with ANOVA, and for analysis of bacteria in male and female patients. Paired 
Student’s t-tests were employed to analyse transformed results from ADC vs. squamous 
tissue from one individual. For cytokine analysis of the four groups, ANOVA was 
applied, while for the ADC and non-ADC tissue from matched patients, Wilcoxon 
Matched Signed Rank tests were performed for IL-8 and IL-1β, while paired data was 
insufficient for statistical analysis of TNF-α and IL-18.  A P value of <0.05 was classed 
as statistically significant. 
 
3.3 Results 
3.3.1 Demographics 
All patients were between the ages of 22 and 87, with mean ages of 58 to 63 in all 
patient cohorts, with a greater female to male ratio in control and GORD subjects (27:12 
and 23:14, respectively). However, in BO and cancer patients, this shifted to a ratio of 
31:14 and 25:9 males to females respectively, confirming previous evidence that men 
are at greater risk of BO and cancer (Lofdahl et al., 2008). Twelve patients undergoing 
surgery for oesophageal resection volunteered to take part in this study. Samples were 
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taken during surgery from areas of cancerous and normal squamous tissue. Histological 
analysis revealed squamous cell carcinoma (SCC) in four of these patients, while the 
remaining eight were diagnosed with ADC. The remaining 22 ADC patient samples 
were acquired during upper gastrointestinal endoscopy. No significant variances were 
identified between ADC and SCC patient data, therefore, results from these two patient 
groups were analysed as a whole (cancer cohort).  
 
Of 45 Barrett’s patients, 53% (n = 24) had a hiatal hernia, nine IM, and two dysplasia. 
Interestingly, 34/45 BO patients were prescribed a PPI, whereas only 10/34 cancer 
patients were taking these drugs. Ten out of 39 controls and 26/37 GORD were taking 
PPIs, indicating that many of these cancer patients had not previously been diagnosed 
with oesophageal or gastric conditions. The cancer patients were also taking the least of 
any other drugs, including NSAID, cardiac or anti-depressants. Conversely, cancer 
patients had the highest alcohol consumption, with only eleven subjects stating an 
infrequent alcohol intake, compared to 20/39 controls, with remaining patients drinking 
between 1 and 70 units of alcohol per week (Table 3.4). 
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Table 3.4: Clinical details of patients taking part in study for molecular analysis of oesophageal 
microbiotas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a biopsies taken 5 cm above the OGJ. b Intestinal metaplasia. c Cancer patients diagnosed with 
adenocarcinoma or squamous cell carcinoma. 
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3.3.2 Real-time PCR analysis of oesophageal bacteria 
Molecular analysis of bacterial abundance was carried out with whole DNA extracted 
from patient biopsies. Total eubacterial populations had a relatively stable spread in all 
patients, however, comparisons of the four means with ANOVA, found a significant 
difference, with P = 0.0438. Newman-Keuls post-hoc testing found the variation was 
attributable to differences in the means of control and ADC patients (P < 0.05) (Fig. 
3.3). Analysis of individual bacterial genera indicated that the composition of these 
bacterial populations varied widely. Gaps in cell numbers existed in these patients 
signifying the need for a larger range of assays to be undertaken.  
 
Figure 3.4 shows results from the bifidobacterium assay, levels of these bacteria were 
reduced in GORD patients before recovering towards normal in cancer. ANOVA did not 
show a significant variation between means in these patients. However, the Bartlett’s 
test for equal variance highlighted a shift in the distribution of data (P = 0.0163). 
Bacteroides levels were variable throughout (Fig. 3.5), with statistically significant 
variation between all four groups (P = 0.0338). Fusobacteria populations were 
significantly reduced in GORD compared with normals (P < 0.001, Newman-Keuls) 
(Fig. 3.6). ANOVA gave a P value of 0.0001, indicating highly significant variation 
between the mean of all four patient groups.  
  
Veillonella also showed a decrease in diseased patients compared with normals (P < 
0.0001 (Fig. 3.7)). Distribution of data and therefore, levels of this species in each 
individual, were highly variable, indicated by the Bartlett’s test (P = 0.0005). 
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Lactobacilli were similar in most patients, with a small number of outliers in each group 
(P = 0.0008, Bartlett’s) (Fig. 3.8). Staphylococci (Fig. 3.9) varied significantly 
throughout patient cohorts, with a P value of 0.0003 for all four means (ANOVA) and P 
= 0.0043 (Bartlett’s). Additionally, Newman-Keuls post-hoc testing revealed significant 
differences between controls and the three disease groups. In Fig. 3.10, Helicobacter 
pylori data indicates that prevalence was low in the majority of patients. In the control 
group there were 3 outliers with higher populations, however the others were similar to 
GORD and BO patients. The cancer group had the lowest H. pylori prevalence, in 
accordance with the theory of cancer protection from this species. ANOVA found a 
significant difference between all means (P < 0.0001), with statistically significant 
reductions between ADC and controls, GORD and BO (P < 0.001, 0.001, 0.01, 
respectively). 
 
 
Real-time PCR results with primer sets amplifying the rpoB gene for the genus 
campylobacter are shown in Fig. 3.11, with expression from only five normals and three 
cancer subjects. Due to primer dimer products found in negative samples, results were 
only taken from samples with a positive band visualised on agarose gels. ANOVA did 
not show any significant differences in the mean bacterial population for each group. 
Populations of campylobacter were higher in BO patients than in GORD, with an almost 
significant difference in their means found with the Student’s t-test (P = 0.0814). 
Although there were only three cancer patients, their prevalence was significantly higher 
compared to GORD (P = 0.0266); however, the quality of this analysis is limited by the 
sample size. 
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Fig. 3.3: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total eubacteria for each patient. Results were obtained for 24/39 controls, 27/37 GORD, 25/45 
BO and 26/34 cancer patients. P = 0.0438, ADC vs. Control, P < 0.05. 
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Fig 3.4: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total bifidobacteria for each patient. Results were obtained for 37/39 controls, 37/37 GORD, 
45/45 BO and 30/34 cancer patients. GORD vs. BO and control (P = 0.003 and 0.0402 
respectively, (t-test)). 
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Fig. 3.5:  Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total bacteroides for each patient. Results were obtained for 38/39 controls, 37/37 GORD, 41/45 
BO and 26/34 cancer patients. P = 0.0338 (ANOVA). Comparison of GORD vs. BO and ADC 
gave a P value of 0.0159 and 0.0202, respectively (t-test). 
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Fig. 3.6: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total fusobacteria for each patient. Results were obtained for 15/39 controls, 15/37 GORD, 
24/45 BO and 18/34 cancer patients. Comparison of all four cohorts gave a P value of 0.0001, 
with control versus GORD, BO and cancer patients being highly significant (P < 0.01).  
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Fig. 3.7: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total veillonella for each patient. Results were obtained for 38/39 controls, 37/37 GORD, 45/45 
BO and 25/34 cancer patients. Comparison of all four cohorts gave a P value of <0.0001, 
control and BO vs. ADC (P < 0.001), GORD vs. control and BO (P < 0.05).  
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Fig. 3.8: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total lactobacillus for each patient. Results were obtained for 38/39 controls, 37/37 GORD, 
45/45 BO and 30/34 cancer patients. Bartlett’s test for equal variances (P = 0.0008), no other 
significant differences observed. 
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Fig. 3.9: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts of 
total staphylococcus for each patient. Results were obtained for 38/39 controls, 37/37 GORD, 
45/45 BO and 29/34 cancer patients. Comparison of all four cohorts gave a P value of 0.0003 
(ANOVA) and 0.0043 (Bartlett’s). Control vs. GORD, BO and ADC (P < 0.05). 
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Fig. 3.10: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of H. pylori for each patient. Results were obtained for 29/39 controls, 20/37 GORD, 26/45 BO 
and 23/34 cancer patients. Comparison of all four cohorts gave a P value of 0.0001 (ANOVA) 
and 0.06 (Bartlett’s). ADC vs. control, GORD and BO (P < 0.01). 
 120 
Campylobacter
Control GORD Barrett's Cancer
1
10
100
1000
10000
 
Fig. 3.11: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of total campylobacter for each patient. Results were obtained for 5/39 controls, 19/37 GORD, 
19/45 BO and 3/34 cancer patients. Comparison of GORD vs. BO and cancer gave P values of 
0.0814, and 0.0266, respectively (t-test). 
 
Analysis of microbiological results in patients prescribed a PPI compared with those not 
receiving PPI did not show any statistically significant differences. Interestingly, none 
of the five control patients with occurrence of campylobacter were taking a PPI. 
However, levels of campylobacter in the diseased patients were similar in both cohorts 
(Fig. 3.12).  
 
Variations in bacterial colonisation of male and female patients were also analysed (Fig. 
3.13). Eubacterial numbers were highest in males, with a significant difference between 
male and female control patients (P = 0.0355). Statistically significant differences 
between the sexes were also found in control patients with colonisation by veillonellas 
(P = 0.0066). While fusobacteria were more prevalent in female subjects than males in 
patients with both GORD and cancer (P = 0.0093, and 0.0167, respectively).
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Slightly higher levels of campylobacter were detected in males with BO, and especially 
ADC, with the opposite seen in control and GORD (no statistically significant 
differences).  
 
Cancerous and normal matched tissue from twenty-six patients was also analysed to 
compare intra-individual variances in the microbiota dependent only on tissue 
morphology. Data was not normally distributed and was thus transformed, allowing 
results to be analysed using a paired Student’s t-test. The eubacterial assay indicated that 
there was no expression in a number of the non-cancerous tissues. Limited statistical 
analysis revealed a P value of 0.0137 (Fig. 3.14), with higher prevalence of bacteria seen 
in the matched normal squamous tissue compared with that at the cancerous site. 
Bifidobacteria had similar detection values in both tissues, although, levels were 
generally diminished in matched diseased tissue (P = 0.0091) (Fig. 3.15). 
Staphylococcal (Fig. 3.16) prevalence was similar in all tissue types; however, 
population means were significantly higher in the matched non-cancerous tissue (P = 
0.0001). Bacteroides (Fig. 3.17) were found in similar numbers throughout, however, 
the majority of patients revealed a decrease in colonisation of these species on cancerous 
tissue (P = 0.0083). Veillonella (Fig. 3.18) was found in higher numbers in the normal 
tissue (P = 0.0263). Similar results were obtained with H. pylori assays (Fig. 3.19), with 
higher mean values for normal tissue (P = 0.0005). In a number of patients, H. pylori 
was detected in either cancerous or non-cancerous tissue only. However, in all of the 
subjects where this species was found in both tissue types, the prevalence was increased 
in normal squamous tissue.   
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Fig. 3.14: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of eubacteria for each patient. Results were obtained for 26 cancerous and 11 normal squamous 
tissues (P value 0.0137). 
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Fig. 3.15: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of bifidobacteria for each patient. Results were obtained for 30 cancerous and 22 normal 
squamous tissues (P value 0.0091).  
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Fig. 3.16: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of staphylococcus for each patient. Results were obtained for 30 cancerous and 22 normal 
squamous tissues (P value 0.0001). 
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Fig. 3.17: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of bacteroides for each patient. Results were obtained for 30 cancerous and 22 normal 
squamous tissues (P value 0.0083) 
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Fig. 3.18: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of veillonella for each patient. Results were obtained for 25 cancerous and 11 normal squamous 
tissues (P value 0.0263). 
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Fig. 3.19: Gene copy number per 1000 GapDH molecules of biopsy showing individual counts 
of H. pylori for each patient. Results were obtained for 23 cancerous and 20 normal squamous 
tissue (P value 0.0005). 
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3.3.3 Molecular analysis of cytokine expression 
Analysis of a small number of cytokines (Section 3.1.2) previously associated with BO 
and ADC was performed to measure variations in host responses with disease 
progression. cDNA was extracted from patient biopsies and expression was measured 
against GapDH molecules. No statistical differences were found between mean cytokine 
levels in diseased groups compared with controls for any of the pro-inflammatory 
cytokines tested. The number of patients with expression of TNF-α were low compared 
with the other three assays, since there was no detection through real-time PCR for a 
number of the samples. Levels of mRNA expression for each cytokine were widespread 
through all patients, ranging from 1x10-5 to 1x106 (Fig. 3.20 – Fig. 3.23). 
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Fig. 3.20: Gene copy number per 1000 GapDH molecules of biopsy showing individual mRNA 
expression for TNFalpha in each patient. Results were obtained for 14/39 controls, 13/37 
GORD, 8/45 BO and 5/34 cancer patients. No Significant differences were observed.  
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Fig. 3.21: Gene copy number per 1000 GapDH molecules of biopsy showing individual mRNA 
expression for IL-18 in each patient. Results were obtained for 22/39 controls, 27/37 GORD, 
32/45 BO and 12/34 cancer patients. No Significant differences were observed. 
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Fig. 3.22: Gene copy number per 1000 GapDH molecules of biopsy showing individual mRNA 
expression for IL-8 in each patient. Results were obtained for 28/39 controls, 28/37 GORD, 
32/45 BO and 17/34 cancer patients.  No Significant differences were observed. 
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Fig. 3.23: Gene copy number per 1000 GapDH molecules of biopsy showing individual mRNA 
expression for IL-1beta in each patient. Results were obtained for 29/39 controls, 22/37 GORD, 
25/45 BO and 13/34 cancer patients. No Significant differences were observed. 
 
 
Cancerous and non-cancerous tissue from the same cancer patient was also analysed for 
variances in the cytokine response in these two sites. No significant differences were 
identified, possibly due to the minimal volume of data available, mainly from normal 
squamous matched tissue. This is likely attributable to either not receiving normal 
healthy tissue from the clinician carrying out the procedure, or, no expression was 
detected during real-time PCR analysis. Plots of these cytokine data are not shown.  
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3.4 Discussion 
This chapter aimed to further characterise the oesophageal microbiota composition in 
patients with GORD, BO and cancer, compared to controls. The use of real-time PCR is 
a faster technique compared to culture, allowing a greater number of samples to be 
analysed quantitatively. Results from Chapter 2 did not identify a key organism that was 
present only in disease, and it was concluded that mucosal populations in the 
oesophagus shift to a more varied, Gram negative composition, which may result in 
disease progression.  
 
This study represents the first investigations of the oesophageal microbiota in cancer, 
with 34 patients recruited for culture and molecular analysis. The demographic data 
confirms that the majority of patients who develop cancer are males (Lofdahl et al., 
2008). Interestingly, 50% of controls, 40% of GORD, and 38% of BO, stated that they 
did not drink alcohol, compared with 32% of cancer patients. This progressive increase 
in alcohol consumption with disease progression is interesting with data on alcohol and 
oesophageal ADC risk being inconclusive and contradictory (Pandeya et al., 2009). The 
majority of these patients who did drink consumed only low levels, however, an ADC 
patient stated intake of 50 units of beer per week, while one SCC subject drank 70 units 
of wine per week. Alcohol consumption is a known major risk factor for SCC 
development, with polymorphisms in ALDH2 and ADH1B1, enzymes involved in 
alcohol metabolism (Lao-Sirieix et al., 2010; Pandeya et al., 2009). 
 
Microbiological data from this part of the study corresponds with results from Chapter 
2, indicating a shift in mucosal population composition during disease progression. 
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Information is limited due to the nature of real-time PCR, with data only collected for 
those bacteria chosen for analysis. Therefore, assays for the major genera identified in 
Chapter 2 were developed, however, this does not take into account individual variations 
and minor species. In contrast, characterisation of the oesophageal microbiota using 
PCR clone libraries (Pei et al., 2004, 2005; Yang et al., 2009), allows total bacterial 
DNA to be identified, therefore, all species present are detected. Nevertheless, as 
discussed previously, this technique has pitfalls. The DNA detected by real-time PCR 
may also have multiple origins and could provide false information. Due to the design of 
this study, using cultural results to design real-time PCR assays, it is hoped that these 
pitfalls have been avoided, providing quantitative results for viable bacteria colonising 
the oesophageal mucosa. There is a large gap in numbers between total eubacteria and 
individual bacterial genera in these patient cohorts. However, cultural and molecular 
analyses of the oesophageal microbiota identified streptococci as the predominant 
bacteria, comprising between 12% and 78% of the total community (Pei et al., 2004, 
2005; Yang et al., 2009; Macfarlane et al., 2007, this study). An assay for the genus 
Streptococcus could not be designed, with primers unable to detect all species in this 
genus. Additionally, assays for neisseria, actinomyces and rothia were not utilized in 
this research, which, from information in Chapter 2, account for up to 6%, 10% and 
10%, respectively (Fig. 2.14 – 2.16). The lack of data for these four genera may account 
in large part for the discrepancy in the real-time PCR results.  
 
Levels of H. pylori were low in all patients, but the organisms were detected in a greater 
percentage of controls compared with diseased tissues. This species was not recovered 
from any patients by culture (Chapter 2), which could be due to their low prevalence in 
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the oesophagus, being undetectable on culture medium. In control, GORD and BO 
patients this species had similar detection levels, clustering at 1-100 gene copy numbers 
per 1000 GapDH molecules. Conversely, in cancer patients, detection levels were 
distributed across a greater range, but at lower values. A statistically significant 
reduction in H. pylori prevalence was found in the disease cohorts compared with 
controls. This corresponds with previous studies describing cancer protection by this 
species, possibly due to presence of the cagA pathogenicity island. Jones et al. (2003) 
co-cultured this species with the ADC cell line, OE33, and normal oesophageal cells. H. 
pylori cagA+ and cagA- species were added to these cell lines, intact and sonicated, to 
measure their ability to apoptose oesophageal cells. Adenocarcinoma cells underwent 
apoptosis at a higher rate than control cells, a process which was dependent on the 
presence of cagA+ genes (Jones et al., 2003). Results from this study may explain why 
H. pylori is protective against cancer, since its presence in the oesophagus of healthy 
patients prevents abnormal cells from continuing to survive, halting metaplastic 
progression to dysplasia.  
 
Many bacteria in the genus Bifidobacterium are known probiotics, and there has been 
extensive research into their anti-inflammatory properties. The prevalence of this genus 
was reduced in GORD patients compared with controls, however, it increased with 
further disease progression. Results from cancerous and normal squamous matched 
tissues identified a reduction in the number of bifidobacteria in cancerous tissue. 
Although two patients had a marked increase in colonisation in their diseased tissue, 
76% of these matched patients showed the reverse.  
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Kim et al. (2010) tested the effect of B. lactis on the inflammatory response of human 
colon adenocarcinoma cell cultures (HT-29), and in mice with induced colitis-associated 
cancer. This species down-regulated NF-kappa B pathways and inhibited NF-kappa B 
regulated genes in these intestinal epithelial cells and in in vivo models, reducing the 
number and size of tumours present in mice (Kim et al., 2010). As discussed previously 
(Section 3.1.3), NF-kappa B regulates the expression of IL-8, IL-1β, and TNF-α, which 
are all extensively studied cytokines in oesophageal disease progression (Fitzgerald et 
al., 2002a, 2002b; O’Riordan et al., 2005).  
 
The reduction in prevalence of bifidobacteria in GORD patients could allow further 
inflammation and disease progression. The occurrence of bifidobacteria in BO and 
cancer had a similar spread to that of controls, however, microbiome composition has 
much intra-individual variation, with this study highlighting these changes between 
healthy and diseased tissues in the oesophagus. Biopsies were only taken from the 
diseased tissues of GORD and BO patients, and therefore, the presence of this genus in 
non-diseased tissues may have been higher, with a reduction in those tissues which were 
inflamed or metaplastic, allowing for continued disease progression. Research into the 
use of probiotic therapy in oesophageal disease needs to be conducted, investigating 
their ability to reduce inflammation and inhibit disease progression.  
 
The enteropathogen Campylobacter, has been identified as a possible factor in 
oesophageal disease progression (Macfarlane et al., 2007; this study), and these 
organisms may also be inhibited by bifidobacteria. Research by Gibson and Wang 
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(1994) used plate co-culture to measure the inhibition zones of extracted bifidobacterial 
antimicrobial substances with a range of enteropathogens, including campylobacters. 
Bifidobacterium angulatum, B. infantis and B. longum exerted the greatest inhibitory 
effects on campylobacter growth, again indicating that these probiotic bacteria could be 
used instead of, or in conjunction with, antibiotics to treat intestinal diseases. The anti-
inflammatory nature of bifidobacteria has also been studied with a view for their 
possible use in treatment of ulcerative colitis (Furrie et al., 2005a). This study provided 
patients with either a synbiotic (B. longum and Synergy 1) or a placebo for one month, 
taking biopsies before and after treatment to measure modifications in the host response. 
This synbiotic therapy upregulated β-defensins, and reduced the expression of TNF-α 
and Il-1α in the treatment group (Furrie et al., 2005a).  
 
Research by Collado et al. (2005) found that antimicrobial peptides produced by 
bifidobacteria are also active against H. pylori. Six bifidobacterial strains were isolated 
from human faeces, and their cell-free supernatants were tested in co-culture with H. 
pylori from gastric biopsies, to measure the resultant inhibition zones. These strains 
produced inhibitory peptides, such as bacteriocins, however, they were not further 
classified by this research. Additionally, these bacteria were resistant to the majority of 
antibiotics, and could potentially be used in the treatment of H. pylori associated 
gastritis. These studies suggest a possible role for probiotic therapy in oesophageal 
disease; however, consideration of the effects of bifidobacteria on H. pylori must be 
taken into account, due to the proposed protective role of this species.   
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The nitrate-reducing veillonellas were diminished ten-fold in diseased patients 
compared with controls, while fusobacteria were reduced 100-fold between control and 
GORD patient cohorts. This pattern of reduction in GORD, before an increase back to 
normal numbers and spread in BO and cancer is similar in many of the bacterial groups 
studied (including staphylococci, lactobacilli and bifidobacteria). However, for 
veillonella and fusobacteria, numbers were lower in cancer patients than in controls, 
similar to H. pylori. Veillonella and fusobacteria can co-aggregate, with veillonellas 
being a secondary coloniser and fusobacteria, a bridge organism in biofilm 
development. Veillonella only weakly adhere to epithelial surfaces, relying on other 
species to which they can co-aggregate with: mainly streptococci and actinomyces. A 
recent study by Periasamy and Kolenbrander (2010), investigated single and multi-
species colonisation, finding an increased presence of multi-species biofilms when 
veillonella were present, indicating a promotion of mutualistic community development 
by this species. Additionally, studies of oral populations show that this genus only 
adhere to species present in the same niche, with veillonellas from the tongue only 
adhering to other bacteria on the tongue, not from other surfaces (Kolenbrander, 2006). 
This spatio-temporal preference for inter-bacterial adherence may also be important for 
oesophageal communities. Oral bacteria from all sites are washed into the oesophagus 
and therefore, distinct co-aggregates and biofilms may only develop between certain 
species, dependent on the primary colonisers of the oesophageal mucosa and their 
original habitat. This mechanism may be important in understanding the unique 
microbiota that develops in the oesophagus, and its variability between each individual. 
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This loss in prevalence of veillonella, fusobacteria and H. pylori in diseased patients, 
particularly in the cancer cohort, indicates a change in whole biofilm structure. Further 
research into the prevalence of streptococci and actinomyces in these subjects is 
required to better understand the ecological significance of these early colonisers, and 
the detrimental effect to the microbiota due to their displacement. In the molecular study 
by Yang et al. (2009), streptococci constituted the majority of the ‘Type I’ microbiota in 
normal patients, with a reduction in this genus and other Gram positive species, with 
disease progression (‘Type II’). Loss of this genus could initiate a further change in 
biofilm structure, with bridge organisms, such as fusobacteria, being equally reduced.  
 
Similar to data from Chapter 2, Campylobacter prevalence increased in diseased 
subjects, with a 10-fold difference in means between GORD and cancer patients. Only 
three cancer patient biopsies yielded results for the presence of campylobacter. 
However, this was most likely due to issues with the assay, with results from Chapter 2 
indicating an increase in prevalence of this species with disease progression. Lack of 
data for cancer patients, and their presence in cancerous and non-cancerous matched 
tissues is unfortunate, and further research is required with these patients.  
 
Studies into the cytokine responses of oesophageal tissues in health and disease 
produced a large variation in results for each patient, with no significant differences 
found. This is in contrast to previous studies into the host responses (Fitzgerald et al., 
2002a, 2002b; Isomoto et al., 2003; O’Riordan et al., 2005), where IL-1β and IL-8 were 
increased in disease, or shifts in their expression were correlated (Section 3.1.3). In the 
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present study few results were obtained for normal squamous tissue in cancer patients, 
and no relationships were identified between GORD grades or presence of 
Campylobacter species. Investigation of the host response in oesophageal disease by 
Fitzgerald et al. (2002b) used PCR with densitometry analysis of the resulting bands to 
quantify levels of total RNA for each cytokine. The primers used for PCR (Jung et al., 
1995) were also tested for use in this study, however, unspecific bands were identified in 
some samples and low levels of primer-dimer were expressed. Fitzgerald et al. (2002b) 
also employed ELISA, finding a correlation between relative differences in cytokine 
expression, although data from immunostaining was not formally quantified. The study 
by O’Riordan et al. (2005) also used ELISA to measure cytokine levels. This technique 
measures protein rather than gene expression, with no direct correlation between mRNA 
expression and protein production (Mehra et al., 2003). The concentration of a protein is 
determined not only by mRNA but also by its related translation to protein, and 
additional factors involved in protein degradation. This, together with primer issues, 
could explain the differences in results between these studies and the present research. 
Therefore, to fully assess the cytokine response in oesophageal health and disease, 
analysis of both gene expression and protein level is required.  
 
TNF-α is expressed in specific areas of tissues and glands, and therefore, only in certain 
cells of metaplastic or dysplastic regions (Tselepis et al., 2002). Consequently, in a 
whole biopsy, cell-cell variation in expression may occur, and measurement of 
expression in the biopsy could mask increased expression in specific cells. In addition, 
the inflammatory gradient between proximal and distal sites of the diseased tissue may 
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account for these data (Fitzgerald et al., 2002a). Individual host responses, genetics and 
variations in the microbiota may be important factors in the inflammatory response to 
oesophageal disease. With such a diverse range of results for each cytokine in this study, 
further genetic and proteomic analysis is required to fully investigate these interactions.   
 
As with Chapter 2, no definite conclusions can be made from this microbiological or 
immunological data, with no aetiologic agent identified.  However, these results 
correspond with previous research of the oesophageal microbiota, indicating a shift with 
disease progression, and a conformational change in biofilm composition, represented 
by changes in prevalence of certain species and their co-aggregation partners. The 
ability of H. pylori to induce apoptosis in ADC cells, and the reduction of this species in 
oesophageal disease is of great interest, indicating that the progression of disease to 
cancer could depend on the host’s microbiota, rather than changes in the epithelia 
leading to a shift in the microbiome.  
 
The question remains; does the host’s individual microbiota initiate disease progression 
when exposed to reflux, or, do the changes in epithelial cell type result in the 
modification of bacterial populations? A long-term study of individuals at risk of 
oesophageal disease, and the alteration in each subject’s microbiota during progression, 
could be the key to understanding the involvement of bacteria in oesophageal 
dysfunction.  
 
 
  
 
Chapter 4 
 
Chemostat model of the oesophagus to 
investigate the effects of refluxate on 
microbiota composition and its 
associated pathogenicity 
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4.1 Introduction 
4.1.1 In vitro model systems  
Chemostats have been used in research and industry for over fifty years, for 
investigation of a single bacterium to a whole gut microflora, and planktonic to biofilm 
populations. However, use of these in vitro systems declined in the last thirty years 
when genetic techniques became increasingly popular. Modern genetics has allowed 
much greater understanding of microbial genomes, protein, mRNA and metabolite 
profiles, providing a molecular understanding of microbial physiology. These 
techniques have employed batch culture to obtain bacterial cells, however, recent studies 
have shown that this growth method can alter cell physiology and gene expression (ter 
Linde et al., 1999; Causton et al., 2001). Therefore, the use of chemostat cultures in 
conjunction with genomic and proteomic approaches provides a more accurate 
representation of microbial processes in their natural environment (Wick et al., 2001; 
Piper et al., 2002).   
 
4.1.2 In vitro models of the oral cavity 
Since the early 19th century ‘artificial mouth’ models have been in development, 
progressing from basic and simple apparatus, to that of computerised multi-station 
artificial mouth systems (Tang et al., 2003). In 1976, Dibdin and co-workers used 
continuous culture apparatus to model the oral cavity and dental plaque development 
(Dibdin et al., 1976). Since this time, in vitro continuous culture systems have been used 
extensively to model the oral microbial community, allowing full, controlled 
investigation of biofilm composition and bacterial metabolism (Marsh et al., 1983; 
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McKee et al., 1985). Studies which use plaque, or two or three defined species for 
inoculation are not necessarily reproducible, due to the variation in plaque composition 
over time. Additionally, the recovery of samples can disturb biofilm communities, 
therefore, this latter study aimed to overcome these issues. Nine oral organisms 
(Streptococcus mutans, S. sanguis, S. mitior, Veillonella alcalescens, Actinomyces 
viscosus, Bacteroides intermedius, Fusobacterium nucleatum, Neisseria sp. A1078 and 
Lactobacillus casei) were employed to determine the effect of glucose-excess and 
glucose-limited environments on microbial establishment, and whether these models 
could generate reproducible results (McKee et al., 1985). When glucose was limited (28 
mmol l-1) all nine species were established and maintained in the planktonic 
environment, with Streptococcus mitior and Veillonella alcalescens predominating. 
However, in an excess of glucose (390 mmol l-1) species diversity was reduced, with L. 
casei being the predominant bacteria. Biofilm samples also developed on the surface of 
the chemostat vessel, with interactions observed between fusobacteria, veillonellas and 
streptococci. The growth of anaerobic fusobacteria and veillonella indicate that other 
species sequestered oxygen, providing conditions for survival. Additionally, the 
increased diversity under glucose limitation suggests that competition for nutrients is an 
important factor for survival, requiring a mix of substrates for development of complex 
communities. This study provided insight into the communications between bacteria 
when in juxtaposition, and the protection provided by a biofilm.  
 
This research group continue to use chemostat models for investigation of the role of 
oral bacteria in health and disease, investigating the development of biofilms and the 
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effects of carbohydrates, nutrient availability and oxygen on bacterial growth rates 
(Bradshaw et al., 1989, 1996a, 1996b). These studies highlighted the effect of 
environmental changes on species composition, and the disruption of biofilms under 
nutrient and pH stress. The bacteria, veillonella, S. mutans and L. casei increased 
significantly when exposed to pulses of carbohydrate, especially when pH was not 
controlled, producing an acidic environment (Bradshaw et al., 1989). Additionally, 
anaerobe presence was increased as biofilms aged, suggesting that the complex 
communities offered protection to obligate anaerobes from the toxic effects of oxygen 
(Bradshaw et al., 1996a, 1996b).   
 
4.1.3 Bacterial responses to the environment 
Bacteria colonise a large variety of niches with differing environmental conditions. 
Inside the host, they may encounter unfavourable conditions such as nutrient and 
oxygen depletion or abundance, acidity and presence of bile acids and digestive 
enzymes. Bacteria possess a number of strategies to over come these conditions, often 
producing virulence factors for survival. Under stress, organisms can produce toxins 
such as haemolysins, allowing acquisition of iron, and mucinolytic enzymes to further 
degrade oligosaccharides in mucus for energy.  
 
Microorganisms present throughout the gastrointestinal tract must be capable of 
synthesising a variety of hydrolytic and mucinolytic enzymes, enabling the breakdown 
of surface mucus. The mucins present in epithelial mucus layers are composed of large 
quantities of galactose and hexosamines, with fucose, sialic acids (neuraminic acid) and 
 143 
sulphate groups present in variable proportions (Macfarlane et al., 2005). The presence 
of sulphate and sialic acids confers resistance to glycosidase degradation; therefore, 
bacteria must also produce proteases, peptidases and sulphatases additional to enzymes 
for breakdown of sugar complexes.  
 
A study of the stress response in Clostridium septicum, a highly pathogenic species, 
identified a catabolite regulated mucinolytic response to nutrient depletion. During 
stress, these bacteria transformed to swarm cells, with increased virulence and toxin 
production (Macfarlane et al., 2001), producing mucinolytic enzymes and haemolysins. 
A more recent study with C. jejuni, found that when exposed to MUC2, the most 
common mucin secreted by goblet cells in the gastrointestinal tract, there was an up-
regulation of genes for colonisation and pathogenicity (Tu et al., 2008). Genes for 
cytolethal distending toxins, cytotoxin, motility and mucin degradation were all 
upregulated, however, with further increases in concentration of this mucin, total 
bacterial CFU was reduced. This could be due to the bacteriocidal activities of certain 
mucin oligosaccharides, as evidenced by the inhibition of H. pylori growth by α1,4-
linked N-acetylglucosamine in the gastric mucin, MUC6 (Kawakubo et al., 2004).  
 
Through degradation of carbohydrates in the epithelial mucus layer, the function of 
mucin is lost, allowing invasion and attachment to epithelial cells. The surface structures 
of mucins are variable throughout the GI tract both intra- and inter-individually, both in 
humans and animals. These differences may explain the variation in response of bacteria 
throughout diverse niches and environmental conditions.  
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Chemostats have been used to model oral, gastric (O’May et al., 2005b) and colonic 
(Macfarlane et al., 1998) communities; however, this study represents the first 
chemostat for study of the oesophageal microbiota. This model was designed using the 
hypothesis that the major bacteria colonising the oesophagus originate in the oral cavity, 
with selected species adhering to the mucus layer of this organ, rather than washing into 
the stomach. Therefore, a two-stage system was developed, containing a vessel (oral, 
A), held above a second (oesophagus, B), allowing gravitational flow, representative of 
the human structure. Inside each vessel, discs were suspended to allow biofilm 
formation: hydroxyapatite (mineral in tooth enamel) and artificial mucin gels 
(representing mucus layer), respectively. Following five days of biofilm development, 
these mucin gels, representative of the colonising oesophageal microbiota, were exposed 
daily to a bile acid solution.  
 
This research firstly aimed to design an in vitro model representative of the normal 
oesophageal microbiota, and secondly, to investigate the effect of refluxate on these 
communities. It was hypothesised that, if an oral community was generated in vessel A, 
consequently, under the nutrient deplete conditions of vessel B, a varied population of 
bacteria, similar to that in the oesophagus would establish. Furthermore, due to the 
exposure of these biofilms to acid and bile, in similar time periods to those seen 
clinically, the bacterial community would be modified, selecting for acid and bile 
tolerant species. Additionally, this microbiota would be more representative of that seen 
in disease patients, becoming progressively Gram negative, with increased production of 
virulence proteins, and enzymes for substrate acquisition. 
 145 
4.2 Materials and Methods 
4.2.1 In vitro modelling system 
A chemostat two-stage model of the oesophagus was designed to attempt to establish a 
biofilm representative of the oesophagus through colonisation with oral bacteria. Two 
glass vessels each with a working volume of 480 ml were connected in series (Fig. 4.1). 
Media contained in g L-1: type III mucin 0.25, casein 0.25, bacteriological peptone 1.0, 
yeast extract 2.5, glucose 1.0, tryptone soy broth 0.1, NaCl 4.5, KCl 1.5, KH2PO4 1.0, 
MgCl2 0.125, CaCl2 0.15, hemin 0.005, cysteine 0.5, vitamin K1 0.01. Media was 
autoclaved and cooled on a stirrer before addition of a filter-sterilised solution 
containing potassium nitrate, sodium succinate, di-sodium fumarate and sodium 
formate, all 1g L-1.  
 
Both oral (A) and oesophageal (B) vessels (Fig. 4.1) were sterilised for 20 min 
containing the above media, with all equipment attached. Each vessel possessed a pH 
meter, two inlets for acid/alkali addition, a gas inlet for attachment of nitrogen, and a gas 
outlet filter to allow removal of excess gas produced. Once both vessels were cooled, the 
oral vessel (A) was connected to the oesophagus (B), and the latter attached to a sterile 
waste vessel. Culture pH was controlled at 7.0 by addition of 1M HCl and 2M NaOH 
using a pH 1000 pH system (New Brunswick Scientific, St. Albans, Herts, UK), 
attached to a CW711/EXT/250 pH electrode (Thermo-Russell, Auchterarder, UK). 
Vessels were sparged with O2-free N2 gas to keep a headspace (10 cm3 min-1), and a 
37oC water-jacket maintained temperature in each vessel (Haake B3 recirculating water 
bath,	  Fischer Scientific UK Ltd., Loughborough, UK).  
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Fig. 4.1: Image of model oral-oesophageal chemostat system. Oral chemostat (A), connected 
above oesophageal chemostat (B), with fresh media (C) pumping in to the oral chemostat via 
pump (D). All media and chemostat vessels were continuously stirred (E), and temperature and 
pH controlled through a water bath (F) and two pH pumps (G). Waste removed from the 
oesophageal chemostat via tubing (H). Nitrogen gas was introduced to each vessel through a 
flow cell to keep a headspace of 10 cm3 min-1 (I). 
 
 
4.2.2 Establishment of an oesophageal biofilm 
Fresh saliva from a healthy volunteer (female, 26 years old, with no known signs or 
symptoms of periodontal disease) was used to inoculate the oral vessel. 10 - 15 ml was 
collected and added to the oral vessel and left overnight to establish. Twenty-four hours 
later oral vessel A was allowed to flow over into the oesophageal vessel (tubing 
unclamped). Fresh medium (C) was pumped into vessel A at a dilution rate of 0.1 h-1. 
This subsequently fed vessel B, which was consequently carbohydrate depleted.  
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Cultures were grown for 5 days (12 turnovers) to allow achievement of a steady state 
before samples were taken from the planktonic phase for viable counts of bacteria on a 
selection of agar plates. At the time of this sample sterile porcine mucin gels (2% mucin 
type III, 0.8% bacteriological agar) in metal discs (0.8 cm diameter) were placed in the 
oesophageal vessel on metal plates suspended on the central rubber bung. To investigate 
the biofilm potential in the oral chemostat hydroxyapatite discs (Clarkson 
Chromatography, PA, USA) were placed inside the metal discs, held with 1% 
bacteriological agar.  
 
Planktonic phase samples were vortexed to homogenise any bacterial aggregates and 
serially diluted in half strength peptone water. Dilutions of neat to 10-8 were plated onto 
a variety of selective and non-selective agars: Nutrient agar, Blood azide (both aerobic), 
Chocolate agar (microaerophilic growth), Columbia blood agar supplemented with 
succinate, nitrate, formate and fumarate (1 g L-1 each), Anaerobe basal blood agar 
(microaerophilic and anaerobic growth), Wilkins-Chalgren blood agar (plain and Gram 
negative supplements), Beerens (Beerens, 1990), Rogosa and Reinforced clostridial agar 
(all anaerobic). All blood plates contained 5% (v/v) defibrinated horse blood, with all 
agars, supplements and blood purchased from Oxoid, Basingstoke, UK.  
 
Mucin and hydroxyapatite discs were left for 48 hours to allow attachment and invasion 
of bacteria and establishment of a biofilm. At 48 hours sample discs were removed from 
each vessel and biofilms broken down with a glass homogeniser and 9 ml half strength 
peptone water before plating out as above.  
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Hydroxyapatite discs were removed from the oral vessel on days 7, 13 and 21 (2, 8 and 
16 days of biofilm growth respectively), to monitor the development of the biofilm over 
time. Oesophageal biofilm samples were taken on days 7, 11 and 12 (2, 5 and 6 days of 
growth respectively) in the initial experiment. When repeated, oral biofilms were 
measured on days 7 and 16 (2 and 11 days growth), while mucin biofilms were removed 
on days 7, 11, 12, 15 and 20. Exposure of mucin traps to bile acid solution commenced 
on day 11 of both experiments, and these model oesophageal biofilms were sampled on 
day 1 at 0 and 8 hours, day 2 after overnight recovery (test 1) and days 4 and 9 of 
exposure (test 2) (Table 4.1). 
 
4.2.3 Exposure to acid and bile salts    
Bile salts No. 3 (Oxoid, UK) (0.4 g L-1) was made to pH 3 (1 M HCl) and filter 
sterilised. After mucin traps had established a biofilm for 5 days they were removed and 
exposed to a petri dish of this solution for 30 min at 2 hour intervals, over an 8 hour 
time period. This was carried out each day for a planned 14 days, with samples taken 
throughout for microbiological, haemolytic and enzymatic analysis. Additionally, after 6 
days of exposure to this bile acid cocktail, control and exposed biofilms were removed 
for tests with cell culture (Chapter 5). Table 4.1 describes all steps taken throughout 
each run of experimentation. 
 
4.2.4 Characterisation of bacterial isolates 
The MIDI system was employed for identification of all isolated bacteria, as described 
in Section 2.2.3 of Chapter 2. 
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4.2.5 Haemolysis assay 
A mucin trap was removed from vessel B and homogenised with 10 ml half strength 
peptone water, and utilised for total bacterial counts, haemolysis, glycosidase and 
neuraminidase assays. A solution of 24 ml NaCl and 0.5 ml CaCl2 was added to 0.5 ml 
defibrinated horse blood (Oxoid, UK), 0.9 ml of this was added to 0.1 ml of sample and 
incubated at 37oC for 1 hour. This was centrifuged at 15,000 g for 30 s before measuring 
absorbance at 540 nm (Cecil BioQuest CE 2501, Bath, UK) (Allison et al., 1992). One 
unit of haemolytic activity resulted in an increase in absorbance of 0.1 h-1. Results are 
expressed as units per 1x108 CFU (U log10 8 CFU-1). 
 
4.2.6 Glycosidase assay 
N-acetyl-β-D-glucosaminidase, β-galactosidase and α-fucosidase levels were measured 
by monitoring the release of chromogen from p-nitrophenyl-N-acetyl-β-D-
glucosaminide, p-nitrophenyl-β-D-galactopyranoside and p-nitrophenyl-α-D-
fucopyranoside respectively (15 mM in 0.01 M Tris buffer at pH 6.5). For each assay, 
0.5 ml of the respective p-nitrophenyl substrate (above) was mixed with 0.25 ml of 
homogenated biofilm sample (Section 4.2.5); these were incubated at 37oC for 1 hour. A 
solution of 0.5 M Na2CO3 and 0.5 M NaHCO3 was added to stop the reaction (0.75 ml) 
and the absorbance was read at 420 nm. Tris buffer was used as a blank, with controls of 
the substrate and buffer alone, and sample and buffer run simultaneously. A standard 
curve was used to calculate enzyme activities using p-nitrophenyl (4-nitrophenol) 
dilutions from 1-1000 nM in Tris buffer. One unit of glycosidase activity corresponded 
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to 1 µmol of p-nitrophenyl released h-1. Results are expressed as units per 1x108 CFU (U 
log10 8 CFU-1). 
 
4.2.7 Neuraminidase assay 
Neuraminidase (sialic acid) production was measured using the substrate N-acetyl 
neuraminlactose (1 mg ml-1 in 0.1 M acetate buffer at pH 5.5). 0.1 ml of this solution 
was added to 0.05 ml of homogenised biofilm (Section 4.2.5), with two controls of 0.05 
ml boiled sample with substrate and 0.05 ml acetate buffer with substrate. These were 
incubated at 37oC for 1 hour before boiling for 2 min to stop the reaction. The solution 
was developed in three stages: 0.05 ml of solution A (0.2 M sodium-meta-periodate in 9 
M phosphoric acid) was mixed and left to stand for 20 min at room temperature, 0.5 ml 
of solution B (10% sodium arsenite in solution of 0.5 M sodium sulphate, 0.1 N 
sulphuric acid) was added and shaken to remove the resulting yellow/brown colour, 1.0 
ml of solution C (0.6% thiobarbituric acid in 0.5 M sodium sulphate) was added and 
shaken before boiling for 15 min. After development, tubes were centrifuged at 13,000 g 
for 3 min and the absorbance read at 549 nm. A standard curve was constructed using 1 
mg ml-1 N-acetylneuraminic acid in 0.1 M acetate buffer (pH 5.5). Dilutions were made 
from 0 - 1 mg ml-1 and developed as above. One unit of neuraminidase activity was 
defined as 1 µg of N-acetylneuraminic acid released h-1. Results are expressed as units 
per 1x108 CFU (U log10 8 CFU-1). 
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4.2.8 FAME analysis 
At intervals throughout experimentation (Table 4.1), 4 ml of planktonic phase medium 
was removed from each vessel, the samples were centrifuged at 2600 rpm for 15 min, 
supernatant was frozen at -20oC for future analysis, and the pellet was left in an oven for 
2 days to determine dry weight. Due to time constraints analysis could not be carried out 
on these samples, however, may be used in future to obtain information on production of 
SCFA and whether a steady-state was obtained in this chemostat model.  
 
4.2.9 Statistical analysis 
Statistical analysis was conducted using Prism Statistical Package (Section 2.2.5). Data 
were analysed using unpaired Student’s t-tests, with a normal distribution assumed (K-S 
test). A P-value of <0.05 was classed as significant.  
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Table 4.1: Chemostat model of the oral cavity and oesophagus – 
timetable of experimentation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         a Enzyme assays – both glycosidase and neuraminidase assay tests. 
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4.3 Results 
4.3.1 Mechanical failures during experimentation 
An in vitro continuous culture system was designed to model oral and oesophageal 
bacterial communities using fresh saliva. Microbial identification with FAME profiles 
was utilised to characterise the bacteria isolated in these continuous culture systems. 
During the first experimental run, the water bath pump malfunctioned, it is possible this 
occurred prior to day 22, and therefore experimental data for day 21 is somewhat 
questionable. The experiment was repeated under identical conditions with temperature 
and pH being monitored daily to identify any further mechanical failure. The pH 
electrode malfunctioned on day 21 of the second run (day 10 of refluxate testing), 
resulting in the oesophageal vessel being washed out with 1 M HCl. Therefore, the 
experiment was stopped at this time and could not be repeated again due to time 
constraints. The gas chromatography machine failed to calibrate at the start of bacterial 
characterisation for organisms isolated in the second experiment. Despite efforts, this 
machine could not be used for determination of these bacterial isolates; therefore, no 
microbiological data is available for the second chemostat experiment.  
 
4.3.2 Establishment of a model oral and oesophageal microbiota 
Figure 4.2 shows the total viable counts obtained in both sets of experiments for the 
initial planktonic and biofilm populations, with similar mean log10 CFU established in 
both. Statistically significant variations were identified between bacterial populations in 
these vessels: oral planktonic and biofilm (P <0.0001), oesophageal planktonic and 
biofilm (P = 0.0028), and oral and oesophageal planktonic phase (P = 0.0015). 
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Fig. 4.2: Graph represents mean log10 CFU ml-1 (planktonic) and mean log10 CFU disc-1 
(biofilm on hydroxyapatite and mucin gels, both 0.8cm diameter). Error bars represent 4 sets of 
data from two experimental runs with duplicate total counts from WC blood plates. 
 
Microbiological data from the first experimental run shows that within five days a 
complex population of species was established in this chemostat model. 
Corynebacterium matruchotii and Veillonella parvula comprised the greatest mean log10 
CFU ml-1 of culturable bacteria in the planktonic phase of the oral and oesophageal 
vessels respectively (Table 4.2). Streptococci had the greatest species variation with 
seven different species isolated throughout experimentation (Tables 4.3 and 4.4), while 
S. gordonii was isolated from only the oral vessel. In the planktonic phase Gemella and 
Eubacterium were found only in the oral vessel, while Staphylococcus and Veillonella 
singularly colonised the oesophageal system. Streptococci, corynebacteria and 
fusobacteria were isolated from both vessels of this system, with higher numbers of all 
three genera found in the oral planktonic phase (Table 4.2). Mucin and hydroxyapatite 
platforms were placed in the oesophageal and oral vessels respectively, on day 5, with 
samples removed over time to measure biofilm development. After two days of biofilm 
Planktonic (Day 5) Biofilm (Day 7)
0.0
2.5
5.0
7.5
10.0
12.5
Oral
Oesophageal
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establishment, oral and oesophageal proportions of total streptococci colonised these 
surfaces similarly, at numbers ca. log10 lower than in the planktonic phase. 
Corynebacterium, Gemella and Eubacterium species were not identified in these biofilm 
populations, while staphylococci and veillonella were isolated from the biofilm of both 
models. Faecalibacterium prausnitzii and Rothia denticariosa were also isolated, with 
the latter only in mucin gels (Tables 4.2-4.4). 
 
Table 4.2: Composition of planktonic and biofilm populations in chemostat vessels 
modelling the oral and oesophageal microbiota a. 
 
 
 
 
 
 
 
 
a Data represents mean log10 CFU ml-1 ± SD (planktonic) and mean log10 CFU disc-1 ± SD (biofilm 
on mucin gels, 0.8 cm diameter). 
 
 
 
4.3.3 Effect of bile acid exposure on the oesophageal biofilm 
A different biofilm microbiota was established in the oesophageal chemostat compared 
with the oral vessel. Slightly lower mean log10 CFU established in both vessels 
compared with the planktonic phase, and although similar genera were identified, there 
was variation in species composition. Figure 4.3 shows total counts for the oesophageal 
vessel over time. This data collectively represents the total counts from WC blood plates 
stored anaerobically during both experimental runs from duplicate culture plates. On day 
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2 of biofilm colonisation, numbers were log10 2 CFU disc-1 lower than in the planktonic 
phase (P = 0.0028), this total count remained constant for the following 4 days (day 11), 
however, the composition of this microbiota changed. On day 11, the diversity of 
streptococcal species was reduced coinciding with the loss of veillonella, rothia and 
faecalibacteria (Table 4.4). Following 8 hours of bile acid exposure total counts were 
diminished (log10 7.5, P = 0.0076), however, recovered overnight (log10 8.2, P = 0.0131). 
Over the following 8 days of exposure to bile acid solution total counts steadily reduced 
(log10 7.0 CFU disc-1), while species composition changed, becoming more varied and 
Gram negative (Fig. 4.3, Table 4.4). Statistical analyses of these total counts identify 
highly significant variations during the experimental model of reflux disease. Numbers 
after overnight recovery compared with at 0 hour of testing gave a P value of 0.0252, 
while recovery (day 12) vs. day four (day 15) produced a P value of 0.0312 (Fig. 4.3). 
From start of testing at 0 hour to days 4 and 9 of exposure (days 15 and 20, 
respectively), total counts were reduced highly significantly (P = 0.0009 and 0.0001). 
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Fig. 4.3: Graph represents mean log10 CFU ml-1 (planktonic) and mean log10 CFU disc-1 
(biofilm on mucin gels, 0.8 cm diameter) from the oesophageal vessel. Error bars represent four 
sets of data from two experimental runs with duplicate total counts from WC blood plates (only 
1 set of data for days 15 and 20, test 2). 
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Table 4.3: Viable counts for bacteria isolated from the chemostat vessel representing 
the oral cavity (vessel A) a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Numbers represent the mean log10 CFU ml-1 ± SD (planktonic) and mean log10 CFU disc-1 ± SD (0.8 
cm diameter hydroxyapatite discs for bacterial attachment).  b Day 7 of chemostat  - 2 days biofilm 
growth on hydroxyapatite discs.  c Day 13 of chemostat – 8 days biofilm growth on hydroxyapatite 
discs. d Day 21 of chemostat – 16 days biofilm growth on hydroxyapatite discs. 
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Table 4.4: Viable counts for bacteria isolated from the chemostat vessel representing 
the oesophagus (vessel B) a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Numbers represent the mean log10 CFU ml-1 ± SD (planktonic) and mean log10 CFU disc-1 ± SD (0.8 
cm diameter mucin gels for biofilm establishment). b Day 7 of chemostat  - 2 days biofilm growth on 
mucin gels. c Day 11 of chemostat –  6 days biofilm growth on mucin gels, 0 hour before bile acid 
exposure. d Day 11 of chemostat –  following 8 hours of bile acid exposure.  e Day 12 of chemostat – 7 
days biofilm growth, overnight recovery from bile acid exposure. 
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Despite a lack of microbiological data for the second experimental run, Fig. 4.2 
highlights the similarity in total counts between these two tests. Morphological 
observation of the species isolated in the oral and oesophageal vessels of the second run 
were similar to those of the first, indicating that these two tests produced analogous 
results. On day 2 of biofilm formation similar total counts were found in all vessels. 
However, in the second run tetracocci were isolated on Anaerobe basal blood agar, and 
branching rods, possibly bifidobacteria or actinomyces were isolated from the oral 
vessel. Following 8 hours of periodic washings of the oesophageal biofilm with bile acid 
cocktail, thin straight Gram negative rods were observed, which were suspected to be 
fusobacteria or leptotrichia. Tiny, thin and curly Gram negative rods were isolated from 
this sample, suggesting that campylobacter and capnocytophaga were selected due to 
refluxate, comparable to the first test (Table 4.4).  
 
After four days of exposure to bile acids for 8 hours a day, morphological observations 
suggest that the presence of Gram positive organisms was significantly reduced, with 
very little coccal species found. Studies of bacterial isolates indicates that they were 
replaced by Gram negative species, with both rod and tiny cocci morphologies. 
Furthermore, on day 20 (day 9 of exposure) tetracocci, tiny cocci and a great range of 
rod morphologies were observed. Utilising information from the first run and data from 
Chapter 2 (Table 2.2 – 2.4), the genera Micrococcus, Veillonella, Neisseria, 
Fusobacterium, Leptotrichia, Campylobacter, Capnocytophaga and Selenomonas were 
proposed.  
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4.3.4 Global populations 
Figures 4.4 and 4.5 show the percentage that each bacterial group constituted during the 
stages of community development, for the oral and oesophageal models respectively, in 
the initial experimental run. These data provide a global view of the microbial 
composition of each sample.  
 
Streptococci represent the greatest proportion of the planktonic phase in both the oral 
and oesophageal vessels (Figs. 4.4 and 4.5), comprising 55%, and 45%, respectively. By 
day 21, streptococci had reduced to 9% of the oral biofilm population from ca. 50% on 
days 7 and 13, although this may represent the detrimental effect of the water bath 
malfunction. Fusobacteria comprised 19% of the planktonic phase, with equal 
representation in the oral biofilms of days 7 and 13, reducing slightly to 9% by day 21. 
Corynebacterium matruchotii, Gemella haemolysins and Eubacterium S17 made up ca. 
9% each of the planktonic population, however these latter two species were not isolated 
again during this experiment. Corynebacterium matruchotii reappeared on day 21 at 8% 
of the population, suggesting that it was present throughout at undetectable levels. On 
day 7, after 2 days of biofilm establishment, veillonella and faecalibacteria were isolated 
at 10% and 11% each of the whole population, veillonella were not isolated again, 
however, Faecalibacterium prausnitzii was isolated on day 21 in similar proportions of 
the community. Bifidobacterium comprised 12-15% of the biofilm on days 13 and 21, 
while actinomyces appeared on day 13 (14%) and decreased by day 21 (9%). By day 21, 
this oral community had become more diverse with species from 10 genera isolated, 
including peptostreptococci, gardnerella and clostridia. However, due to malfunctioning 
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of the water bath, temperature conditions may have varied by this day, making these 
results ambiguous (Fig. 4.4).  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4: Global percentages of the oral community in 
chemostat vessel A (test 1). 
 
 
The oesophageal community varied in comparison to that in the oral vessel (Fig. 4.5, 
Table 4.4). In the planktonic phase, streptococci similarly held the greatest proportion, 
with the bridge organism, fusobacteria, comprising 24%. Corynebacteria and 
veillonellas represented ca. 12% each, with the former being isolated only on day 11 in 
the biofilm after 8 hours of bile acid exposure (9%). Veillonella species were isolated 
after 2 days of biofilm establishment; however, they were not detected in future 
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samples. Staphylococci represented the smallest proportion of the planktonic community 
(4%), and in conjunction with streptococci were the only genera detected in all samples 
throughout the experiment. Staph. warneri was isolated from all samples increasing in 
abundance throughout, reaching a peak at 21% of the community on day 11 before the 
start of testing, in conjunction with Staph. epidermidis. On exposure to bile acid, this 
genus suffered a reduction after 8 hours (11%), recovering to 16% by day 12. 
Faecalibacterium prausnitzii and Rothia denticariosa were found in low numbers (9% 
and 7%, respectively) on day 7, and were not detected in future samples. Fusobacteria 
were isolated from the mucin traps on days 7 and 11 (25% and 22%, respectively), 
however, after 8 hours of bile acid exposure were undetectable, reappearing after an 
overnight recovery period (18%).  
 
On day 11, before the start of refluxate testing, species diversity had increased, with 
staphylococci (21%) appearing to replace streptococci (down to 20%). Clostridium 
malenominatum and Peptostreptococcus micros appeared briefly, but were not isolated 
from future mucin gels. Prevotella tannerae comprised 8% of this community, 
increasing to almost 12% after 8 hours of refluxate exposure; however, this species was 
not detected subsequently. The oesophageal biofilm community was affected by the 
exposure to bile acid solution. Streptococci greatly increased in this 8 hour period (20% 
to 36%), while staphylococci were reduced by 10%. Actinomyces were isolated in this 
sample period in low numbers (9%), and continued to hold this proportion of the 
community on day 12. The species Campylobacter concisus also appeared after 8 hours 
of refluxate exposure, becoming the second most predominant species in the mucin gel 
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microbiota (12%). Campylobacter was only identified in this one sample; however, this 
could be due to variations in each mucin gel, or due to low culture numbers. The species 
Capnocytophaga sputigena was originally isolated at 0 hour of testing (9%), increasing 
to 11% of the community after 8 hours of refluxate. By day 12 this organism had 
increased from log10 5.8 CFU to log10 6.9 CFU disc-1, however, its percentage in the 
whole community was reduced (9%). The decreased percentage of this bacterium, 
despite its increased growth, was due to the appearance of Propionibacterium acnes and 
the pathogenic organism, Selenomonas infelix (9% and 8%, respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.5: Global percentages of the oesophageal community in 
chemostat vessel B (test 1). 
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4.3.5 Effect of bile acid exposure on toxin and mucinolytic enzyme production 
The effect of a bile acid cocktail on the virulence of oesophageal biofilms was 
investigated using this continuous culture system. Table 4.5 shows that haemolysin 
formation increased from 5.9 U before exposure to 43.4 U log10 8 CFU-1 after 8 hours of 
periodic contact with this solution. Over the following 9 days the level of haemolysin 
production increased dramatically to 367 U log10 8 CFU-1, indicating that the toxicity of 
this community increased with stress due to refluxate, possibly due to an increasingly 
Gram negative composition. Additionally, the majority of this haemolysin was cell 
bound, although higher levels of extracellular protein were present by day 20.  
 
Table 4.5: Formation of haemolytic toxin in the model oesophageal chemostat after 
exposure to a bile acid cocktail (pH 3) a. 
 
 
 
 
 
 
 
 
 
 
a Results are means ± SD of data obtained in the second experiment with duplicate samples 
tested, data expressed as units of activity (U) log10 8 CFU-1. b 0 hour of exposure to bile and acid. 
c Following 8 hours of exposure to bile and acid. 
 
Table 4.6 shows an increase in the activities of a number of enzymes involved in mucin 
breakdown (β-galactosidase, α-fucosidase, and N-acetyl β-glucosaminidase). All three 
enzymes were increased by day 20, however, very little change was seen in the first 8 
hours. After 4 days of exposure (day 15) levels of β-galactosidase had increased from 
1.5 to 2.5, and by day 9 reached 8.0 U log10 8 CFU-1. α-fucosidase levels had a greater 
increase from 1.2 on day 1 to 13.6 U log10 8 CFU-1 by day 9 of exposure. While N-acetyl 
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β-glucosaminidase showed the greatest increase, rising from 2.8 at 0 hour to 3.6 after 8 
hours, furthermore, by day 4 levels were 7.5, increasing to 28.0 U log10 8 CFU-1 on day 9 
(Table 4.6). β-Galactosidase activity was found in similar levels both cell-bound and 
extracellularly, while α-fucosidase had slightly higher cell bound activity. N-acetyl β-
glucosaminidase was found cell-bound and extracellularly, however, by day 9 this 
enzyme was found in higher quantities cell-bound, constituting 70% of its total activity.  
 
Table 4.6: Formation of mucinolytic enzymes in the model oesophageal chemostat after 
exposure to a bile acid cocktail (pH 3) a. 
 
 a, b, c See legend to Table 4.5. d ND, not detected.  
 
These results show that with exposure to bile acid, stress leads to an increase in these 
mucinolytic enzymes, predominantly N-acetyl β-glucosaminidase. However, numbers 
were low, being expressed per 1 x 108 CFU, while total cell counts in these mucin gels 
were between log10 7.5 to log10 8.2 CFU disc-1 during refluxate testing.  
 
Neuraminidase was not expressed by these cells, data is not shown. 
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4.4 Discussion 
The aim of this research chapter was to design a system which would model the oral and 
oesophageal microbiotas, allowing in vitro investigation of the effect of refluxate on an 
established oesophageal community. This study represents the first attempt to design a 
model of the oesophagus for investigation. Initial microbiological results indicate that 
two distinct communities were established in the oral and oesophageal chemostat 
vessels, with greater diversity and increased presence of Gram negative species in the 
oesophageal vessel, particularly following exposure to a bile acid cocktail. 
 
If this model is to be utilised for future research, certain aspects of its design and 
implementation could be improved. Firstly, the lack of further inoculations may have 
hindered the establishment of a complete model biofilm. A study by McKee et al. 
(1985), used batch cultures of nine pure isolates to inoculate their chemostat, these 
cultures were then used to reinoculate the vessel on two subsequent occasions to 
enhance establishment of the oral community. Consideration of the use of multiple 
defined batch cultures was considered for this study, however, it was concluded that a 
truer representation of a normal, healthy and diverse oesophageal microbiota would be 
obtained through inoculation with fresh saliva from a healthy volunteer. Although this 
model did largely represent the oesophageal community, key species such as neisseria, 
lactobacillus and bacteroides were not isolated. The study by McKee and co-workers 
observed that neisseria only developed in the oral community after the third inoculation 
(McKee et al., 1985); therefore, further additions of fresh saliva in this present study 
may have permitted a more complex, diverse and representative community to develop.  
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The composition of dental plaque varies both spatially and temporally, being modified 
by cleaning, eating, drinking and general health status (ten Cate, 2006; Signoretto et al., 
2010), therefore, the use of fresh saliva may not generate reproducible results. 
Consequently, for future research, comparison of the community established after 
multiple inoculations with mixed defined cultures vs. saliva should be investigated, to 
determine the most reliable and representative method for development of an in vitro 
oesophageal microbiota.  
 
During the initial experiment, increased collection of planktonic samples throughout the 
21 days would have provided further information about the development of a steady 
state in these vessels. During exposure of mucin gels to bile acid, samples should have 
been taken regularly after day 12, as the mechanical breakdown of this model by day 21 
reduced the abundance of data for successive exposures. Additionally, during reflux 
exposure to the oesophageal vessel, the ability to take control samples of the mucin gels 
would have provided valuable information about the full effect of bile acid on the 
community. Control samples could not be utilised to their full potential due to lack of 
space in the vessel, however, if this model was to be redesigned for future work, larger 
vessels with a greater capacity for sample collection could be employed. The initial 
experimental model provided full microbiological data, however, this was a pilot trial to 
gauge the potential of creating this in vitro oesophageal community. Regrettably, 
haemolytic and mucinolytic enzyme experiments were not carried out in this first run, 
while the second experiment provided the reverse, therefore, no matched 
microbiological and enzymatic data is available. 
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Limited results from this study indicate that two distinct microbiomes established in the 
oral and oesophageal vessels, with a further shift in composition of biofilms formed on 
mucin gels. Three bacterial phyla were identified in the oral vessel of test one: 
Firmicutes, Actinobacteria and Fusobacteria. In these phyla, eight genera of Firmicutes 
were isolated: Streptococcus, Staphylococcus, Faecalibacterium, Gemella, 
Eubacterium, Veillonella, Peptostreptococcus and Clostridium. The Actinobacteria, 
Corynebacterium, Actinomyces, Bifidobacterium and Gardnerella were identified with 
the genus Fusobacterium in the third phylum.  
 
Species from five phyla were detected in the oesophageal vessel, both planktonically 
and in biofilm communities: Firmicutes, Actinobacteria, Fusobacteria, Bacteroidetes and 
Proteobacteria. In these phyla, seven genera of Firmicutes were isolated: Streptococcus, 
Staphylococcus, Faecalibacterium, Veillonella, Peptostreptococcus, Clostridium and 
Selenomonas. The Actinobacteria, Corynebacterium, Actinomyces and Rothia were 
identified, with Fusobacterium from its phylum, Fusobacteria. The Bacteroidetes, 
Prevotella and Capnocytophaga were detected, while the Proteobacteria Campylobacter 
was also isolated.  These same five phyla correspond with the findings in Chapter 2, 
investigating the bacterial communities found in vivo in the oesophagus of 34 patients. 
Of all genera identified, only capnocytophaga and selenomonas species were not 
isolated from the clinical study. The genera Gemella, Eubacterium, Bifidobacterium and 
Gardnerella were isolated from patients, however, in this chemostat model were only 
cultured from the oral vessel. Additionally, micrococcus, neisseria and leptotrichia were 
found in patients, and although not characterised in this study, morphological 
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observations from the second experimental run indicate that these species may have 
been present. The genera Bacteroides, Lactobacillus, Enterococcus, Lactococcus and 
Arcobacter were only isolated from patients in the clinical study. 
 
Lactobacillus was increasingly identified in ADC patients (Fig. 2.8), and was proposed 
to have originated in the gastric microbiota, being regurgitated during reflux disease. 
The lack of entry of a gastric microbiota into the oesophageal vessel is a limitation of 
this study, since it was proposed that changes in the oesophageal populations with 
disease are due to not only the effects of bile and acid in refluxate, but also its microbial 
content.  Total CFU cm-2 in control, GORD, BO and ADC patients (Chapter 2), ranged 
from mean log10 4.0 to log10 8.6 CFU cm-2, while in this oesophageal chemostat model, 
total counts ranged from mean log10 8.0 on day 2 of biofilm formation, to log10 7.0 CFU 
disc-1 (0.8 cm) after bile acid exposure. Total counts in the planktonic phase reached 
mean log10 9.7 CFU ml-1 in the oesophagus, and mean log10 10.0 CFU ml-1 in the oral 
vessel, similar to previous studies (McKee et al., 1985; Bradshaw et al., 1989). 
Therefore, although this model is lacking some common oesophageal species, as a first 
attempt, it appears that a continuous culture system could be used as a model of the 
oesophageal microbiota, to better understand its composition, and investigate the effects 
of treatments on these indigenous communities.  
 
Although certain species held similar proportions of the community throughout the 
initial experiment, variations were found throughout, with some bacteria being 
temporarily undetectable, reappearing in subsequent mucin gels. These discrepancies 
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could be due to a number of reasons: effect of primary colonisers, variability in each 
suspended disc, or low abundance for culture collection. The development of a complex 
biofilm is dependent on primary, secondary and bridge colonisers such as Streptococcus, 
Fusobacterium, Actinomyces and Veillonella (discussed in Section 1.5.2). In this model, 
streptococci and fusobacteria were commonly isolated, however, veillonella species 
were only identified planktonically and on day 2, while actinomyces were detected on 
days 11 and 12. As seen in oral community development, diverse niches allow 
development of differing biofilm structures, with variation in respective species 
composition (Kolenbrander, 2006). The primary colonisers of a surface provide a niche 
for specific species dependant on their individual metabolic requirements; therefore, in 
this model each mucin gel may have supported a slightly varied community dependent 
on its initial colonisers. It is likely, that in the planktonic phase, bacterial aggregates 
were formed, with streptococci and fusobacteria interacting with a variety of species, 
possibly undetected by culture due to low abundance. Although medium was continually 
agitated and mixed, these aggregates were potentially the original colonisers of the 
mucin platforms, hence, leading to variation in the community structure of each biofilm. 
Over 700 species are present in the oral cavity, with over half unidentifiable using 
culture methods (Aas et al., 2005), however, as discussed in Chapter 2, molecular and 
culture based studies of oesophageal communities do not show the same discrepancies. 
Nevertheless, it is possible, that many species were present in mucin gel communities in 
low abundance and were not detected by culture.  
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Fusobacteria are highly important species in community development, being bridge 
organisms between primary and secondary colonisers, additionally facilitating 
association between aerobic and anaerobic species (Bradshaw et al., 1998).  In this study 
by Bradshaw and co-workers (1998), a continuous culture system was set up to 
investigate the effects of F. nucleatum on microbial communities and co-aggregation 
dynamics. Results showed that this species could bind to many streptococci, 
actinomyces and lactobacilli, which were also able to coaggregate independently, 
however, this species also allowed close association between species such as Neisseria 
subflava which poorly aggregated with the above genera. Furthermore, this organism 
allowed the survival and persistence of a number of anaerobic species, which were 
reduced on removal of F. nucleatum from the system. Representatives of this genera 
were present throughout this research study, in the oesophageal vessel, excluding the 
sample taken after 8 hours of bile acid exposure, where they were temporarily 
undetectable, similar to that found in a previous study of the oral cavity with the 
antimicrobial agent, chlorhexidine (McDermid et al., 1987). On day 11, where 
fusobacteria were not recovered, there was a sudden presence of Campylobacter 
concisus and actinomyces. Moreover, in the previous sample, before refluxate exposure, 
streptococci were drastically reduced, while staphylococci increased in prevalence, and 
peptostreptococci, clostridia, prevotella and capnocytophaga appeared. Therefore, these 
two initial colonisers may be very important in community development, leading to 
disruption of the whole population due to changes in their relative abundances.  
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Costerton et al. (1994) reported that in vivo biofilm populations were distinct from their 
planktonic counterpart, with primary colonisers being selected dependant on their 
adherence abilities. The metabolic profiles of these founding bacteria determine the 
successive colonisers of the community (Costerton et al., 1994). A past study by 
Liljemark et al. (1981) utilized hydroxyapatite to measure the adherence potential of 
streptococci and its coaggregation partners. Results indicated that an increased 
proportion of streptococci in a streptococci/actinomyces aggregate resulted in continued 
increase in size of the mass, however, this lead to a lower proportion of non-aggregated 
bacteria adhering to the surface (Liljemark et al., 1981). Additionally, studies (Liljemark 
et al., 1981; Costerton et al., 1994) have shown that large aggregates result in a lower 
number of species adhering to a surface, while the greatest increase in adherence and 
diversity occurred with smaller aggregates with lower prevalence.  
 
In this study, where the planktonic phase was left to reach steady state for five days 
before addition of mucin gels, larger aggregates may have formed. This could have a 
detrimental effect on mucin biofilm composition, due to a limitation in species 
adherence due to a greater mass of simple aggregates. Golub et al., (1979) found that 
Streptococcus sanguinis was able to bind to saliva within 5 minutes. Therefore, a 
comparison of varying lengths of time for addition of mucin gels, together with the 
mode of inoculation, to allow optimum community diversity and representation, should 
be carried out for future models.  
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Results from the second chemostat model indicate that the biofilm populations did not 
have haemolytic activity at the start of experimentation (Table 4.5). Levels of 
haemolysin were extremely low on day 11, although no results were taken before this 
time, samples taken in the following three time periods indicate a stress response by the 
microbiota, or selected species within. Data represents a 12 - 15% increase per day, 
however, within the first 8 hours, after the first shock bile acid exposure, levels of 
activity increased by 86%. The lack of microbiological data for this second experiment 
do not allow a correlation of haemolytic activity with the presence of specific species. 
However, the increase in Gram negative species, such as Campylobacter, Selenomonas, 
Neisseria, Leptotrichia and Capnocytophaga, proposed through morphological 
observation, could be associated with this increased haemolytic activity. Studies with 
Campylobacter concisus have revealed the presence of a membrane bound 
phospholipase A (PLA) protein (Istivan et al., 2004, 2008). This species additionally 
seems to secrete iron regulated cytotoxin, which could explain the increase in both cell 
bound and extracellular activity with stress. H. pylori has a similar PLA, regulated by 
the pldA gene, which is involved in colonisation of the gastric mucosa and the related 
damage to this organs tissue (Dorrell et al., 1999). Bile salts in high concentration can 
affect bacterial membranes, therefore altering their permeability; this can induce DNA 
damage and lead to oxidative stress, possibly resulting in increased haemolysis (Begley 
et al., 2005). Additionally, the exposure of bile salts to C. jejuni resulted in an increased 
expression of CiaB protein (Malik-Kale et al., 2008), possibly pili, and the flagellin, 
flaA, involved in motility and virulence (Begley et al., 2005).  
 175 
Although data is limited, initial analysis indicates that with reflux exposure, microbiota 
composition is altered, becoming more diverse and Gram negative, correlating with data 
from Chapters 2 and 3. Furthermore, this exposure results in an increased stress 
response, with greater virulence potential and production of mucinolytic enzymes, 
illustrated by the amplified expression of both cell bound and extracellular haemolysins. 
This chemostat, modified and improved, could prove a useful in vitro model to enhance 
understanding of the oesophageal microbiota, and the effects of environmental factors. 
Bacterial isolates from this model may also be used to investigate their effects on 
epithelial cells using cell culture, providing information on genetic, epigenetic and 
inflammatory responses to these control and stressed populations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 5 
 
Co-culture studies investigating the 
involvement of bacteria in cancer 
 using oesophageal cell lines 
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5.1 Introduction 
The human microbiome is part of a highly complex system which has evolved with its 
host to be mutually beneficial, balancing its interactions with the epithelia to maintain 
normal host physiology. This ecosystem can also comprise opportunistic and pathogenic 
species, which under unstable conditions, such as changes in host cell activity or the 
immune response, can leave the host susceptible to infection and disease. Cell lines for 
most tumour types are available, and are utilised extensively in co-culture with bacteria 
to measure responses of eukaryotic cells to infection. Cell line co-culture experiments 
can allow a deeper understanding of host responses to a specific organism, in this case, 
Campylobacter concisus, however, as discussed previously, it is unlikely that 
pathogenicity is caused wholly by the presence of a single species. Therefore, rather 
than a single organism, the whole biofilm it is complexed with should be investigated to 
better understand mechanisms of disease.  
 
Little research has been carried out on the host response to Campylobacter concisus 
using cell lines, however, C. jejuni has been extensively studied. MacCallum and co-
workers (2006) exposed a range of colon cancer cell lines and patient tissues to this 
organism.  C. jejuni caused an increase in IL-8 production, especially in primary tissue, 
where a full immunological network was present. A further study by Zheng et al. (2008) 
exposed the colon carcinoma cell line, T84, to C. jejuni and C. coli. These species 
required CDT and flagella functionality to induce an inflammatory response, indicated 
by IL-8 production dependent on TLR activation of the NF-kappa B signalling pathway. 
Incubation of clinical C. concisus strains with CHO cells resulted in cytolytic 
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destruction of cells with vacuolation (Istivan et al., 2004) due to the haemolytic effects 
of phospholipase A, encoded by the gene, pldA (Istivan et al., 2008). Results indicate 
that Campylobacter species, especially C. concisus, are present increasingly with 
oesophageal disease (Macfarlane et al., 2007; this study) and may increase the 
haemolytic activity of the biofilm due to bile acid stress (Chapter 4). This chapter’s 
research was designed to take a preliminary look at the effect of this species on the 
oesophagus using a range of cell lines.   
 
Results from Chapters 2 and 3 indicate that there is not a single aetiologic agent in 
oesophageal disease progression, with a shift in the whole microbiota being indicative of 
disease. Pei’s group in New York published a small pilot study investigating the effects 
of Streptococcus mitis and Veillonella atypica on the macrophage cell line THP-1 (Lu et 
al., 2006). Incubation of these heat inactivated bacteria with the cell line for 72 or 96 
hours resulted in increased expression of COX-2 and NQ01; both of which are involved 
in inflammation and protection from oxidative and toxic stresses, such as bile acid 
reflux. Additionally, when in combination with acid, COX-2 expression was further 
amplified, while NQ01 was weakened. It is not fully understood why this study used 
only the cell line THP-1, and not also an oesophageal cell line such as OE19 or FLO-1. 
Nevertheless, this preliminary study indicates that opportunistic bacteria from the 
oesophagus may promote the inflammatory status of reflux oesophagitis, especially 
when exposed to acid.  
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This chapter aimed to not only investigate the effects of Campylobacter concisus on a 
range of oesophageal cell lines, but to carry out preliminary experiments with biofilm 
samples taken from the in vitro model of the microbiota established in Chapter 4. 
Fortunately, results from this chemostat modelling indicate that a community 
representative of that in vivo was developed, with the microbiological effects of 
refluxate exposure simulating the clinical development of GORD to ADC.  
 
Multiple cell lines of oesophageal origin were employed in this study to fully represent 
the progression of disease. Cells derived from Barrett’s-associated ADC and squamous 
cell carcinoma were used along with the newly developed hTERT immortalised 
Barrett’s cell lines, CP-A, -B and –D (Palanca-Wessels et al., 2003). The CP-A strain 
contains wild-type p53, while the other two have a loss of heterozygosity and mutation 
in this gene. This study of immortalised Barrett’s cell strains indicated that although 
telomerase can reduce genetic instability, levels of chromosomal instability persist, 
allowing continued neoplastic progression. 
 
A number of recent studies have characterised the p53, COX-2 and Ki-67 status of the 
metaplastic-dysplastic sequence of BO and ADC. With progression from a normal 
oesophagus to ADC, over-expression of the mutated tumour suppressor gene, p53, has 
been observed, with increasing expression correlated with metastasis and invasion 
category (Feith et al., 2004; Murray et al., 2006; Binato et al., 2009). COX-2 and Ki-67, 
a marker of proliferation, were both progressively amplified with disease severity (Feith 
et al., 2004; Binato et al., 2009). It has also been proposed that the most significant 
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increase in COX-2 expression occurs in the early stages of disease between squamous 
epithelia and Barrett’s metaplasia, being associated with the inflammatory response 
(Ling et al., 2007). 
 
In this study, a range of oesophageal cells were exposed to both Campylobacter 
concisus and chemostat biofilms (Chapter 4). Measurements for adhesion and invasion 
of bacteria and cytotoxicity were performed, while cell samples were also taken for 
western blot and immunohistochemistry analysis. These assays were carried out in the 
final stages of the project as a highly preliminary experiment, with antibodies that were 
easily accessible at the University. Western blot analyses of the readily available p53, 
p21 and COX-2 proteins were performed. Samples were also sent to the Histopathology 
unit for standard Ki-67 staining.  
 
This research hypothesised that with exposure of a range of oesophageal cells to 
campylobacter and a representative microbiota, expression of these host response 
proteins, and in particular COX-2, would be increased. Additionally, due to the 
increased virulence of the oesophageal biofilms exposed to bile acid, invasion potential 
and cytotoxicity would be enhanced.  
 
 
 
 
 181 
5.2 Materials and methods 
5.2.1 General cell culture 
The Barrett’s-associated adenocarcinoma cell line FLO-1 was a kind gift of Dr R 
Fitzgerald (Department of Oncology, Hutchison Medical Research Council Research 
Centre, University of Cambridge). Stocks of these FLO-1 cells were maintained in 
Dulbecco’s Modified Eagle Medium containing L-glutamine (580 mg L-1) and D-
glucose (1000 mg L-1), supplemented with 10% foetal calf serum (FCS) and 1% 
penicillin/streptomycin (Gibco/Invitrogen, Paisley, UK). Squamous cell carcinoma 
OE21, and oesophageal adenocarcinoma, OE19, were maintained in Roswell Park 
Memorial Institute (RPMI) 1640 media containing identical supplements. Pre-neoplastic 
cell lines of Barrett’s oesophagus were established from well-characterised patient 
biopsies using human telomerase for immortalisation (Palanca-Wessels et al., 2003). 
CP-A is a non-dysplastic cell line, while CP-B and -D are cells of high-grade dysplasia 
origins. These Barrett’s cell lines were a kind gift of Dr Peter Rabinovitch (Fred 
Hutchison Cancer Center, Seattle WA, supplied by Dr Rebecca Fitzgerald). These 
Barrett’s cell lines were maintained in Keratinocyte Serum-free medium with 
supplements of 30 mg L-1 Bovine Pituitary Extract and 0.2 µg L-1 recombinant 
Epidermal Growth Factor with 1% penicillin/streptomycin (all Gibco/Invitrogen, 
Paisley, UK).  
 
All cells were grown as adherent monolayers in T25 and T75 (25 cm2 and 75 cm2) cell 
culture flasks (Corning, High Wycombe, UK) and incubated at 37oC in a 5% CO2 
humidified atmosphere. Stock cells were grown to 90-95% confluency, at time of 
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passage growth medium was removed, cells were washed with PBS, and treated with 
warmed trypsin solution (both Gibco/Invitrogen, Paisley, UK) before incubation at 37oC 
for 2-10 min to facilitate removal of cells. Trypsin was inactivated by the addition of 
RPMI 1640 or DMEM supplemented with FCS. Cells were seeded into fresh flasks at a 
dilution of 1 in 10 of the neutralised cell suspension. After trypsinisation to remove the 
Barrett’s cells, 250 mg L-1 soybean trypsin inhibitor (STI) was utilised for neutralisation.  
 
Frozen stocks of all cell lines were maintained in their respective medium supplemented 
with 10% FCS and 10% dimethyl sulphoxide (DMSO), and snap frozen with liquid 
nitrogen before storage at -80oC.  
 
5.2.2 Bacterial strains 
Campylobacter concisus CCUG 34767 (Culture Collections, University of Goteborg, 
Sweden), Campylobacter concisus NWBO1, a strain isolated from a GORD patient in 
this study, and Campylobacter concisus NWBO2, isolated from a BO patient, were kept 
anaerobically at 37oC on Columbia blood agar plates. NWBO1 showed large haemolytic 
zones on this media, indicating a highly virulent strain, which was utilised for further 
testing. 
 
5.2.3 Co-culture assays with Campylobacter concisus 
All cell lines were grown to confluence in 75 cm2 TC flasks, and seeded into 12 or 24 
well plates to adhere overnight. Cells were counted using 1% trypan blue and a 
haemocytometry chamber. Cells were trypsinised as above, and neutralised with their 
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respective media before addition of 2 ml cell culture media and 10 ml plain medium (1 
ml per well) to 12 well plates, and 0.5 ml per well in 24 well plates.  
 
Co-culture experiments were performed with fresh Campylobacter concisus growth. 
Plates with full growth were swabbed into 2 ml WC broth, spun down and resuspended 
in 10 ml of appropriate culture media for each cell line. At the start of co-culture, spent 
medium was aspirated from each well, before addition of 1 ml (12 well plate) and 0.5 ml 
(24 well plate) bacteria inoculated culture media. One plate of full campylobacter 
growth provided an approximate multiplicity of infection (MOI) of 1:100. Table 5.1 
below details the co-culture experiments carried out with these cell lines. 
 
 
 
Table 5.1: In vitro co-culture experiments with Campylobacter concisus,  
detailing conditions and tests carried out. 
a CCUG 34767, Campylobacter concisus isolate. b NWBO1, Campylobacter concisus isolate from GORD 
patient (Chapter 2). c NWBO2, Campylobacter concisus isolate from BO patient.  
 
 
 
Cell line Campylobacter Time points Tests 
OE19 CCUGa, NWBO1b, NWBO2c 9 h Cytotoxicity 
FLO-1 CCUG, NWBO1, NWBO2 9 h Cytotoxicity 
FLO-1 NWBO1  3, 6, 9, 12, 24 h Cytotoxicity, invasion, 
adhesion, western blot 
CP-B NWBO1 3, 6, 9, 12, 24 h Cytotoxicity, invasion, 
adhesion, western blot 
CP-A NWBO1 24 h Cytotoxicity, invasion, 
adhesion, western blot 
CP-D NWBO1 24 h Cytotoxicity, invasion, 
adhesion, western blot 
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Cytotoxicity 
At the specific time point for each experiment, media were removed and cells washed 5 
times in 1% sterile PBS, removed with trypsin/EDTA and neutralised with respective 
media/STI (Barrett’s cells). Cells were counted using Trypan blue and a 
haemocytometer for analysis of viability.  
 
Invasion 
Bacteria were incubated for the set time periods (Table 5.1) on cell monolayers to 
facilitate invasion. At set time points, media was aspirated, and cells were washed 5 
times with sterile 1% PBS to remove any unbound organisms, before incubation for a 
further two hours with 100 µg ml-1 gentamicin to kill extracellular adherent 
campylobacters. Cells were removed via trypsinisation, homogenised, serially diluted 
and spread on Columbia blood agar plates (100 µl) for bacterial counts (37oC, 2 day 
anaerobic growth).  
 
Adhesion 
Epithelial cells were grown to confluence on glass coverslips in the 12 or 24 well plates. 
Non-adherent bacteria were aspirated from the cell monolayer and remaining unbound 
bacteria were removed by five washes with sterile 1% PBS. Cells were fixed for 5-10 
min with ice-cold 70% methanol, and cover slips were removed for visualisation. Co-
cultures were stained with 50 µl carbol fuchsin for identification of Gram negative 
campylobacters. Adherent bacteria were then viewed by phase contrast light 
microscopy. 
 185 
Oncogenic response assays 
Culture media were removed, cells washed 5 times with sterile 1% PBS and the 
monolayer was trypsinised for removal. Cells were centrifuged at 1000 g for 5 min and 
snap frozen under liquid nitrogen for storage at -80oC.  
 
For all assays, duplicate controls with plain culture media were used to verify changes 
induced by Campylobacter concisus.  
 
5.2.4 Co-culture assays with chemostat samples  
All cell lines were grown to 90 – 100% confluence in 75 cm2 TC flasks, and seeded into 
24 well plates (Section 5.2.3) to adhere overnight before addition of chemostat media. 
Cells were counted using 1% trypan blue and a haemocytometry chamber.  
 
Co-culture experiments were performed with fresh biofilm samples taken from the 
oesophageal chemostat vessel (Section 4.2.2). Mucin traps were removed from the 
vessel and biofilms were added to 2 ml peptone water, homogenised, centrifuged at 
1000 g for 1 min before resuspension in the appropriate cell culture medium (0.5 ml per 
well). Homogenisation of the colonised agar allowed the aggregated bacteria to be 
separated and dispersed. Respective media for each cell type was used, with control 
experiments run with plain culture medium. Mucin traps from the oesophageal 
chemostat were removed on day 17, six days after starting refluxate exposure (Table 
4.1). In the first chemostat run, an exposed biofilm sample was tested with OE21 and 
FLO-1 cells, while in the second experimental run, both an exposed and control mucin 
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biofilm were co-cultured with FLO-1 and CP-D cell lines. MOI was dependant on CFU 
per mucin trap. Table 5.2 below details the experiments and methods carried out for 
multi-species co-culture. 
 
Table 5.2: In vitro co-culture experiments with chemostat samples,  
detailing conditions and tests carried out. 
a Chemostat biofilms from the oesophageal vessel. b Chemostat biofilms from the oesophageal vessel 
during test 2, unexposed control taken alongside exposed biofilm. 
 
Cytotoxicity 
At designated time points, media was removed and cells were washed 5 times in 1% 
sterile PBS, removed with trypsin/EDTA and neutralised with respective media/STI 
(Barrett’s cells). Cells were counted using Trypan blue and a haemocytometer for % 
viability. During the second experimental run, cells had died by 12 hours, and all 
samples were taken at this point. 
 
Adhesion 
Epithelial cells were treated as above (Section 5.2.3, Adhesion). However, co-cultures 
were viewed with propidium iodide (PI) stain to visualise dead cells. 50 µl (diluted 
1:500 in dH2O) propidium iodide (BacLight Viability stain, Molecular Probes Europe) 
Cell line Biofilm Time points Tests 
OE21 Test 1, exposed biofilm a 3, 6, 9, 12, 24 h Cytotoxicity, invasion, 
adhesion, western blot 
FLO-1 Test 1, exposed biofilm 3, 6, 9, 12, 24 h Cytotoxicity, invasion, 
adhesion, western blot 
FLO-1 Test 2, control b and exposed 
biofilm 
6, 12 h Cytotoxicity, invasion, 
adhesion, western blot 
CP-D Test 2, control and exposed 
biofilm 
6, 12 h Cytotoxicity, invasion, 
adhesion, western blot 
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was added to cells and left for 15 min in a dark room before visualisation with confocal 
laser scanning microscopy (CLSM). Citifluor (Citifluor, Ltd., London, United 
Kingdom) was used as a mounting medium, and the slides were visualized with a Nikon 
Eclipse E800 upright microscope attached to a Nikon PCM 2000 confocal system. 
Images were captured and overlaid with C-Imaging software (Compix, Inc., Cranberry 
Township, PA). 
 
Invasion and oncogenic response assays 
Methods for invasion assays, acquisition and storage of cells for oncogenic analysis 
were carried out as described above for co-culture with campylobacters (Section 5.2.3). 
For measurement of invasion WC blood plates were utilised.  
 
5.2.5 Western blot analysis of cell co-culture samples 
Oesophageal epithelial cells co-cultured with campylobacter strains and chemostat 
biofilms were assessed for changes in expression of p53, p21 and COX-2. Cell pellets 
were washed in 1% PBS and centrifuged at 1000 g for 5 min. Pellets were then prepared 
with 50 mM Tris pH 8, 150 mM NaCl, 0.1% EDTA, 1% Igepal (Sigma) and a protease 
inhibitor cocktail (Roche). This preparation was heated at 100oC for 10 min and 
vortexed for resuspension. Proteins and marker (PageRuler Plus, Fermentas, UK) were 
separated by SDS–PAGE (NuPAGE 12% Bis-Tris gel with 5% MOPS) at 100 V. The 
gel was then removed and a membrane sandwich assembled with a nitrocellulose blot. 
This was placed in the transfer tank with PVDF transfer buffer (10% Tris/glycine, 20% 
methanol, milliQ water). The transfer protocol was run overnight at 12 V/25 mA. This 
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membrane was then western blotted using standard conditions and appropriate primary 
and secondary antibodies (Table 5.3). 
 
Table 5.3: Antibodies and respective secondary HRP antibodies utilized for western blot 
analysis of co-cultured oesophageal cell lines. 
 
a Antibodies diluted in 5% milk buffer. b Secondary antibodies, diluted 1:2000 with 5% milk buffer, 
purchased from DAKO, Denmark. c p53, kind donation of Professor Sir David Lane, Surgery and 
Molecular Oncology, Ninewells Hospital and Medical School, University of Dundee.  
 
The membrane was removed and cut at 50 kDa, before blocking for 1 hour with milk 
buffer (5% non-fat dry milk, 0.1% Tween-20, 1% PBS). After 1 hour, buffer was 
removed and 10 ml fresh milk buffer was added with 10 µl antibody, this was left to 
shake for 1 hour before removing and washing 3 times with milk buffer (3 min each). 
Secondary antibody (10 µl) was added with 10 ml milk buffer and incubated for 40 min, 
washed 3 times with milk buffer and twice with PBS/Tween-20 (0.1%). The blot was 
then dried and 500 µl each of chemiluminescent reagents A and B (ECL, GE Healthcare 
Life Sciences, UK) were added for 2 min before development in a dark room.  
 
Antibody Dilution a Size (kDa) Secondary HRP 
antibody b 
Source 
β-actin 1:1000 42 Anti-mouse Sigma Aldrich, 
UK 
p53 (DO-1) c 1:1000 53 Anti-mouse University of 
Dundee 
p21 1:1000 21 Anti-rabbit Santa Cruz, CA, 
USA 
COX-2 1:1000 72 Anti-mouse 
Caymen 
Chemicals, MI, 
USA 
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Image J software (NIH, USA) was utilised to measure the density of each band, 
allowing semi-quantitative densitometry and therefore, relative levels of protein for each 
sample. 
 
5.2.6 Ki-67 immunohistochemistry 
Duplicate samples of those measured for protein expression with western blots were also 
sent to the Histopathology Unit, Ninewells Hospital and Medical School for MIB-1 
staining of Ki-67 proliferation using standard techniques.  
 
5.2.7 Statistical analysis 
Due to the preliminary status of these experiments, duplicate tests could not be carried 
out, and there was insufficient data for detailed statistical analysis. Results were 
compared using unpaired Student’s t-tests, with a P value of <0.05 denoting statistically 
significant variations in CFU ml-1 and viable eukaryotic cell counts with each cell type 
and test condition. Analyses were carried out using Prism 4.0 Statistical Package 
(Section 2.2.5). No statistically significant results were found (P values not shown).  
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5.3 Results 
5.3.1 Co-culture with Campylobacter concisus 
An initial experiment with FLO-1 and OE19 cells in co-culture was performed to 
investigate cytotoxicity. These cell lines were exposed to three Campylobacter concisus 
strains: CCUG 34767 (human isolate from a heart ventricle), and two isolates from the 
patient study (Chapter 2): NWBO1 from GORD, NWBO2 from BO biopsies. The two 
cell lines were exposed to these strains for nine hours, with the results shown in Figs. 
5.1 and 5.2. OE19 cells were most affected by NWBO1, and least by NWBO2 (Fig. 
5.1), while the opposite was found for FLO-1 cells (Fig. 5.2). Duplicate samples were 
taken for each, however, numbers were almost identical, with little margin of error 
observed. 
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Fig. 5.1: Counts of viable cells over 9 hours of co-culture with three campylobacter 
strains (CCUG 34767, NWBO1 and NWBO2) with the cell line, OE19.  
Control, uninfected (black). 
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Fig. 5.2: Counts of viable cells over 9 hours of co-culture with three campylobacter 
strains (CCUG 34767, NWBO1 and NWBO2) with the cell line, FLO-1.  
Control, uninfected (black). 
 
 
Following these two initial experiments, FLO-1, CP-A, CP-B and CP-D cell lines were 
exposed to NWBO1. All four experiments show that as invasion of bacteria increased, 
cell viability was reduced, being almost completely apoptosed by 24 hours (Figs. 5.3 to 
5.6). CP-A and CP-D assays were carried out at a later date than FLO-1 and CP-B, with 
samples only taken at 24 hours, compared with 3, 6, 9, 12 and 24 hours.  
 
Co-culture of NWBO1 with CP-B Barrett’s oesophageal cells (Fig. 5.4) revealed a 
sudden reduction in cell viability from 1.8 x 105 to 4.1 x 104 cells in the initial 6 hours, 
decreasing towards zero by 24 hours. Interestingly, no bacteria were found to invade 
within the first 3 hours, dramatically increasing to ca. 3000 CFU ml-1 by 6 hours, in 
conjunction with this rapid cell death (Fig. 5.4). However, after 6 hours, bacterial CFU 
decreased, possibly due to a diminishing number of cells for invasion. FLO-1 cells also 
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showed a rapid decrease in viability, especially in the first 3 hours. For FLO-1 and CP-B 
assays, levels of bacterial CFU were undetectable at 24 hours, with further dilution 
plates required.  
 
CP-A and CP-D cells required little invasion of Campylobacter concisus for apoptosis, 
with 100-200 CFU ml-1 detected after 12 hours of exposure, compared with 4000 CFU 
ml-1 in FLO-1 cells. CP-D cells had a 63% survival rate compared with 12-14% in FLO-
1, CP-A and CP-B cells.  
 
In FLO-1 cells, C. concisus NWBO1 led to an increased abundance of p53 protein, 
while the opposite was observed in the Barrett’s oesophagus cell line, CP-A (Figs. 5.16 
and 5.17, columns 1, 2, 5 and 6). Taken with the results of β-actin in FLO-1, where cell 
density was higher in the control sample (Fig. 5.13), this increased expression after 
exposure was presumably more striking. Western blot analysis showed that CP-A is 
devoid of COX-2 protein. Interestingly, CP-B and CP-D had a large reduction in COX-2 
abundance, in contrast to a dramatic increase in FLO-1 cells (Figs. 5.14 and 5.15).  
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Fig. 5.3: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture 
with Campylobacter concisus NWBO1, isolated from a GORD patient (Chapter 2) 
with the cell line, FLO-1. Control, uninfected (black). 
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Fig. 5.4: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture 
with Campylobacter concisus NWBO1, isolated from a GORD patient (Chapter 2) 
with the cell line, CP-B. Control, uninfected (black). 
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Fig. 5.5: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture 
with Campylobacter concisus NWBO1, isolated from a GORD patient (Chapter 2) 
with the cell line, CP-A. Control, uninfected (black). 
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Fig. 5.6: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture 
with Campylobacter concisus NWBO1, isolated from a GORD patient (Chapter 2) 
with the cell line, CP-D. Control, uninfected (black). 
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Fig. 5.7 shows campylobacters adhering to the surface of cells in small aggregates with 
an area of cell deterioration where bacteria appear to be invading.  
 
Fig. 5.7: Image of Campylobacter concisus, NWBO1, co-cultured with CP-B, highly dysplastic 
Barrett’s cells. Black arrows show two areas of invasion, with aggregates of thin curved rods at 
the surface of cells, and an area of cell disruption and degradation. Eukaryotic and bacterial 
cells were stained with carbol fuchsin. 
 
5.3.2 Co-culture with oesophageal chemostat biofilms 
Figures 5.8 and 5.9 give the results for the first chemostat run, with OE21 cells (Fig. 
5.9) being most effectively invaded and apoptosed compared with FLO-1 cells. 
However, by 12 hours, although bacterial CFU was considerably lower for FLO-1 cells 
(10,000 vs. 250,000 CFU ml-1), similar live eukaryotic cells were collected. Therefore, 
although these columnar cells may be more resilient to bacterial invasion, compared 
with their squamous counterpart, a lower infection level was required to initiate 
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apoptosis, with no living cells detected by 24 hours. At this time point, OE21 cells had a 
bacterial count of 1 x 106 CFU ml-1, thus, in the first 9 hours bacterial quantity was 
undetectable on this scale (20,000 CFU ml-1). 
 
Figures 5.10 and 5.11 show results of co-culture with CP-D and FLO-1 cells 
respectively, in the second chemostat experiment. At 6 hours, FLO-1 cells had a lower 
internal CFU ml-1 than CP-D, both with control and exposed biofilms. At this time 
point, there was a 28% survival rate in CP-D compared with 70% in FLO-1 cells, while 
in the exposed biofilm assay survival was 12% vs. 58%, respectively. By 12 hours, 
control bacteria had invaded to similar CFU ml-1 in both cell lines, while the exposed 
biofilms had a much greater infection level, most predominantly in FLO-1 cells. By 12 
hours, all cells were dead, regardless of treatment; however, CP-D cells underwent 
apoptosis more readily. Results show that in both co-culture experiments, the exposed 
biofilm had greater ability to invade and cause cell death. Images of cells adhered to 
coverslips were taken using propidium iodide dead stain. Fig. 5.12 shows FLO-1 and 
OE21 cells at 3 (A, B) and 12 (C, D) hours, respectively. Bacterial cells are difficult to 
distinguish as eukaryotic cells were also stained with the dye.  
 
No p53 or COX-2 protein was detected for CP-D cells exposed to chemostat samples. 
Conversely, expression of both p53 and COX-2 proteins was dramatically increased in 
FLO-1 cells (Figs. 5.15 and 5.17, columns 9 and 11) after 6 hours, especially after 
exposure to the bile acid stressed biofilm.  
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Fig. 5.8: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture with a 
biofilm community removed from the initial oesophageal chemostat with the cell line, FLO-1. 
Control, uninfected (black). 
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Fig. 5.9: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture with a 
biofilm community removed from the initial oesophageal chemostat with the cell line, OE21. 
Control, uninfected (black). 
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Fig. 5.10: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture with a 
biofilm community removed from the second oesophageal chemostat with the cell line, CP-D. 
Control, uninfected (black). 
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Fig. 5.11: Counts of viable cells and bacterial CFU ml-1 over 24 hours of co-culture with a 
biofilm community removed from the second oesophageal chemostat with the cell line, FLO-1. 
Control, uninfected (black). 
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5.3.3 Western blot and immunohistochemistry analysis 
Duplicate cell samples were taken from co-culture experiments for western blot analysis 
of p53, p21 and COX-2. Due to the small number of cells in each sample, these 
duplicates were pooled for improved analysis. Firstly, β-actin antibodies were utilized to 
confirm presence of cells; results are shown in Fig. 5.13. These blots confirm that after 
12 hours of exposure to biofilms from the second chemostat run, all oesophageal cells 
were dead (Fig. 5.13, lanes J and M), while no β-actin was detected from CP-D cells 
exposed to chemostat biofilms (data not shown). Image J software allowed quantitative 
analysis of each band for COX-2 (Figs. 5.14 and 5.15) and p53 (Figs. 5.16 and 5.17) 
blots, with each cell line and environment grouped together (Figs. 5.15 and 5.17, 
columns 1-13).  
 
Immunohistochemical analysis of Ki-67 did not yield any results, with changes in 
protein expression only seen between different cell lines, with no change after co-culture 
(data not show).  
 
 
 
 
 
Fig. 5.13: Blots of β-actin (42 kDa) for cells co-cultured with Campylobacter concisus and 
chemostat biofilms. A and C are FLO-1 with NWBO1, 24 hours and control, respectively. B and 
D are CP-B with NWBO1, 24 hours and control, respectively. E and F are CP-A with NWBO1, 
24 hours and control, respectively. G and H are CP-D with NWBO1, 24 hours and control, 
respectively. I, J, K, L and M are FLO-1 cells: 6 and 12 hour control, negative, and 6 and 12 
hour exposed biofilms, respectively. N is a positive β-actin control. 
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Fig. 5.14: Blots of COX-2 (72 kDa) for cells co-cultured with Campylobacter concisus and 
chemostat biofilms. A and C are FLO-1 cells with NWBO1, 24 hours and control, respectively. 
B and D are CP-B with NWBO1, 24 hours and control, respectively. E and F are CP-A with 
NWBO1, 24 hours and control, respectively. G and H are CP-D with NWBO1, 24 hours and 
control, respectively. I, J, L, M are FLO-1 cells: 6 and 12 hour control and 
exposed biofilm, respectively. 
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Fig. 5.15: Graph for intensity of bands in COX-2 blots, for cells co-cultured with 
Campylobacter concisus and chemostat biofilms. FLO-1, CP-B, CP-A and CP-D cell lines after 
24 hours of exposure to NWBO1 and a control, columns 1-8 respectively. FLO-1 cells: 6 and 12 
hour control (9, 10), exposed biofilm (11, 12), and control (13). 
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Fig. 5.16: Blots of p53(53 kDa) for cells co-cultured with Campylobacter concisus and 
chemostat biofilms. See legend to Fig. 5.14 for details of samples and conditions. 
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Fig. 5.17: Graphs for intensity of bands in p53 blots, for cells co-cultured with Campylobacter 
concisus and chemostat biofilms. See legend to Fig. 5.15 for details of samples and conditions. 
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5.4 Discussion 
Work outlined in this chapter was designed to be an initial investigation of the effects of 
oesophageal communities on host epithelia in vitro. Despite time constraints and a lack 
of sample data, these results highlight a number of interesting observations, which, with 
future research, could help elucidate this Barrett’s oesophagus conundrum: are specific 
bacteria or alterations in the whole microbiome involved in ADC development, or a 
consequence of changes in cellular morphology and exposure to gastric secretions?  
 
A range of oesophageal cell lines were employed in these experiments to determine 
changes in individual cell type responses when in co-culture, however, every experiment 
was not carried out with all cell lines. If this research were pursued, then understanding 
the effects of bacteria on varying cell types, with a range of host and genetic response 
mechanisms would be invaluable. Additionally, there is a non-cancerous oesophageal 
cell line, HET-1A (Stoner et al., 1991), which would allow full analysis of the variation 
in host response to infection with cell transformation.  
 
There were dramatic variations in response to both campylobacter and multi-species 
biofilms between eukaryotic cell types. When exposed to C. concisus alone, CP-D 
required little invasion compared with FLO-1 to allow apoptosis, although survival was 
63% vs. 14% at 24 hours respectively. Conversely, when co-cultured with a multi-
species biofilm, invasion level at 6 hours was similar for both, with a cell survival of 
28% in CP-D compared with 70% in FLO-1. This suggests resistance to invasion and an 
improved host response to damage by the highly dysplastic cell line, CP-D, when 
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exposed to Campylobacter concisus. Biofilm assays suggest that this cell type could not 
survive invasion of multiple species leading to rapid cell death. The composition of this 
biofilm is unknown. However, if campylobacter species were present, in combination 
with other potential pathogens such as fusobacteria and capnocytophaga, virulence 
potential could be amplified giving credence to the polymicrobial disease theory. 
Campylobacter exerted varied effects on all BO and HGD cell lines (CP-A, -B and –D). 
These three Barrett’s cell forms have distinct karyotypes, with a number of 
abnormalities (Palanca-Wessels et al., 2003). CP-A was isolated from a BO patient, with 
no HGD, LOH or p53 mutation, in contrast to CP-B and CP-D. When exposed to 
campylobacter, CP-A had reduced expression of p53, which, dependant on PCNA status 
(proliferating cell nuclear antigen) could lead to continued replication of DNA, cell 
proliferation, and consequently, ADC.  
 
PCNA is a protein involved in DNA replication and repair. In response to DNA damage, 
p53 interacts with a number of proteins, such as MDM2, to determine cell fate. With 
increased expression of p53, its associated binding to PCNA results in DNA repair. 
However, if PCNA has a low abundance, is non-functional or inactivated, apoptosis 
occurs. Therefore, the PCNA status of these cell lines may account for the differences in 
response, where an increased p53 production in the presence of PCNA can result in 
continued survival of the cell due to DNA repair (Paunesku et al., 2001). It is possible 
that PCNA is present in higher quantities in FLO-1, while in the Barrett’s cell lines, both 
PCNA and p53 have a low abundance or are mutated. Hritz et al. (2009) measured the 
expression of both p53 and PCNA in BO, revealing a progressive and correlated 
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increase with malignant transformation. Hence, future studies may gain further 
understanding of the effects of bacterial stress on oesophageal cells through 
measurement of PCNA abundance using immunohistochemistry. The progression of 
chronic gastritis through the metaplasia-dysplasia sequence to cancer is associated with 
an accumulation of mutant p53 protein (Shiao et al., 1994). A study by Kodama et al. 
(2007) found that mutant p53 is increasingly expressed in the presence of H. pylori 
during gastric carcinogenesis, with a reduced abundance on eradication. In the present 
study, the antibody, DO1, was utilised to measure wild-type p53, however, future 
studies would benefit from assessment of mutant p53 presence after co-culture with 
oesophageal bacteria.  
 
This study would benefit from further work, such as the repetition of experiments to 
confirm the data. Further analysis of both immunological and genetic responses to 
oesophageal communities, in particular, NF-kappa B, PCNA, Bcl-2, and mutant p53, 
may reveal the importance of biofilm composition on disease progression. Data suggests 
that oesophageal cells have varying susceptibilities to bacteria, with cell type and 
genetics influencing the microbiomes invasive and aetiologic abilities. Additionally, 
results from co-culture of chemostat biofilms imply that bacteria complexed into a 
biofilm have increased pathogenicity, especially after exposure to bile acid, related to 
increased p53 and COX-2 expression. Further research into the virulence potential of 
oesophageal bacteria, specifically campylobacters, both with and without bile acid 
stress, may provide insight into the varied cellular responses involved in malignant 
transformation.  
  
 
Chapter 6 
 
General Discussion 
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6.1 Introduction 
Oesophageal adenocarcinoma is becoming increasingly diagnosed, being the ninth 
most prevalent cancer in the UK, with a gender preference to males. Due to its high 
mortality rate, this disease is now the sixth most common cause of cancer death in 
the UK (CRUK, 2010). Human intestinal microorganisms play an essential role in 
the maintenance of health, with their ecology and metabolism being influenced by 
changes in host environmental conditions. Bacteria are associated with a number of 
cancers (Section 1.4.1), with H. pylori involvement in gastric cancer providing a 
paradigm for comparisons with oesophageal adenocarcinoma. This study 
demonstrated an association between changes in oesophageal microbiota 
composition and the presence of campylobacters, with progression of oesophageal 
disease. However, causality could not be elucidated, therefore, the “chicken or egg” 
question remains: does an individual’s microbiota initiate disease, or does reflux 
result in microbial shifts, possibly leading to disease maintenance, and progression to 
malignancy? 
 
Work presented in this thesis details cultural and molecular analyses of a large 
cohort of patients with GORD, BO and ADC, comparing their microbial profiles 
with those of normal healthy subjects. Development of a model oesophageal 
community provided information on biofilm composition and the effects of bile and 
acid refluxate on both the microbiota and its associated oesophageal epithelial 
response. Improved understanding of the oesophageal microbiome and its 
involvement in ADC development will allow better treatment regimes to be 
developed, with a possible role for probiotics and prebiotics to beneficially alter 
community structure, and therefore, gut health.  
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6.2 Oesophageal communities in the progression to adenocarcinoma 
Clinical studies (Chapters 2 and 3) indicate that as the oesophagus becomes 
increasingly damaged by reflux, mucosal populations are affected. As disease 
progresses down the metaplastic-dysplastic sequence from GORD, the microbiota 
becomes increasingly varied and Gram negative. The phyla and genera identified in 
GORD and BO match those from previous studies using PCR clone libraries (Pei et 
al., 2004, 2005; Yang et al., 2009), with genera representing Firmicutes, 
Actinobacteria, Proteobacteria, Fusobacteria and Bacteroidetes. Advancing from 
these initial studies into Barrett’s oesophagus, tissues were collected from patients 
with adenocarcinoma. Traditional culture identified 23 genera and 73 species in 
ADC compared with 19 genera and 56 species in controls. Adenocarcinoma patients 
had a continually more diverse population represented by an increase in Gram 
negative species such as campylobacters and fusobacteria, and Gram positive 
organisms such as Actinomyces, Lactobacillus and Peptostreptococcus. Molecular 
studies using real-time PCR permitted a greater number of samples to be analysed, 
however, only a selection of bacterial assays were designed. Data from this part of 
the study found a significant reduction in fusobacteria, bifidobacteria, veillonella and 
H. pylori.  
 
Results from Macfarlane et al. (2007) found C. concisus in 57% of BO patients, in 
this study 75%, 50% and 60% of GORD, BO and ADC patients respectively, were 
found to have these viable organisms (51%, 42%, and 8% respectively, using 
molecular techniques (Chapter 3)). Cultural analysis identified C. concisus as the 
main species found, most often in complex with other campylobacters and a range of 
other Gram negative species such as leptotrichias, arcobacters and fusobacteria. 
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Additionally, results from both analytical approaches identified diminished 
colonisation by fusobacteria, mostly in GORD patients. As discussed throughout this 
dissertation, mucosal populations and their community dynamics are essential for 
maintenance of health. Fusobacteria are an integral component of oral biofilms, 
being a bridge organism for aggregation of species such as veillonella. The theory of 
a whole shift in the microbiome (type I and II) in oesophageal health and disease 
(Yang et al., 2009) fits with data presented in this study. Discrepancies exist between 
these two studies, most markedly for streptococci, although both identified a more 
varied, anaerobic and Gram negative microbial status in disease. The reduction of 
both streptococci and fusobacteria in GORD patients would alter the community 
dynamic, with opportunity for other species to colonise. Campylobacter, an 
opportunistic pathogen, is proposed in Chapter 2, to form a complex with a range of 
potential pathogens, which could enhance overall pathogenicity, explicated by the 
polymicrobial disease theory, similar to that of the oral “Red Complex” involving 
treponema and porphyromonas (Socransky et al., 1998). Interestingly, a recent 
mouse model study identified a sexual dimorphism in C. jejuni, with increased 
colonisation of this organism in male mice (Strachan et al., 2008). A study into the 
prevalence of ADC in North America, Europe and Australia since 1960, analysed all 
data with a unified exponential growth model, finding that rates of oesophageal ADC 
in males are increasing, most prominently in the UK (Bollschweiler et al., 2001). 
Therefore, campylobacters, possibly in an aggregated complex, may by a factor in 
malignancy. 
 
In diseased tissue, levels of bifidobacteria, staphylococci, bacteroides, veillonella 
and H. pylori were reduced compared with a control tissue from the same individual, 
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with levels of H. pylori being significantly lower in all disease patients compared 
with healthy controls. A reduction in Bacteroidetes has recently been associated with 
obesity (Wexler, 2007), which is a common predisposition to oesophageal disease. 
While the loss of H. pylori from the oesophagus in disease, and furthermore, in 
tumourous tissue, gives credence to the hypothesis of protection by this species 
(Lochhead and El-Olmar, 2008; Atherton, 2008).  
 
6.3 In vitro models of the oesophageal microbiota 
A two-stage continuous culture system was developed to establish populations 
representative of those found in the mouth, which would consequently lead to the 
development of diverse and unique communities similar to those of the oesophagus. 
Initial microbiological results indicated that this attempt was successful with two 
distinct communities generated, supporting the theory of oesophageal colonisation 
from the oral cavity. After exposure of these oesophageal model biofilms to bile acid 
cocktail, a shift in composition was identified, with a reduced total CFU composed 
of a greater variety of species. Additionally, as seen clinically in oesophageal 
disease, these populations had a greater proportion of Gram negative species. When 
exposed to oesophageal cell lines, these stressed communities resulted in a more 
rapid invasion, and consequently, cell death, compared with those not exposed to 
refluxate. This observation is most likely due to an increased haemolytic activity, 
with exposed biofilms expressing higher levels of haemolysin. Furthermore, these 
stressed communities had increased expression of mucinolytic enzymes, which, if 
representative of the situation in vivo would lead to increased invasion potential, 
inflammation and possibly tumour development, through recruitment of cytokines 
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and upregulation of genes for COX-2 protein (Macarthur et al., 2004), as seen with 
FLO-1 cells (Figs. 5.15 and 5.17).   
 
6.4 Main conclusions 
There is growing evidence that prior and chronic bacterial infections are linked to 
tumour formation, although the molecular mechanisms involved remain to be 
elucidated. These results imply that as cell morphology changes the colonisation 
potential of bacteria is altered, with a resulting shift in the microbiota, yet this is only 
one explanation. It is also possible that an individual’s microbiome determines their 
cellular response to refluxate, with opportunistic pathogens increasing their virulence 
potential under adverse conditions, leading to chronic inflammation and tumour 
formation.  
 
There are a number of possible mechanisms attributable to bacterial involvement, the 
first being inflammation due to induction of the immune response. While 
interference with the cell cycle and its associated signalling pathways, such as TNF-
α, Bcl-2 and COX-2, would also result in continued tumour survival and invasion 
(Lax and Thomas, 2002). Finally, bacteria may metabolise potentially carcinogenic 
compounds. Oral squamous cell carcinoma is associated with alcohol consumption, 
as it is proposed that bacterial metabolism of ethanol to acetaldehyde results in DNA 
damage and mutagenesis (Hooper et al., 2006). In the case of oesophageal 
adenocarcinoma, the presence of gastric acid in the distal oesophagus may amplify 
the production of NO from dietary nitrate by mucosal populations, specifically the 
nitrate-reducing Campylobacter species. Additionally, presence of the saccharolytic 
bacteria, lactobacillus, was increased in disease, this species can produce SCFA from 
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carbohydrates, further increasing the environmental acidity. This species was 
isolated from oral tumour sites (Hooper et al., 2006), and may also be involved in 
oesophageal ADC, either due to epithelial damage, or modification of the mucosal 
populations due to selection of acid tolerant species.  
 
It was hypothesised that in ADC, microbial composition would vary, becoming more 
diverse and Gram negative, with a possible key role for campylobacters. Data 
suggests that this is correct, however, the role of campylobacter cannot be fully 
understood without further mechanistic studies. It seems most likely that reflux 
disease due to host characteristics disrupts the microbiome composition, rather than 
individual mucosal populations initiating disease, with further exacerbation by 
refluxate. As bile and acid are exposed to the distal oesophagus, mucosal populations 
may be affected, with only tolerant species surviving. Additionally, opportunistic 
pathogens may thrive, with bile salts enhancing the expression of virulence proteins 
in these organisms (Malik-Kale et al., 2008), resulting in induction of the immune 
response, inflammation and malignant transformation. However, the other possibility 
of bacterial initiation should not be discounted without further research into the 
associations of H. pylori with the commensal oesophageal community. Additionally, 
research is essential to better understand the prevalence and virulence status of C. 
concisus, the associated effects of refluxate exposure, and inter-individual variations 
in the host microbiome.  
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6.5 Future work 
This study represents a preliminary investigation of bacterial colonisation in the 
malignant oesophagus, with much still to be learned about the host microbiota and 
its mechanisms in disease. If further research was pursued, there are a number of 
avenues that could be taken: 
 
1. To further understand the effect of changes in cell morphology on biofilm 
composition, further tissue samples need to be collected from GORD, BO and 
ADC patients, with matched control squamous tissues. This would allow 
determination of the changes in microbiota composition, and also the associated 
immune and oncogenic response with malignancy.  
 
2. Understanding of bacterial involvement in disease initiation or maintenance 
would benefit from a long-term study with “at risk” patients from the start of the 
disease sequence. Removal of oesophageal tissues periodically, at both the 
diseased, and a control site in each patient, for investigation of the microbiota, 
may reveal a single or complexed aetiologic agent. These investigations would 
provide full information on the shifts in microbial composition over time, in both 
patients who do, and do not, progress to adenocarcinoma. A follow on clinical 
trial with probiotics, or a synbiotic containing Bifidobacterium, in conjunction 
with microbial, histological and genetic analysis may provide insight into 
mechanisms of disease and possible treatments.  
 
3. Full genetic analysis of campylobacter species, and other potential aetiologic 
agents, would provide insight into the presence of pathogenicity islands, and 
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other sources of virulence genes. Continuous and batch cultures of these 
organisms with various bile salts and acids, before repeated genetic sequencing, 
may highlight the stress response in these organisms, with possible upregulation 
of haemolysins, toxins and flagellins, representative of virulence potential.  
 
4.  Results from cell culture experiments (Chapter 5), suggest that bacteria play an 
important role in oesophageal disease. Therefore, a full investigation with a 
range of oesophageal cells, both immortalised and primary, with individual 
agents and a full biofilm, may shed light on these important interactions. 
Additionally, exposure of these bacteria to refluxate would provide a better 
understanding of host physiology and microbiome ecology in reflux disease.  
Finally, these co-cultured cells could undergo genetic and proteomic analysis to 
measure effects of single and multiple species, before and after stress, and the 
effects of treatment with commensal and probiotic bacteria. Measurement of a 
range of oncogenes, immune and stress response proteins, cell-cycle regulators 
and transcription factors involved in progression of GORD to ADC, should be 
investigated. 
 
5. If, with extensive research, it is proven that bacteria have an important role to 
play in oesophageal pathogenesis, animal models could be developed. It would 
be of great interest to infect these models with oesophageal cultures from 
patients with GORD, BO and ADC, to observe whether inflammation and 
tumourigenesis could be initiated.  
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